<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">105776</article-id><article-id pub-id-type="doi">10.7554/eLife.105776</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Short activation domains control chromatin association of transcription factors</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fan</surname><given-names>Vinson B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1688-7780</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Abidi</surname><given-names>Abrar A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Graham</surname><given-names>Thomas GW</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Darzacq</surname><given-names>Xavier</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2537-8395</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Staller</surname><given-names>Max V</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9094-5697</contrib-id><email>Mstaller@berkeley.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an7q238</institution-id><institution>Department of Molecular and Cell Biology, University of California</institution></institution-wrap><addr-line><named-content content-type="city">Berkeley</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00za53h95</institution-id><institution>Thomas C. Jenkins Department of Biophysics, Johns Hopkins University</institution></institution-wrap><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Biohub</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an7q238</institution-id><institution>Center for Computational Biology, University of California</institution></institution-wrap><addr-line><named-content content-type="city">Berkeley</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University Frankfurt</institution></institution-wrap><addr-line><named-content content-type="city">Frankfurt am Main</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University Frankfurt</institution></institution-wrap><addr-line><named-content content-type="city">Frankfurt am Main</named-content></addr-line><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="other" id="fn1"><label>†</label><p>Co-first author.</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>09</day><month>01</month><year>2026</year></pub-date><volume>15</volume><elocation-id>e105776</elocation-id><history><date date-type="received" iso-8601-date="2024-12-23"><day>23</day><month>12</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2025-11-20"><day>20</day><month>11</month><year>2025</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2024-12-22"><day>22</day><month>12</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.12.20.629816"/></event></pub-history><permissions><copyright-statement>© 2026, Fan et al</copyright-statement><copyright-year>2026</copyright-year><copyright-holder>Fan et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-105776-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-105776-figures-v1.pdf"/><abstract><p>Transcription factors regulate gene expression with DNA-binding domains (DBDs) and activation domains. Despite evidence to the contrary, DBDs are often assumed to be the primary mediators of transcription factor (TF) interactions with DNA and chromatin. Here, we used fast single-molecule tracking of transcription factors in living cells to show that short activation domains can control the fraction of molecules bound to chromatin. Stronger activation domains have higher bound fractions and longer residence times on chromatin. Furthermore, mutations that increase activation domain strength also increase chromatin binding. This trend was consistent in four different activation domains and their mutants. This effect further held for activation domains appended to three different structural classes of DBDs. Stronger activation domains with high chromatin-bound fractions also exhibited increased binding to the p300 coactivator in proximity-assisted photoactivation experiments. Genome-wide measurements indicate these activation domains primarily control the occupancy of binding rather than the genomic location. Taken together, these results demonstrate that very short activation domains play a major role in tethering transcription factors to chromatin.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>The human body is made up of about 200 different types of cells. Although all these cells contain the same genetic instructions in their DNA, each type performs specific functions. This is possible because different cells activate different sets of genes; for example, liver cells switch on genes specific to the liver, while blood cells turn on blood-specific genes.</p><p>Proteins known as transcription factors bind to DNA and activate specific genes, and they play a critical role in generating gene expression patterns that are unique to each cell type. Transcription factors are thought to be modular with two functional elements: DNA-binding domains that attach to genes, and activation domains that recruit the transcriptional machinery to switch on genes.</p><p>DNA-binding domains have traditionally been considered solely responsible for genome interaction. However, recent research indicates that short segments within the activation domain can also influence the transcription factors' affinity for DNA binding. To examine this, Fan et al. tracked individual transcription factor molecules in living cells and quantified the proportion bound to the genome.</p><p>The results confirmed that short activation domains play a major role in controlling the fraction of transcription factor molecules that bind to the genome. Strong activation domains – which interact robustly with coactivators or other components of the transcriptional machinery – increased the fraction of transcription-factor molecules bound to the genome. This effect was also achieved experimentally by strengthening otherwise regular activation domains through targeted mutation.</p><p>The study further demonstrated that activation domains tether transcription factors to the genome by binding to a coactivator already associated with chromatin, a protein that packages DNA into compact parcels. This binding may indirectly anchor the transcription factor to DNA even before its own DNA-binding domain engages.</p><p>Understanding how transcription factors bind the genome is essential for elucidating gene regulation. Traditional models assume that transcription factors first bind DNA through their DNA-binding domains and then use their activation domains to recruit the transcriptional machinery. The study of Fan et al. supports a model in which activation domains can instead bind coactivators that are already bound to DNA, tethering transcription factors indirectly to chromatin. These insights may ultimately deepen our understanding of gene regulation in development and disease.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>transcription</kwd><kwd>transcription factor</kwd><kwd>activation domain</kwd><kwd>single-molecule imaging</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>Simons Foundation</institution></institution-wrap></funding-source><award-id>1018719</award-id><principal-award-recipient><name><surname>Staller</surname><given-names>Max V</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35GM150813</award-id><principal-award-recipient><name><surname>Staller</surname><given-names>Max V</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>2112057</award-id><principal-award-recipient><name><surname>Staller</surname><given-names>Max V</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>1RM1GM139738</award-id><principal-award-recipient><name><surname>Graham</surname><given-names>Thomas GW</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>Silicon Valley Community Foundation</institution></institution-wrap></funding-source><award-id>RR-8175</award-id><principal-award-recipient><name><surname>Darzacq</surname><given-names>Xavier</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>Biohub, San Francisco</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Staller</surname><given-names>Max V</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Single-molecule tracking of transcription factors in living cells revealed how mutations that make short activation domains stronger increased the fraction of transcription factor molecules bound to chromatin and led to longer residence times on chromatin.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Transcription factors (TFs) contain DNA-binding domains (DBDs) that bind cognate DNA motifs and effector domains that regulate transcription (<xref ref-type="bibr" rid="bib8">Brent and Ptashne, 1985</xref>; <xref ref-type="bibr" rid="bib68">Keegan et al., 1986</xref>; <xref ref-type="bibr" rid="bib100">Ptashne, 1988</xref>; <xref ref-type="bibr" rid="bib120">Struhl, 1989</xref>; <xref ref-type="bibr" rid="bib119">Struhl, 1987</xref>). DBDs are ordered, conserved, and readily predicted from protein sequences (<xref ref-type="bibr" rid="bib29">El-Gebali et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Finn et al., 2016</xref>). Decades of biochemistry have shown that DBDs are sufficient to bind cognate DNA motifs in vitro (<xref ref-type="bibr" rid="bib102">Riley et al., 2014</xref>; <xref ref-type="bibr" rid="bib116">Stormo, 2013</xref>). As a result, for most human TFs, only the DBD was used to define the position weight matrices that describe DNA-binding specificity (<xref ref-type="bibr" rid="bib3">Badis et al., 2009</xref>; <xref ref-type="bibr" rid="bib62">Hume et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Jolma et al., 2013</xref>; <xref ref-type="bibr" rid="bib76">Latchman, 2008</xref>; <xref ref-type="bibr" rid="bib96">Noyes et al., 2008</xref>). Outside the DBD, TFs are predominantly composed of long intrinsically disordered regions (IDRs) that contain short repression domains, which bind corepressor complexes, and activation domains, which bind coactivators (<xref ref-type="bibr" rid="bib49">Hahn and Young, 2011</xref>; <xref ref-type="bibr" rid="bib80">Liu et al., 2006</xref>; <xref ref-type="bibr" rid="bib86">Már et al., 2023</xref>; <xref ref-type="bibr" rid="bib71">Kumar et al., 2023</xref>; <xref ref-type="bibr" rid="bib110">Soto et al., 2022</xref>). Activation domain function is separable from DBD function, as demonstrated by cut-and-paste experiments where activation domains retained function when attached to multiple DBDs (<xref ref-type="bibr" rid="bib61">Hope et al., 1988</xref>; <xref ref-type="bibr" rid="bib60">Hope and Struhl, 1986</xref>; <xref ref-type="bibr" rid="bib83">Ma and Ptashne, 1987</xref>; <xref ref-type="bibr" rid="bib103">Sadowski et al., 1988</xref>; <xref ref-type="bibr" rid="bib108">Sigler, 1988</xref>; <xref ref-type="bibr" rid="bib121">Struhl, 1993</xref>, <xref ref-type="bibr" rid="bib119">Struhl, 1987</xref>).</p><p>Both DBDs and activation domains contribute to DNA binding and chromatin binding. DNA binding results from direct protein-DNA interaction is well established for DBDs in vitro and is measured in vivo with single-molecule footprinting (<xref ref-type="bibr" rid="bib26">Doughty et al., 2024</xref>; <xref ref-type="bibr" rid="bib116">Stormo, 2013</xref>). Chromatin binding includes DNA binding but can also result from protein-protein interactions with histones, other TFs, corepressors, or coactivators that can indirectly tether a TF to DNA (<xref ref-type="bibr" rid="bib111">Spitz and Furlong, 2012</xref>). Nearly all cell-based assays of TF genome localization (e.g. ChIP-seq or CUT&amp;RUN) measure the combination of DNA binding and chromatin binding. Some activation domains interfere with DNA binding (<xref ref-type="bibr" rid="bib44">Golemis and Brent, 1992</xref>). In vitro, interactions between activation domains and DBDs can increase DNA-binding specificity (<xref ref-type="bibr" rid="bib69">Krois et al., 2018</xref>; <xref ref-type="bibr" rid="bib81">Liu et al., 2008</xref>; <xref ref-type="bibr" rid="bib94">Ning et al., 2022</xref>; <xref ref-type="bibr" rid="bib122">Sun et al., 2021</xref>). IDRs can increase nonspecific binding (<xref ref-type="bibr" rid="bib4">Baughman et al., 2022</xref>), regulate DNA binding via posttranslational modifications (<xref ref-type="bibr" rid="bib101">Pufall et al., 2005</xref>), or allosterically regulate DNA binding (<xref ref-type="bibr" rid="bib78">Li et al., 2017</xref>). There is long-standing evidence that the DBD does not confer all genomic targeting information because in ChIP-seq experiments, 30–70% of peaks lack a motif for the query TF (<xref ref-type="bibr" rid="bib51">Harrison et al., 2011</xref>; <xref ref-type="bibr" rid="bib64">Jana et al., 2021</xref>; <xref ref-type="bibr" rid="bib72">Kvon et al., 2012</xref>; <xref ref-type="bibr" rid="bib111">Spitz and Furlong, 2012</xref>; <xref ref-type="bibr" rid="bib124">Teytelman et al., 2013</xref>). There is also low agreement between the promoters a TF binds and the genes it regulates (<xref ref-type="bibr" rid="bib84">Mahendrawada et al., 2025</xref>). Finally, there is extensive literature demonstrating how long IDRs—and not DBDs—control TF genomic localization (<xref ref-type="bibr" rid="bib10">Brodsky et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">Gera et al., 2022</xref>; <xref ref-type="bibr" rid="bib63">Hurieva et al., 2024</xref>; <xref ref-type="bibr" rid="bib66">Jonas et al., 2023</xref>; <xref ref-type="bibr" rid="bib71">Kumar et al., 2023</xref>; <xref ref-type="bibr" rid="bib89">Mindel et al., 2024a</xref>; <xref ref-type="bibr" rid="bib90">Mindel et al., 2024b</xref>). These studies show that long IDRs are necessary and sufficient to localize TFs to target promoter genes; minimal activation domains were reported not to contribute (<xref ref-type="bibr" rid="bib10">Brodsky et al., 2020</xref>). Although the original data could not distinguish between direct DNA binding and chromatin binding via protein-protein interactions with DNA-bound factors (reviewed in <xref ref-type="bibr" rid="bib114">Staller, 2022a</xref>), recent studies suggest an IDR can bind DNA directly (<xref ref-type="bibr" rid="bib118">Strugo et al., 2025</xref>). This genomic targeting by IDRs has also been seen in human cells (<xref ref-type="bibr" rid="bib43">Goldman et al., 2023</xref>). These findings can explain why removing the DBD can increase the number of genomic binding sites detected by ChIP-seq (<xref ref-type="bibr" rid="bib13">Chen et al., 2014</xref>), have little effect on genome binding (<xref ref-type="bibr" rid="bib18">Cowling and Cole, 2007</xref>), or complement null mutants (<xref ref-type="bibr" rid="bib17">Copeland et al., 1996</xref>). We have shown that long IDRs control the fraction of TF molecules bound to chromatin for factors in the HIF family (<xref ref-type="bibr" rid="bib14">Chen et al., 2022</xref>). Other single-molecule imaging studies reported that IDRs impact nuclear diffusion but not genome binding (<xref ref-type="bibr" rid="bib12">Callegari et al., 2019</xref>; <xref ref-type="bibr" rid="bib87">Mazzocca et al., 2023</xref>). A single-molecule footprinting assay found that a strong activation domain can increase TF occupancy (<xref ref-type="bibr" rid="bib26">Doughty et al., 2024</xref>). Together, these studies demonstrate how long IDRs or activation domains modulate chromatin binding.</p><p>In this study, we asked whether short activation domains within an IDR are sufficient to control chromatin association. While both DBDs and activation domains contribute to DNA binding and chromatin binding, the relative magnitude of these contributions cannot be predicted and must be measured. Activation domains recruit remodelers, like BAF, which move nucleosomes (<xref ref-type="bibr" rid="bib67">Kadoch and Crabtree, 2015</xref>), coactivators, like p300/CBP, which modify chromatin (<xref ref-type="bibr" rid="bib25">DelRosso et al., 2024</xref>; <xref ref-type="bibr" rid="bib28">Dyson and Wright, 2016</xref>), and general transcription components like the Mediator complex (<xref ref-type="bibr" rid="bib20">Currie et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Henley et al., 2020</xref>; <xref ref-type="bibr" rid="bib77">Lauberth et al., 2013</xref>; <xref ref-type="bibr" rid="bib85">Malik and Roeder, 2010</xref>; <xref ref-type="bibr" rid="bib123">Tang et al., 2013</xref>) that recruits RNA polymerase II (<xref ref-type="bibr" rid="bib2">Alerasool et al., 2022</xref>; <xref ref-type="bibr" rid="bib41">Gill et al., 1994</xref>). Although mechanistic understanding of activation domains still lags far behind DBDs, recent screens have cataloged many activation domains (<xref ref-type="bibr" rid="bib24">DelRosso et al., 2023</xref>; <xref ref-type="bibr" rid="bib31">Erijman et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Morffy et al., 2024</xref>; <xref ref-type="bibr" rid="bib104">Sanborn et al., 2021</xref>) and shown how the strength of acidic activation domains, the oldest and largest class (<xref ref-type="bibr" rid="bib108">Sigler, 1988</xref>), depends on a balance of acidic, aromatic, and leucine residues (<xref ref-type="bibr" rid="bib24">DelRosso et al., 2023</xref>; <xref ref-type="bibr" rid="bib113">Staller et al., 2018</xref>; <xref ref-type="bibr" rid="bib115">Staller et al., 2022b</xref>; <xref ref-type="bibr" rid="bib127">Udupa et al., 2024</xref>). For consistency, we define activation domain strength as the fluorescence of a GFP reporter construct driven by a heterologous promoter.</p><p>Using single-molecule tracking (SMT) in live cells, we find that activation domains as short as 39–60 amino acids strongly affect the fraction of synthetic TF molecules bound to chromatin. TFs with a higher bound fraction have increased residence time on chromatin as measured by fluorescence recovery after photobleaching (FRAP). The chromatin-bound fraction and residence time of a series of activation domain mutants correlated with their ability to activate transcription. This effect was observed with activation domains attached to three structurally diverse DBDs, indicating that activation domains can control TF association with chromatin independent of DBD identity. Using pharmacological perturbations and proximity-assisted photoactivation (PAPA) experiments (<xref ref-type="bibr" rid="bib45">Graham et al., 2022</xref>), we demonstrate this chromatin association results from activation domains binding to coactivator complexes. CUT&amp;RUN experiments revealed all the synthetic TFs bound to overlapping sets of ATAC-seq accessible loci, suggesting that activation domains are binding to coactivators already engaged with chromatin. Stronger activation domains showed more binding to the same loci. These results suggest a key aspect of activation domain function could derive from increasing the ability of a TF to interact with chromatin.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>SMT of a synthetic TF</title><p>To test whether short activation domains are sufficient to control chromatin binding of TFs, we performed SMT on a synthetic factor. This synthetic TF was developed for high-throughput reporter studies of activation domain function (<xref ref-type="bibr" rid="bib115">Staller et al., 2022b</xref>) and contains an estrogen-binding domain for inducible activation and six synthetic C2H2 zinc fingers (<xref ref-type="bibr" rid="bib98">Park et al., 2019</xref>) engineered to bind to a DNA motif that is not found in the human genome. To facilitate SMT, we added a HaloTag for labeling with photostable synthetic dyes (<xref ref-type="bibr" rid="bib47">Grimm et al., 2021</xref>; <xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). At the N-terminus of this synthetic TF, we fused candidate activation domains and their rationally designed mutants. This synthetic TF is expressed from the weak L40 promoter and has low protein stability (<xref ref-type="bibr" rid="bib115">Staller et al., 2022b</xref>), resulting in low steady-state expression levels. We engineered the cognate reporter into the AAVS1 locus of U2OS cells and derived a monoclonal line to assay transcriptional activity by GFP expression (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, Materials and methods). This reporter locus is the only perfect motif match for the synthetic DBD in the genome. We stably integrated each synthetic TF into this cell line and verified that estradiol induction robustly induces GFP expression (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>A synthetic transcription factor (TF) for quantifying chromatin association and reporter activity.</title><p>(<bold>A</bold>) Schematic of the synthetic TF used in this study: activation domains (39–60 amino acids) are fused to HaloTag, an estrogen-binding domain, six synthetic C2H2 zinc fingers (ZF1), and a V5 epitope tag. Black line indicates linkers between domains. (<bold>B</bold>) AlphaFold2 model of the synthetic TF. (<bold>C</bold>) Schematic of the synthetic reporter locus (not to scale) installed at AAVS1. Four zinc-finger binding sites are engineered upstream of a minimal promoter, minCMV. These elements are upstream of GFP, which is produced in response to estradiol induction. (<bold>D</bold>) Overlay of GFP and phase-contrast images of reporter-bearing cells expressing VP16-synthetic TF at 0 hr (left) and 72 hr (right) after estradiol induction. Quantification of the percentage of GFP-positive cells over time from live imaging is shown in the right plot. (<bold>E</bold>) Left: Trajectories extracted from single-molecule tracking (SMT) movies from cells expressing two example proteins. Thousands of these trajectories are pooled to generate inferred diffusion spectra, right. Lower panel indicates the cumulative distribution function of the diffusion spectra. We consider the shaded gray region (D&lt;0.1 µm<sup>2</sup>/s) the chromatin-associated fraction of a protein.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig1-v1.tif"/></fig><p>We performed fast SMT on these synthetic TFs using highly inclined and laminated optical sheet (HILO) illumination at fast (~7.5 ms) frame rates (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="video" rid="video1">Video 1</xref>), localized and tracked single molecules, and a published Bayesian mixture model to infer the distribution of their diffusion coefficients (<xref ref-type="bibr" rid="bib53">Heckert et al., 2022</xref>). We define proteins with a diffusion coefficient D&lt;0.1 μm<sup>2</sup>/s as immobile and assume immobile molecules are bound to chromatin (<xref ref-type="bibr" rid="bib14">Chen et al., 2022</xref>; <xref ref-type="bibr" rid="bib37">Ferrie et al., 2024</xref>). Importantly, this chromatin association does not necessarily indicate direct binding to DNA but could include interactions with factors directly bound to DNA. Molecules with higher diffusion coefficients are untethered and are likely freely diffusing or diffusing in complex with other factors (<xref ref-type="bibr" rid="bib36">Ferrie et al., 2022</xref>; <xref ref-type="bibr" rid="bib114">Staller, 2022a</xref>). In this work, we focus on the fraction of immobile molecules bound to chromatin.</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-105776-video1.mp4" id="video1"><label>Video 1.</label><caption><title>Exemplary single-molecule tracking (SMT) movie of a cell expressing VP16-synthetic transcription factor (TF).</title><p>SMT movie shown in real time of a cell expressing VP16-synthetic TF. Trajectories overlaid and colored according to their mean jump length, where brighter-colored spots belong to faster-moving trajectories. Initially, frames are dense with detections and are rejected for analysis. Detections outside a curated nuclear mask are also rejected.</p></caption></media></sec><sec id="s2-2"><title>Short activation domains control the fraction of TF molecules bound to chromatin</title><p>Given the evidence that long IDRs can control the fraction of molecules bound to chromatin, we tested the hypothesis that minimal activation domains can also contribute to this phenotype. In previous examples, the IDRs that controlled the bound fraction were the majority of the protein (<xref ref-type="bibr" rid="bib14">Chen et al., 2022</xref>). Here, our synthetic TF is ~800 AAs and the activation domain is 39–60 residues on the N-terminus.</p><p>Despite comprising only 5–7% of the total polypeptide sequence, these short activation domains dominated the chromatin-bound fraction of our synthetic TF. Three acidic activation domains derived from VP16, CITED2, and HIF1α each yielded different bound fractions and diffusion spectra (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). These differences were also apparent in jump-length histograms and generally agreed with parameters modeled from Spot-On (<xref ref-type="bibr" rid="bib50">Hansen et al., 2018</xref>; <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), independently validating this result. This bound fraction was positively correlated with GFP expression of the reporter locus measured by flow cytometry (<xref ref-type="fig" rid="fig2">Figure 2B and C</xref>), suggesting a link between the strength of activation domains and their propensity to associate with chromatin (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). The synthetic TF without an activation domain (hereafter the empty TF) also had a low (but not the lowest) fraction of molecules bound to chromatin.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Short activation domains are sufficient to control the fraction of transcription factor (TF) molecules bound to chromatin.</title><p>(<bold>A</bold>) Diffusion spectra (top) and cumulative distributions (bottom) of synthetic TFs bearing various activation domains. Numbers indicate the fraction of molecules with diffusion coefficients below 0.1 µm<sup>2</sup>/s (shaded region), which we infer to be chromatin-bound. (<bold>B</bold>) Flow cytometry measurements of cells bearing various activation domains after 24 hr of estradiol treatment. Distributions are shown in the top panel, where the dashed line is an arbitrary gate for GFP-positive cells. (<bold>C</bold>) Bar plot for mean fluorescence intensity (MFI), the geometric mean of GFP values for cells in the positive gate. (<bold>D</bold>) For each synthetic TF, the MFI of GFP+ cells is plotted against its bound fraction. Error bars indicate bootstrapping standard deviations of the bound fraction (Materials and methods). (<bold>E</bold>) HIF1α and CITED2 fluorescence recovery after photobleaching (FRAP) recoveries over time plotted as rolling means (solid lines). Curve fits to a double-exponential equation (Materials and methods) are shown in dashed lines.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Jump length histograms and Spot-On fits for two synthetic transcription factors (TFs).</title><p>(<bold>A</bold>) Jump-length histograms of CITED2-synthetic TF and HIF1α-synthetic TF over increasing frame intervals. (<bold>B</bold>) Graphical representation of three-state Spot-On fits to the jump-length histograms shown in (<bold>A</bold>). Height of the bars indicates population fraction, and position along the x-axis denotes the diffusion coefficient of the fit. Both fractions bound and diffusion coefficients are consistent with the analyses shown in the main text.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Analysis of a single-molecule tracking (SMT) dataset for sources of variance.</title><p>(<bold>A</bold>) Key statistics from one example SMT dataset for VP16. Each cell line was imaged on 2 days, and the data were combined for analyses. (<bold>B</bold>) Cell-wise mean posteriors from state array inference (Materials and methods, saspt). Each row represents the diffusion spectrum from one cell as a normalized heatmap. (<bold>C</bold>) Jump resampling experiment (Materials and methods), sampling 1–100,000 jumps from the whole dataset over 1000 bootstrapping replicates. Orange lines: medians; boxes: Q1-Q3; whiskers: Q1–1.5 IQR and Q3+1.5 IQR. (<bold>D</bold>) Variance of jumps from jump resampling experiment. Each point represents the variance of the 1000 bootstrapping replicates, sampled in three different ways (Materials and methods). (<bold>E</bold>) Minimum values from (<bold>D</bold>), summarizing sources of variance in this dataset. Cell-to-cell variability is about two orders of magnitude larger than day-to-day variability in this dataset.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>Diffusion spectra of activation domain-synthetic transcription factor (TF) constructs in WT U2OS cells.</title><p>WT U2OS cells without an integrated reporter locus were electroporated (Materials and methods) with plasmids carrying different activation domain-synthetic TF constructs and imaged. Diffusion spectra are shown as in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig2-figsupp3-v1.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>Fluorescence recovery after photobleaching (FRAP) curves for histone H2B, HIF1α-synthetic transcription factor (TF), and CITED2-synthetic TF.</title><p>(<bold>A</bold>) Aggregate FRAP recovery curves showing a rolling-mean average (black line) and fits to a single-exponential line in blue and double-exponential line in red (Materials and methods) for cells expressing H2B-HaloTag. (<bold>B</bold>) As in (<bold>A</bold>) for HIF1α-WT. (<bold>C</bold>) As in (<bold>A</bold>) for CITED2-WT. Single-exponential fits to synthetic TF recoveries were poor. (<bold>D</bold>) Normalized radial bleach profiles (Materials and methods) for cells expressing an H2B control. For the five frames immediately after the bleaching period, a radial profile centered at the bleach spot center is plotted and normalized between 0 and 1. The pixel size is 105.46875 nm. There are no obvious bleach spot shape changes as fluorescence recovers during photobleaching. (<bold>E</bold>) As in (<bold>D</bold>) for cells expressing HIF1α-WT synthetic TF. (<bold>F</bold>) As in (<bold>D</bold>) for cells expressing CITED2 AD synthetic TF.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig2-figsupp4-v1.tif"/></fig></fig-group><p>As previously reported (<xref ref-type="bibr" rid="bib27">Driouchi et al., 2025</xref>; <xref ref-type="bibr" rid="bib129">Walther et al., 2024</xref>), we find substantial cell-to-cell variability when making SMT measurements in these cell lines (<xref ref-type="fig" rid="fig2s2"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure 2—figure supplement </ext-link>2</xref>), which necessitated large datasets with many cells and trajectories for reporting reproducible diffusion spectra (Materials and methods; <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The difference in bound fractions also held when these synthetic TFs were transfected into cells without reporter loci (<xref ref-type="fig" rid="fig2s3"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure 2—figure supplement </ext-link>3</xref>), implying that the majority of immobile molecules bound nonspecifically to genomic sites without a match to the cognate motif.</p><p>SMT at fast frame rates provides snapshots of the diffusive states of these factors but cannot accurately determine how long a given factor remains bound. To complement this experiment, we measured TF residence time on chromatin with FRAP (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, <xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4</xref>). We fit our FRAP recovery curves to a double-exponential equation (Materials and methods, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, <xref ref-type="bibr" rid="bib93">Mueller et al., 2012</xref>). We found that the SMT-bound fraction correlated with FRAP recovery times, with stronger activation domains conferring longer dwell times (<xref ref-type="video" rid="video2">Videos 2</xref> and <xref ref-type="video" rid="video3">3</xref>). This recovery time difference is consistent with another synthetic system where strong activation domains have longer dwell time on chromatin (<xref ref-type="bibr" rid="bib126">Trojanowski et al., 2022</xref>). Together, these results indicate that stronger activation domains have a higher fraction of molecules bound to chromatin and that these molecules have longer residence times on chromatin.</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-105776-video2.mp4" id="video2"><label>Video 2.</label><caption><title>Exemplary fluorescence recovery after photobleaching (FRAP) movie of a cell expressing CITED2-synthetic transcription factor (TF).</title><p>FRAP movie, nuclear mask, photobleach spot mask, and an overlay of the movie and spot mask are shown above the normalized intensity of the FRAP recovery over time. Movies of many cells expressing CITED2-synthetic TF are aggregated and fit to generate a recovery curve, like that in <xref ref-type="fig" rid="fig2">Figure 2E</xref> (green).</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-105776-video3.mp4" id="video3"><label>Video 3.</label><caption><title>Exemplary fluorescence recovery after photobleaching (FRAP) movie of a cell expressing HIF1α-synthetic transcription factor (TF).</title><p>FRAP movie, nuclear mask, photobleach spot mask, and an overlay of the movie and spot mask are shown above the normalized intensity of the FRAP recovery over time. Movies of many cells expressing HIF1α-synthetic TF are aggregated and fit to generate a recovery curve, like that in <xref ref-type="fig" rid="fig2">Figure 2E</xref> (purple).</p></caption></media></sec><sec id="s2-3"><title>Mutations in activation domains modulate chromatin binding</title><p>Intrigued by the apparent correlation between activation domain strength and bound fraction, we investigated multiple allelic series of mutations that increased and decreased activity of our activation domains (<xref ref-type="bibr" rid="bib115">Staller et al., 2022b</xref>). We selected mutants that we have previously shown to have large effects on reporter gene activity and that change one to seven residues in each activation domain.</p><p>Within each allelic series, we saw a positive correlation between activation domain strength and bound fraction. Stronger activation domain mutants had higher bound fractions. These mutations change activity by perturbing different physicochemical parameters. For CITED2 (<xref ref-type="fig" rid="fig3"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure </ext-link>3A</xref>), two alleles that decrease activity, either by mutating key hydrophobic residues (motif mutation) or replacing all six leucines with phenylalanines (L&gt;F), decreased bound fraction. A CITED2 allele that neutralizes a single positive charge (K&gt;A) increased activity and increased bound fraction. For VP16, two alleles that abrogate activation domain activity, F442A (<xref ref-type="bibr" rid="bib19">Cress and Triezenberg, 1991</xref>) and 7As, both reduced the bound fraction (<xref ref-type="fig" rid="fig3"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure </ext-link>3B</xref>). In HIF1α, adding acidity by mutating three arginines to aspartates (R&gt;D) or two glutamines and one asparagine to glutamate (QN&gt;E) increased the fraction bound (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In the SREBP activation domain, removing aromatic and/or leucine residues decreased activity and decreased the bound fraction (<xref ref-type="fig" rid="fig3s1"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure 3—figure supplement </ext-link>1</xref>). We employed a bootstrapping approach to estimate error in SMT diffusion spectra (Materials and methods, <xref ref-type="fig" rid="fig3s2"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure 3—figure supplement </ext-link>2</xref>) and noted that this trend held within each allelic series and across the full set of mutants (<xref ref-type="fig" rid="fig3"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure </ext-link>3D</xref>). In individual cells, the bound fraction was not correlated with TF abundance (<xref ref-type="fig" rid="fig3s3"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure 3—figure supplement </ext-link>3</xref>) or the charge of the activation domain (<xref ref-type="fig" rid="fig3s4"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure 3—figure supplement </ext-link>4</xref>). Within each allelic series, stronger activation domain mutants had higher bound fractions, and weaker mutants had lower bound fractions.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Mutations in individual activation domains modulate the fraction of molecules bound to chromatin.</title><p>(<bold>A</bold>) The amino acid sequence of CITED2 and its mutant constructs is shown above their diffusion spectra and the cumulative distributions. Numbers indicate the fractions bound, the probability density in the shaded region of the diffusion spectra. (<bold>B</bold>) As in A for VP16. (<bold>C</bold>) As in A for HIF1α. (<bold>D</bold>) Summary of activation domain activity and chromatin-bound fractions. Mean fluorescence intensity of GFP+ cells plotted against bound fractions. Error bars indicate standard deviations of a cell-wise bootstrapping scheme (Materials and methods, <xref ref-type="fig" rid="fig3s2"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure 3—figure supplement </ext-link>2</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>An additional allelic series with cholesterol transcription factor (TF) SREBP’s activation domain.</title><p>(<bold>A</bold>) Top: Sequence of the WT SREBP activation domain appended to the synthetic TF, and alanine mutations for three mutants of the SREBP activation domain. Bottom: Diffusion spectra of cells expressing the labeled SREBP activation domain-synthetic TF constructs. (<bold>B</bold>) Flow cytometry distributions of GFP reporter expression in cells expressing various SREBP activation domains after 24 hr of estradiol induction. (<bold>C</bold>) Mean (geometric) fluorescence intensity of GFP-positive cells versus fraction bound for the SREBP constructs. Horizontal error bars denote standard deviation of bootstrapping replicates. Fraction bound correlates with mean fluorescence intensity in these four alleles.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Example outputs from a cell-wise bootstrapping scheme to estimate error in single-molecule tracking (SMT) diffusion spectra.</title><p>Left panels: Plots showing all 96 bootstrapping replicate spectra (Materials and methods) as individual lines. Right panels: Plots showing the mean of the bootstrapping replicates (solid lines), their standard deviations (dark gray shading), and their 95% confidence intervals (light gray shading). Numbers are the bootstrapping bound-fraction means and their standard deviations. (<bold>A</bold>) CITED2-WT; (<bold>B</bold>) CITED2-motif mut; (<bold>C</bold>) CITED2-L&gt;F; (<bold>D</bold>) CITED2-K&gt;A.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig3-figsupp2-v1.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Cell-wise relationships between chromatin-bound fraction, transcription factor (TF) expression, and reporter output.</title><p>(<bold>A</bold>–<bold>D</bold>) Scatterplots of fraction bound measured by single-molecule tracking (SMT) versus TF abundance, mean intensity in the HaloTag-ligand dye channel. Each point represents data from a single cell and is colored according to the legends. There is no obvious relationship between TF abundance and fraction bound on a cell or population level. (<bold>E</bold>–<bold>H</bold>) Scatterplots of mean intensity in the GFP channel versus fraction bound. Each point represents data from a single cell plotted on the same axes and colored according to the legends in the upper right. Cell lines expressing synthetic TFs adopt different distributions for both fraction bound and reporter expression, but neither parameter predicts the other in individual cells.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig3-figsupp3-v1.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>Activation domain net charge and fractions bound for constructs in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</title><p>Net activation domain charges are defined as the number of K and R residues minus the number of D and E residues. Net charges are plotted against fractions bound for each activator, as in <xref ref-type="fig" rid="fig3">Figure 3</xref>. There is no obvious relationship between net charge and bound fraction.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig3-figsupp4-v1.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>Mutations in activation domains change reporter activity and fluorescence recovery after photobleaching (FRAP) recovery.</title><p>(<bold>A</bold>) Flow cytometry measurement of GFP reporter expression after 24 hr of estradiol induction for cells expressing CITED2 alleles appended to the synthetic transcription factor (TF). The CITED2-WT curve is repeated from <xref ref-type="fig" rid="fig2">Figure 2B</xref>. (<bold>B</bold>) As in (<bold>A</bold>) for VP16 alleles. The VP16-WT curve is repeated from <xref ref-type="fig" rid="fig2">Figure 2B</xref>. (<bold>C</bold>) As in (<bold>A</bold>) for HIF1α alleles. The HIF1α-WT curve is repeated from <xref ref-type="fig" rid="fig2">Figure 2B</xref>. (<bold>D</bold>) Aggregate FRAP recovery curves (rolling averages, solid lines) for HIF1α and superactive allele of HIF1α (QN&gt;E). Double-exponential fits are plotted as dashed lines. HIF1α-WT FRAP curve also appears in <xref ref-type="fig" rid="fig2">Figure 2D</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig3-figsupp5-v1.tif"/></fig></fig-group><p>Furthermore, for HIF1α, the QN&gt;E allele had slower FRAP recovery, indicating a longer residence time on chromatin (<xref ref-type="fig" rid="fig3s5"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure 3—figure supplement </ext-link>5D</xref>). These data support the idea that strong activation domains increase the fraction of TF molecules bound to chromatin and extend the duration of their binding.</p></sec><sec id="s2-4"><title>Activation domains control chromatin binding of a second DBD</title><p>We next tested whether the observed relationship between activation domain strength and bound fraction depends on the DBD of our synthetic TF. We replaced the synthetic zinc fingers with the SOX2 DBD, which belongs to a different structural family, the high-mobility group (HMG) DBDs (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). These domains are minor-groove binders with many specific cognate sites throughout the genome. For this orthogonal DBD, our CITED2-K&gt;A mutant had a dramatically higher fraction bound than WT, while the inactive motif mutant modestly decreased chromatin association (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The L&gt;F mutation in this chimeric factor prevented its localization to the nucleus, precluding SMT. None of these constructs activated our GFP reporter (<xref ref-type="fig" rid="fig4s1"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure 4—figure supplement </ext-link>1</xref>). This last finding further reinforces that most of the observed chromatin binding in SMT is not at the reporter locus. With this second DBD, strong activation domains show more chromatin binding.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Activation domain alleles control the fraction of molecules bound to chromatin when fused to an alternative DNA-binding domain (DBD) or in a full-length transcription factor (TF).</title><p>(<bold>A</bold>) Left: We replaced the synthetic zinc finger DBD with the human SOX2 DBD. Right: Diffusion spectra and cumulative distributions for three alleles of CITED2. Shaded region indicates density contributing to the bound fraction. (<bold>B</bold>) Top: Schematic of the HIF1α and HIF2α intrinsically disordered region (IDR) swap chimeras from <xref ref-type="bibr" rid="bib14">Chen et al., 2022</xref>. Bottom: Diffusion spectra and cumulative distributions of the constructs shown. The HIF1α IDRs control the fraction of molecules bound to chromatin under hypoxic conditions. (<bold>C</bold>) Top: We introduced three superactivating point mutations (QN&gt;E) into full-length HIF1α’s second activation domain. Bottom: Diffusion spectra and cumulative distributions of the constructs shown. These three mutations in HIF1α increase the fraction of molecules bound to chromatin, recapitulating the differences seen in synthetic TFs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>AAVS1-integrated GFP reporter with synthetic ZF-binding sites is not activated by SOX2DBD-activation domain constructs.</title><p>Fluorescence intensities from the GFP channel of microscope images were quantified from experiments in <xref ref-type="fig" rid="fig4">Figure 4A</xref> and compared to those in <xref ref-type="fig" rid="fig3">Figure 3A</xref>. Orange lines: medians; boxes: Q1-Q3; whiskers: Q1–1.5 inter-quartile range and Q3+1.5 inter-quartile range. Left: GFP intensities from cells with SOX2DBD fused to various mutants of CITED2. Right: GFP intensities from cells with the synthetic ZF DBD fused to various mutants of CITED2.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title>Activation domains control chromatin binding of full-length TFs</title><p>We next investigated activation domain mutations in full-length TFs. We previously showed that the bound fraction of the HIF1α and HIF2α paralogs is controlled by long IDRs, not their DBDs (<xref ref-type="bibr" rid="bib14">Chen et al., 2022</xref>). In chimeric TFs, the IDR of HIF2α yields more chromatin binding than that of HIF1α. Previous studies were conducted in VHL-deficient renal carcinoma cells, which resulted in the stabilization of HIF proteins in this cell line (<xref ref-type="bibr" rid="bib9">Brodaczewska et al., 2016</xref>). We recapitulated these results in our U2OS cells using deferoxamine, a drug that prevents HIF degradation and mimics aspects of hypoxia (<xref ref-type="bibr" rid="bib48">Guo et al., 2006</xref>). In this condition, we reproduced the effect of IDR swaps on the diffusion of HIF factors: HIF2α had a higher bound fraction than HIF1α, and the HIF2α IDR was sufficient to confer this higher bound fraction (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Conversely, the HIF1α IDR conferred a lower bound fraction when attached to the HIF2α DBD. For these paralogs, the IDR controls the bound fraction.</p><p>We tested if the mutations in the activation domain could control the fraction of full-length HIF1α bound to chromatin. Introducing the strongest of these mutations, QN&gt;E, into AD2 (C-terminal activation domain) of full-length HIF1α increased the fraction of molecules bound to chromatin (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). This result shows that the strength of minimal activation domains in endogenous factors can control the fraction of molecules bound to chromatin. Further, this experiment demonstrated that the relationship between activation domain strength and bound fraction holds for another structurally distinct DBD, the basic helix-loop-helix (bHLH) family.</p><p>Together, we found that strong activation domains control the bound fraction of one synthetic and two natural DBDs. These DBDs are taken from three structurally distinct classes: zinc finger, HMG, and bHLH. We have further shown this result holds for both synthetic TFs and full-length endogenous TFs. We speculate that acidic activation domains may contribute to the fraction of molecules bound to chromatin for other full-length TFs.</p></sec><sec id="s2-6"><title>Quantifying activation domain coactivator interactions in vivo</title><p>We tested the hypothesis that protein-protein interactions between activation domains and coactivators can explain the positive correlation between activation domain strength and the fraction of molecules bound to chromatin. If increasing activation domain binding to known coactivator partners can increase TF chromatin binding, it would explain our results without invoking any new molecular mechanisms. In vitro, strong activation domains bind coactivators more tightly than weak ones (<xref ref-type="bibr" rid="bib25">DelRosso et al., 2024</xref>; <xref ref-type="bibr" rid="bib57">Henderson et al., 2018</xref>; <xref ref-type="bibr" rid="bib104">Sanborn et al., 2021</xref>). In the nucleus, coactivators are limiting for transcriptional activity (<xref ref-type="bibr" rid="bib42">Gillespie et al., 2020</xref>) and have long residence times on chromatin (<xref ref-type="bibr" rid="bib16">Cho et al., 2018</xref>; <xref ref-type="bibr" rid="bib104">Sanborn et al., 2021</xref>). For p300, the majority of molecules are bound to chromatin at steady state (<xref ref-type="bibr" rid="bib37">Ferrie et al., 2024</xref>).</p><p>To assess more directly whether chromatin binding of synthetic TFs correlates with coactivator binding, we used PAPA, in which excitation of a ‘sender’ fluorophore reactivates a nearby ‘receiver’ fluorophore from a dark state, thereby revealing proximity between two labeled proteins (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). To this end, we fused SNAP-tag2 (<xref ref-type="bibr" rid="bib70">Kühn et al., 2025</xref>) to synthetic TFs in a U2OS cell line with HaloTagged endogenous p300 (<xref ref-type="bibr" rid="bib37">Ferrie et al., 2024</xref>). After labeling SNAP-tag2 with the receiver fluorophore JFX650 and HaloTag-p300 with the sender fluorophore JF549, we placed JFX650 in a dark state with 639 nm illumination and assayed proximity-dependent reactivation following excitation of JF549 with 561 nm light. As previously described, we used direct reactivation of JFX650 with 405 nm light as an internal normalization standard (<xref ref-type="bibr" rid="bib21">Dahal et al., 2025</xref>; <xref ref-type="bibr" rid="bib46">Graham et al., 2025</xref>; <xref ref-type="bibr" rid="bib45">Graham et al., 2022</xref>) and calculated a normalized PAPA ratio relative to nuclear SNAP-tag2 alone, a noninteracting negative control (<xref ref-type="bibr" rid="bib1">Abidi et al., 2025</xref>) (Materials and methods, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). A very marginal PAPA signal was observed between p300 and the synthetic TF without an activation domain, while a small but significant increase was observed upon fusion to the HIF1α activation domain (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). A dramatic increase in PAPA signal was observed for the superactive mutants, consistent with stronger binding to p300. These data support the model that activation domains increase chromatin binding of TFs by engaging coactivators. These results also demonstrate that PAPA can detect interactions between a coactivator and minimal activation domains and that this measure is commensurate with activation domain strength.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Proximity-assisted photoactivation (PAPA) of synthetic transcription factors (TFs) shows that stronger activation domains promote interaction with p300.</title><p>(<bold>A</bold>) Schematic of our PAPA experiment using p300 endogenously tagged with HaloTag and an exogenous SNAP-tagged synthetic TF. First, red SNAP-tag2-liganded dyes are shelved (left, Materials and methods). A pulse of violet light (405 nm) indiscriminately reactivates these shelved dyes, while green light (561 nm) excites the sender, HaloTag-liganded dye, which reactivates nearby SNAP-tag dyes selectively. (<bold>B</bold>) Normalized PAPA ratio quantifying the proximity between p300-HaloTag and the constructs labeled. Error bars are 95% confidence intervals derived by bootstrapping (Materials and methods). (<bold>C</bold>) Diffusion spectra and cumulative distributions after segregation of green-reactivated (p300 proximal molecules) and violet-reactivated (direct reactivation) trajectories for cells expressing HIF1α WT. Density in the gray shaded region is quantified as the bound fraction. Light green and purple shading denotes the standard deviation of bootstrapping trials. (<bold>D</bold>) As in (<bold>C</bold>) for HIF1α RK &gt;D. (<bold>E</bold>) As in (<bold>C</bold>) for HIF1α QN &gt;E.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Proximity-assisted photoactivation (PAPA) analysis intermediates.</title><p>(<bold>A</bold>) For one PAPA replicate imaging cells expressing SNAP-tag2, the number of localizations as a function of frame number is plotted as a black line. Localizations immediately following a violet or green pulse (and considered reactivated for downstream analyses) are plotted as bold violet and green lines, respectively. (<bold>B</bold>) As in (<bold>A</bold>) for cells expressing HIF1α WT. (<bold>C</bold>) As in (<bold>A</bold>) for cells expressing HIF1α QN&gt;E. (<bold>D</bold>) Cell-wise normalized PAPA ratios (Materials and methods) are plotted across three replicates for cells expressing SNAP-tag2 and colored according to the legend. A line whose y-intercept is zero is fit to these points and plotted as a dashed red line. (<bold>E</bold>) As in (<bold>D</bold>) for cells expressing HIF1α WT. (<bold>F</bold>) As in (<bold>D</bold>) for cells expressing HIF1α QN&gt;E.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig5-figsupp1-v1.tif"/></fig></fig-group><p>In addition, we can examine the diffusion spectra of the p300 proximal molecules (green-reactivated) and the total population (violet-reactivated). For the two superactive mutants, this analysis shows that the p300 proximal population has a much higher bound fraction (<xref ref-type="fig" rid="fig5">Figure 5D and E</xref>). Increased binding between synthetic TFs and p300 measured by PAPA correlated with a higher chromatin-bound fraction in the SMT. Together, these results support the idea that activation domain coactivator binding can tether TFs to chromatin.</p></sec><sec id="s2-7"><title>Disrupting coactivator function perturbs TF-chromatin associations</title><p>We further investigated if activation domain binding to coactivators can tether TFs to chromatin by pharmacologically perturbing coactivator function. First, we used norstictic acid to selectively disrupt VP16 binding to the Med25 domain of Mediator (<xref ref-type="bibr" rid="bib39">Garlick et al., 2021</xref>). Like most coactivators, Mediator has a longer dwell time on DNA than that of sequence-specific TFs (<xref ref-type="bibr" rid="bib16">Cho et al., 2018</xref>; <xref ref-type="bibr" rid="bib130">Whitney and Lionnet, 2024</xref>). If the synthetic TF with VP16 is tethered to chromatin via activation domain interactions with Med25, norstictic acid treatment would decrease the fraction of molecules bound to chromatin. In line with this prediction, norstictic acid caused a small but significant decrease in the bound fraction of synthetic TF with VP16 (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). The empty TF experienced no significant change in binding (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), and two alleles of VP16 also showed decreases in fraction bound in response to norstictic acid (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). This perturbation further supports the idea that synthetic TFs can be tethered to chromatin by activation domain interactions with coactivators.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Perturbing coactivator function alters transcription factor (TF) bound fraction.</title><p>(<bold>A</bold>) VP16-synthetic TF diffusion spectra and cumulative distributions for cells treated for 2 hr with norstictic acid or vehicle (DMSO). Density in light gray is quantified as the bound fraction. Shading around the spectra and cumulative distributions indicates standard deviation of bootstrapping trials. (<bold>B</bold>) Diffusion spectra and cumulative distributions of cells expressing the synthetic TF with no activation domain treated for 2 hr with norstictic acid or vehicle (DMSO). Density in light gray is quantified as the bound fraction. Shading around the spectra and cumulative distributions indicates standard deviation of bootstrapping trials. (<bold>C</bold>) As in (<bold>A</bold>) for A485, a p300 inhibitor. (<bold>D</bold>) As in (<bold>B</bold>) for A485, a p300 inhibitor. The DMSO curve is repeated from (<bold>B</bold>). (<bold>E</bold>) As in (<bold>A</bold>) for BRM-014, a BAF inhibitor (BAFi). (<bold>F</bold>) As in (<bold>B</bold>) for BRM-014, a BAF inhibitor (BAFi). The DMSO curve is repeated from (<bold>B</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Drug perturbations on the synthetic transcription factor (TF) bearing mutants of the VP16 activation domain.</title><p>(<bold>A</bold>) Diffusion spectra (top) and cumulative distributions (bottom) for VP16 F442A-synthetic TF-expressing cells treated for 2 hr with norstictic acid or vehicle (DMSO). Shading indicates standard deviation of bootstrapping trials. (<bold>B</bold>) As in (<bold>A</bold>) for VP16 7As-synthetic TF.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig6-figsupp1-v1.tif"/></fig></fig-group><p>For the second pharmacological perturbation, we selected the coactivator p300, which has a high bound fraction, a relatively long residence time (<xref ref-type="bibr" rid="bib37">Ferrie et al., 2024</xref>), and is a key binding partner for the HIF1α, CITED2, and VP16 activation domains (<xref ref-type="bibr" rid="bib28">Dyson and Wright, 2016</xref>). Inhibition of p300 with A485 inhibits catalytic activity, decreases global transcription (<xref ref-type="bibr" rid="bib75">Lasko et al., 2017</xref>), and increases the fraction of p300 molecules bound to chromatin (<xref ref-type="bibr" rid="bib37">Ferrie et al., 2024</xref>). Under A485, we predict that the same steady-state binding between an activation domain and p300 will result in more synthetic TF molecules binding to p300 on chromatin and give the appearance of more synthetic TF binding to chromatin. Consistent with this prediction, A485 treatment mildly but significantly increased the fraction of synthetic TF with VP16 bound to chromatin relative to control (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). The empty synthetic TF experienced the opposite effect, with a decrease in binding to chromatin (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Together, the A485 and norstictic acid perturbations support the idea that TFs can be tethered to chromatin through protein-protein interactions with coactivators.</p><p>As a third perturbation of coactivator function, we inhibited the BAF (mammalian Swi/Snf) complex with BAFi (BRM014). BAF inhibition leads to rapid genome-wide chromatin compaction and decreased global transcription (<xref ref-type="bibr" rid="bib106">Schick et al., 2021</xref>). In single-molecule footprinting experiments, inhibiting BAF decreased promoter occupancy of a Tet-VP48 synthetic TF (<xref ref-type="bibr" rid="bib26">Doughty et al., 2024</xref>). For our synthetic TF, inhibition of BAF significantly decreased the fraction of molecules bound to chromatin relative to the vehicle control (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). The empty synthetic TF did not experience a significant change in binding (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). This result suggests that a substantial portion of our immobile TFs are binding chromatin at open or actively transcribing loci.</p></sec><sec id="s2-8"><title>Synthetic TFs bind active loci genome-wide</title><p>The increases in chromatin binding measured by SMT cannot distinguish between stronger binding to the same genomic loci and binding to new genomic loci. To differentiate between these two possibilities, we undertook CUT&amp;RUN experiments (<xref ref-type="bibr" rid="bib109">Skene and Henikoff, 2017</xref>) on five of our synthetic TFs (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). For full-length HIF1α and HIF1β TFs, CUT&amp;RUN experiments indicated most genomic loci are bound by both TFs, implying that an increased bound fraction in SMT experiments is primarily due to higher occupancy at the same loci (<xref ref-type="bibr" rid="bib14">Chen et al., 2022</xref>). This result sets the expectation that our activation domain mutations that increase chromatin-bound fraction in SMT are unlikely to bind new genomic loci and instead will have higher occupancy at the same loci across the genome.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>CUT&amp;RUN on synthetic transcription factors (TFs) with different activation domains reveals most binding occurs at open chromatin.</title><p>(<bold>A</bold>) We performed CUT&amp;RUN on the parental cell line bearing the GFP reporter locus and five cell lines, each expressing synthetic TFs with a variable activation domain. Cells for all conditions were probed with an anti-V5 antibody, which should bind specifically only to the V5 epitope of the synthetic TFs. (<bold>B</bold>) Genomic binding signal at the engineered AAVS1 locus, shown to scale. All the synthetic TFs, including the empty TF, bound the cognate binding sites in the reporter construct. (<bold>C</bold>) Mean binding signal of the various synthetic TFs between the dashed lines of (<bold>B</bold>), which include the ZF1 binding sites and minimal promoter. (<bold>D</bold>) Binding of synthetic TFs and ATAC-seq signal at an exemplary locus. TF binding signal is strongest at ATAC-seq peaks, with stronger activation domains conferring more genomic binding in some cases. Not all ATAC-seq peaks are bound by the synthetic TFs. (<bold>E</bold>) ATAC-seq (left) and synthetic TF factor binding (right plots) signals plotted across 80118 ATAC-seq peaks, sorted by decreasing ATAC-seq peak strength. The five synthetic TFs share a color scale; the ATAC-seq signal uses a separate scale. Binding patterns for the synthetic TFs generally follow the strength of the ATAC-seq signal.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Synthetic transcription factors (TFs) bearing various activation domains generally bind to similar, open regions of the genome.</title><p>(<bold>A</bold>) Stacked bar plot quantifying ATAC-seq and CUT&amp;RUN peaks overlapping (blue) and not overlapping (orange) ATAC-seq peaks for various activation domain-synthetic TFs. (<bold>B</bold>) ATAC-seq signal and synthetic TF binding signal is plotted in descending peak strength order for the TF shown labeled on the left. The five synthetic TFs share a color scale; the ATAC-seq signal uses a separate scale. The synthetic TFs with various activation domains generally bind to similar regions of the genome, especially those within ATAC-accessible regions.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig7-figsupp1-v1.tif"/></fig></fig-group><p>All the TFs, including the empty TF, were bound to the cognate binding sites of the reporter gene at the AAVS1 locus. Normalizing between samples revealed that the HIF1α QN&gt;E superactive mutant had more occupancy than the WT HIF1α TF (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Genome-wide, the binding profiles of all synthetic TFs mostly overlapped pre-existing ATAC-seq peaks (<xref ref-type="fig" rid="fig7">Figure 7D</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). The HIF1α superactive allele bound more loci than the WT allele, but the patterns were highly overlapping (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>). Together, these results indicate that most synthetic TF binding events occur at accessible loci. We conclude that the increased bound fraction we observe in the SMT primarily results from more binding to the same active loci.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>How a TF binds the genome is controlled by both DBDs and IDRs, but it remains difficult to predict the relative contributions of these two regions. We demonstrated that very short activation domains can control the fraction of TF molecules bound to chromatin, sometimes accounting for more binding than the DBD. Mutations that increase activation domain strength in reporter assays increase the fraction of molecules bound to chromatin. Conversely, mutations that decrease activation domain strength decrease the fraction of molecules bound to chromatin. This trend holds for allelic series of four acidic activation domains, for three structurally diverse DBDs, and for synthetic and full-length TFs.</p><p>SMT has revealed many new dimensions of TF nuclear dynamics and has been instrumental for our discovery. The technique has shown that TF-chromatin interactions are generally short-lived (<xref ref-type="bibr" rid="bib11">Brouwer and Lenstra, 2019</xref>; <xref ref-type="bibr" rid="bib79">Lionnet and Wu, 2021</xref>; <xref ref-type="bibr" rid="bib82">Liu et al., 2014</xref>), that coactivator chromatin binding is long-lived (<xref ref-type="bibr" rid="bib37">Ferrie et al., 2024</xref>), and that IDRs can make larger contributions to chromatin binding than DBDs (<xref ref-type="bibr" rid="bib14">Chen et al., 2022</xref>). Here, we demonstrate that minimal activation domains (39–60AA) can control the fraction of molecules bound to chromatin. Our results are consistent with an SMT study of an activation domain deletion in p53 showing reduced association with dense chromatin (<xref ref-type="bibr" rid="bib87">Mazzocca et al., 2023</xref>).</p><p>There are three hypotheses for how increasing activation domain strength causes a higher fraction of TF molecules bound to chromatin: (1) activation domains could directly bind DNA, (2) activation domains could modulate DBD interactions with DNA, or (3) activation domains could bind to coactivators that are bound to chromatin, tethering the TF to chromatin.</p><p>Our short acidic activation domains are unlikely to bind DNA directly due to electrostatic repulsion: both the activation domains and DNA are negatively charged and repel each other. While protein net charge can play a large role in nuclear diffusion (<xref ref-type="bibr" rid="bib131">Xiang et al., 2020</xref>), we found no correlation between net charge and fractions bound in factors we tested (<xref ref-type="fig" rid="fig3s4"><ext-link ext-link-type="uri" xlink:href="https://www.zotero.org/google-docs/?pS8p5m">Figure 3—figure supplement </ext-link>4</xref>).</p><p>It is also possible that our activation domains are interacting with the DBD to modulate DNA binding, an emerging theme in TF biology (<xref ref-type="bibr" rid="bib4">Baughman et al., 2022</xref>; <xref ref-type="bibr" rid="bib5">Bentley et al., 2023</xref>; <xref ref-type="bibr" rid="bib7">Bjarnason et al., 2024</xref>; <xref ref-type="bibr" rid="bib52">He et al., 2019</xref>; <xref ref-type="bibr" rid="bib69">Krois et al., 2018</xref>; <xref ref-type="bibr" rid="bib122">Sun et al., 2021</xref>). For our results, intramolecular interactions are not the main drivers of chromatin binding because the phenotype is consistent across three structurally distinct DBDs.</p><p>Our PAPA experiments support the hypothesis that protein-protein interactions between activation domains and coactivators explain the positive correlation between activation domain strength and the fraction of TF molecules bound to chromatin. The overall chromatin-bound fraction of SNAP-tagged synthetic TFs was higher than that of the Halo-tagged versions, perhaps reflecting differences in physical properties of the two tags, such as volume and charge (<xref ref-type="fig" rid="fig3">Figure 3C</xref> vs <xref ref-type="fig" rid="fig5">Figure 5C–E</xref>, violet curves). TFs reactivated by PAPA from p300 had a higher chromatin-bound fraction than those directly reactivated by violet light (DR), indicating the expected correlation between p300 binding and chromatin binding (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Compared to WT, the two superactive HIF1α alleles showed stronger binding to p300 by PAPA and a more pronounced shift toward chromatin-bound molecules when comparing PAPA to DR trajectories. Curiously, while the bound fraction of PAPA trajectories increased with activation domain strength, DR trajectories, if anything, showed the opposite trend. One possible explanation is that a large fraction of TF molecules bind p300, and each round of PAPA followed by re-bleaching depletes these complexes from subsequent rounds of direct reactivation—with more interaction resulting in greater depletion. This work marks the first time that PAPA has been applied to measure TF-coactivator interactions in vivo, which we anticipate will be a powerful new experimental approach to study transcription. Together with the PAPA experiments, the pharmacological perturbations support our hypothesis that activation domain-coactivator interactions strongly influence TF binding to chromatin (<xref ref-type="fig" rid="fig8">Figure 8</xref>). We cannot distinguish whether the coactivator directly binds DNA, binds a nucleosome, or binds another TF bound to DNA, but we suspect all three binding modes are involved.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Model for how activation domains contribute to chromatin binding by interactions with coactivators.</title><p>(<bold>A</bold>) A solitary transcription factor (TF) diffusing in the nucleoplasm, a lone wolf. (<bold>B</bold>) A TF bound to a coactivator with its activation domain diffusing through the nucleoplasm. (<bold>C</bold>) Three TFs bound simultaneously to a coactivator diffusing in the nucleoplasm as a complex or wolfpack. (<bold>D</bold>) A TF nonspecifically bound to random DNA. (<bold>E</bold>) A TF specifically bound with its DBD to a cognate DNA motif at the reporter locus. (<bold>F</bold>) TFs specifically bound to motifs at the reporter locus and simultaneously bound to a coactivator. (<bold>G</bold>) Proposed model for how the activation domain tethers the synthetic TF to chromatin through the coactivator. This situation occurs at active loci where the coactivator has been recruited by the orange and blue TFs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-fig8-v1.tif"/></fig><p>In the CUT&amp;RUN data, stronger activation domains cause higher occupancy at the reporter locus, but the vast majority of other genomic binding occurs at other active loci. Consequently, we believe our activation domain-mediated chromatin binding is distinct from the ability of long IDRs to direct TFs to specific genomic loci (<xref ref-type="bibr" rid="bib10">Brodsky et al., 2020</xref>; <xref ref-type="bibr" rid="bib40">Gera et al., 2022</xref>; <xref ref-type="bibr" rid="bib43">Goldman et al., 2023</xref>; <xref ref-type="bibr" rid="bib63">Hurieva et al., 2024</xref>; <xref ref-type="bibr" rid="bib89">Mindel et al., 2024a</xref>). Instead, we believe the SMT is observing the same underlying biological process that causes activation domains to enhance promoter occupancy in single-molecule footprinting experiments (<xref ref-type="bibr" rid="bib26">Doughty et al., 2024</xref>) and long TF residence times on promoters (<xref ref-type="bibr" rid="bib105">Schaepe et al., 2025</xref>). It is remarkable that short activation domains can have such a large effect on binding.</p><p>Genome binding is an emergent property of full-length TFs, with contributions from the DBD, activation domains, and their interactions. In textbook models, the DBD binds DNA first, and then the activation domain recruits the coactivators. We speculate that recruitment can occur in both directions: sometimes the first event will be the activation domain binding to a coactivator that is already engaged at an active locus, and then the DBD will bind the local DNA (<xref ref-type="fig" rid="fig8">Figure 8</xref>). Different activation domains bind distinct coactivators (<xref ref-type="bibr" rid="bib2">Alerasool et al., 2022</xref>), but only some of these interactions, which can have affinities of 10 nanomolar (<xref ref-type="bibr" rid="bib6">Berlow et al., 2017</xref>; <xref ref-type="bibr" rid="bib23">De Guzman et al., 2004</xref>), will be strong enough to tether TFs to chromatin.</p><p>Our results also challenge the traditional interpretation of activation domain strength. Previously, we had assumed that all our synthetic TFs had similar DNA occupancy because they have the same DBD. Our results here show that strong activation domains increase occupancy at a reporter locus. As a result, the higher reporter activity is a convolution of more binding and more coactivator recruitment (<xref ref-type="bibr" rid="bib26">Doughty et al., 2024</xref>). This finding motivates the need for new assays for activation domain function that can separate binding from reporter activity.</p><p>In this work, we focused on the fraction of molecules bound to chromatin. We also see some changes in the distribution of inferred diffusion constants of mobile molecules, some of which are bimodal. After norstictic acid treatment, the slow-moving population shrank and the fast-moving population grew. The slow-moving population is also prominent in the PAPA data. We speculate that the slow-moving population might be TFs bound to coactivators exploring the nucleus in clusters or ‘wolf packs’ (<xref ref-type="fig" rid="fig8">Figure 8C</xref>), as we previously hypothesized (<xref ref-type="bibr" rid="bib114">Staller, 2022a</xref>).</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>U2OS cell culture</title><p>U2OS cells (osteosarcoma from a 15-year-old human female) were originally obtained from the UC Berkeley Cell Culture Facility. Cells were maintained at 37°C in a humidified atmosphere with 5% CO<sub>2</sub> and cultured in reconstituted DMEM containing 4.5 g/L glucose (Thermo 12800082) supplemented with 9.1% fetal bovine serum (FBS, HyClone), L-glutamine (Sigma), GlutaMax (Thermo), and 100 U/mL penicillin-streptomycin (Thermo). Cells were generally passaged every 3 days by splitting 1:8, using 0.25% trypsin to facilitate detachment.</p><p>Cell lines used in this study tested negative for mycoplasma about monthly by PCR (<ext-link ext-link-type="uri" xlink:href="https://bitesizebio.com/23682/homemade-pcr-test-for-mycoplasma-contamination/">https://bitesizebio.com/23682/homemade-pcr-test-for-mycoplasma-contamination/</ext-link>). Cells were tested to be U2OS cells with STR profiling at the UC Berkeley Cell Culture Facility.</p><p>For imaging experiments, cells were plated the evening prior to imaging to achieve 60–80% confluency on the day of imaging. Cells were grown on glass-bottom dishes (MatTek P35G-1.5-14-C) in phenol-red-free DMEM containing 4.5 g/L glucose and supplemented with 9% FBS and 100 U/mL penicillin-streptomycin (‘imaging medium’).</p></sec><sec id="s4-2"><title>U2OS cell line generation</title><p>To generate the reporter cell line, U2OS cells were transfected in six-well dishes using Lipofectamine 3000, with 3 µg of DNA and 6 µL of Lipofectamine 3000 per well. Each well received 1 µg of a combined Cas9 and sgRNA plasmid targeting the AAVS1 locus (Addgene plasmid #227272) and 2 µg of repair template containing the reporter locus, similar to that of the previously described construct (<xref ref-type="bibr" rid="bib115">Staller et al., 2022b</xref>).</p><p>The reporter construct is based on a published reporter (Addgene #176294), but we replaced puromycin resistance with blasticidin resistance, added VKYY to the start of the GFP to boost translation (<xref ref-type="bibr" rid="bib128">Verma et al., 2019</xref>), inserted a small t intron, and inserted a WPRE before the SV40 poly(A) signal.</p><p>Two days after transfection, cells were passaged onto a 10 cm dish and selected with blasticidin (Fisher A1113903) at 5 µg/mL. When this dish was confluent, single clones were isolated by limiting dilution into 96-well plates and sequence-validated to have at least one copy of the reporter locus by PCR and Sanger sequencing. Clones were also tested by transient transfection of a VP16 synthetic TF by measuring fold-induction in response to estradiol induction. We picked the most robustly induced clone for this study. Cells were maintained in media containing 5 µg/mL blasticidin.</p><p>All synthetic zinc-finger- and SOX2DBD-bearing constructs were cloned using Gibson Assembly and verified via whole-plasmid sequencing (Plasmidsaurus). Starting with a published synthetic TF (Addgene #176293), we moved the TF into PiggyBac backbone with a L30 promoter, replaced mScarlet with HaloTag, added a V5 tag, and replaced the neomycin resistance with puromycin resistance. These constructs were stably integrated into the reporter clone described above. For integrations, we transfected 2 µg of a synthetic construct with 1 µg of a vector expressing Super PiggyBac Transposase (<xref ref-type="bibr" rid="bib132">Yusa et al., 2011</xref>) in this reporter clone. Two days after transfection, we passaged cells onto a 10 cm dish and selected cells with puromycin (Invivogen) at 1 µg/mL. We continued passaging these cells for at least 2 weeks before proceeding with experiments. Cells were maintained in media containing 5 µL/mL blasticidin and 1 µg/mL puromycin.</p></sec><sec id="s4-3"><title>Selection of activation domain mutations</title><p>We selected mutations that strongly changed activation domain activity in our published assay (<xref ref-type="bibr" rid="bib115">Staller et al., 2022b</xref>). The QN&gt;E mutation prevents hydroxylation, a modification which normally destabilizes the protein and interferes with p300 binding (<xref ref-type="bibr" rid="bib59">Hewitson et al., 2002</xref>; <xref ref-type="bibr" rid="bib73">Lando et al., 2002a</xref>; <xref ref-type="bibr" rid="bib74">Lando et al., 2002b</xref>).</p></sec><sec id="s4-4"><title>Nucleofection and drug treatments</title><p>For <xref ref-type="fig" rid="fig4">Figure 4B and C</xref>, U2OS cells were electroporated using a homemade buffer (<xref ref-type="bibr" rid="bib22">Danner, 2020</xref>) and the X-001 protocol of the Lonza Nucleofector II. This method mitigates autofluorescence artifacts from lipid-based transfection reagents. One million U2OS cells were electroporated with previously described constructs (<xref ref-type="bibr" rid="bib14">Chen et al., 2022</xref>) and treated with deferoxamine mesylate salt (Sigma D9533) at 100 µM overnight.</p><p>For <xref ref-type="fig" rid="fig5">Figure 5A, D</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>, uninduced cells were treated for 2 hr with 10 µM norstictic acid (Santa Cruz Biotechnology) or the equivalent DMSO. These cells were stained with HaloTag ligand (as in ‘Sample preparation for imaging experiments’) and induced with 1 µM β-Estradiol (Sigma E2758; ‘estradiol’) immediately before imaging.</p><p>For <xref ref-type="fig" rid="fig5">Figure 5B and E</xref>, uninduced cells were treated for 2 hr with 10 µM A485 (Fisher) or the equivalent DMSO. These cells were stained with HaloTag ligand (as in ‘Sample preparation for imaging experiments’) and induced with 1 µM estradiol immediately before imaging.</p><p>For <xref ref-type="fig" rid="fig5">Figure 5C and F</xref>, uninduced cells were treated for 2 hr with 10 µM BRM/BRG1 ATP Inhibitor-1 compound 14 (MedChemExpress; ‘BAFi’) or the equivalent DMSO. These cells were stained with HaloTag ligand (as in ‘Sample preparation for imaging experiments’) and induced with 1 µM estradiol immediately before imaging.</p><p>Except for treatments noted above in this section, cells in all other conditions were treated with 1 µM estradiol for 12–16 hr the night before they were imaged for SMT.</p><p>For all flow cytometry experiments, cells were treated with 1 µM estradiol for 24 hr.</p></sec><sec id="s4-5"><title>Incucyte live-cell imaging</title><p> To assay reporter induction at fine time intervals, we used the Incucyte S3 system to acquire images every 2 hr post estradiol induction. The day before the experiment, cells were plated at around 25% confluence. The day of the experiment, cells were induced with 1 µM estradiol, and the first image was taken about 5 min later (as the 0 hr time point).</p><p>Images in phase and the green channel (to quantify GFP) were acquired with the 10× objective. The Incucyte S3 software was used to segment cells and quantify the amount of GFP in each cell. These amounts were used to draw an arbitrary gate separating GFP-positive and -negative cells. The percentage of GFP-positive cells was computed and plotted as a function of time using Python.</p></sec><sec id="s4-6"><title>Flow cytometry</title><p>The day of the assay, cells were stained for 10 min with 35 nM of JFX650-HaloTag ligand and 10 µM Hoechst 33342 (Thermo), rinsed once with imaging medium, and incubated in imaging medium for 25 min. Cells were lifted using 0.25% trypsin, quenched with imaging medium, and filtered through a cell strainer to remove clumps.</p><p>Flow cytometry was conducted on a BD Bioscience LSR Fortessa in the UC Berkeley Flow Cytometry Core. Conditions presented together as panels were collected on the same day with the same voltages. These voltages were not always kept consistent from day to day, as daily CST calibration often changed cytometer baselines. 30,000 measurements were made for each condition.</p><p>Data were analyzed using FlowJo, with consistent gating applied across conditions that are presented together in a panel. The reporter fluorescence distributions were frequently bimodal, so we quantified reporter activity in two ways. First, we used the fraction of cells that were GFP positive, but this metric had a limited dynamic range. Second, we used the mean fluorescence intensity of GFP-positive (GFP+) cells, which had a larger dynamic range.</p></sec><sec id="s4-7"><title>SMT movie acquisition</title><p>The day of imaging, cells were stained for 5 min with JFX650-HaloTag ligand (generously gifted by the Lavis lab), added to a final concentration of 5 nM and 2 µM Hoechst 33342 (Thermo), rinsed once with imaging medium, and incubated in imaging medium for 10 min. The dishes were rinsed one more time, replenished with imaging medium, and mounted on the microscope with Nikon immersion oil Type F.</p><p>The microscope used for SMT is as previously described (<xref ref-type="bibr" rid="bib50">Hansen et al., 2018</xref>). In brief, this imaging setup consisted of a Nikon TI microscope fitted with a 100×/NA 1.49 oil-immersion TIRF objective, a motorized mirror, a Perfect Focus system, an EM-CCD camera, and an incubation chamber maintained at 37°C with a humidified 5% CO<sub>2</sub> atmosphere. The laser launch includes lasers of the following wavelengths: 405 nm (140 mW, OBIS, Coherent), 488 nm, 561 nm, and 639 nm (all 1 W, Genesis, Coherent). Laser intensities were regulated using an acousto-optic tunable filter (AA Opto-Electronic, AOTFnC-VIS-TN) and triggered via the camera’s TTL exposure output signal. Lasers were delivered to the microscope through an optical fiber, reflected by a quad-band dichroic mirror (405 nm/488 nm/561 nm/633 nm, Semrock), and focused at the back focal plane of the objective. The incident laser angle was adjusted to achieve HILO illumination (<xref ref-type="bibr" rid="bib125">Tokunaga et al., 2008</xref>). Emission light was filtered using the appropriate Semrock single band-pass filters.</p><p>For the diffusion spectra shown in each panel, all conditions were imaged on the same day to minimize day-to-day variability. A second replicate was imaged on a different day, and the data from both days were pooled to generate the reported spectra.</p><p>All experiments except those in <xref ref-type="fig" rid="fig4">Figure 4B, C</xref>, <xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref> used an automated imaging scheme derived from one previously described in <xref ref-type="bibr" rid="bib129">Walther et al., 2024</xref>. Briefly, custom NIS Elements Macro Language and Python scripts instructed the microscope to raster over a coverslip, taking 81.92 µm × 81.92 µm images at each grid point. Cell presence in a field was determined using StarDist segmentation (<xref ref-type="bibr" rid="bib107">Schmidt et al., 2018</xref>) in the Hoescht channel; images in additional channels of interest (GFP: 488 nm, JFX650: 639 nm) were also acquired. If cells were identified, one was randomly selected for imaging at 7.48 ms using the following protocol: 1200 frames with 2 ms stroboscopic illumination of the 639 nm laser (1 W, 100%), followed by 1200 frames with 2 ms stroboscopic illumination of the 639 nm laser (1 W, 100%) combined with 30% 405 nm laser power during camera transition intervals, and finally 1200 frames with 2 ms stroboscopic illumination of the 639 nm laser (1 W, 100%) combined with 60% 405 nm laser power during camera transition intervals. The 405 nm laser pulses during transition times were used to reactivate dark JFX650 fluorophores (<xref ref-type="bibr" rid="bib30">Endesfelder and Heilemann, 2015</xref>) while minimizing background contribution by the laser pulse itself.</p></sec><sec id="s4-8"><title>PAPA SMT movie acquisition</title><p>The day of imaging, cells were stained for 10 min with 50 nM JFX549-HaloTag ligand and either 5 nM JFX650-SNAP-tag ligand (for SNAP-tag2 control conditions) or 50 nM JFX650-SNAP-tag ligand (for all other conditions; all dyes were generous gifts from the Lavis lab). Dishes were rinsed once with imaging medium and incubated in imaging medium for 15 min. The dishes were rinsed once more, replenished with imaging medium, and mounted on the microscope (same as described in ‘SMT movie acquisition’) with Nikon immersion oil Type F.</p><p>All PAPA experiments used the microscope setup and automation scheme previously described in ‘SMT movie acquisition’ with the following differences.</p><p>We used the 561 nm laser to measure p300-HaloTag nuclear intensities, and only cells with mean intensity values between 2000 and 20,000 were considered for imaging. StarDist-segmented objects with an area less than 3500 pixels (89.6 µm<sup>2</sup>) or more than 7000 pixels (179.2 µm<sup>2</sup>) were rejected. We also acquired images using the 639 nm laser for the SNAP-tagged proteins’ expression levels and only considered nuclei with mean intensities above 5000. If more than one suitable cell was found for imaging, we selected the largest cell to image to recover the most localizations possible.</p><p>After a cell was selected by this automated scheme, the imaging macro shrank the region of interest to encapsulate the nucleus and applied the 639 nm laser at 100% intensity for 5 s to ‘shelve’ fluorescent SNAP-tagged molecules. Then, we used the following illumination sequence with eight phases (all 7.48 ms frames):</p><list list-type="order" id="list1"><list-item><p>200 frames of 1 W 639 nm laser at 100% intensity: these frames are not saved and serve to shelve SNAP-tagged molecules before the next reactivation pulse.</p></list-item><list-item><p>30 frames of 1 ms stroboscopic 1 W 639 nm laser at 100% intensity: these frames are saved and are a readout for ‘spontaneous reactivation’, reactivation of molecules that is independent of a green or violet pulse.</p></list-item><list-item><p>2 frames of 405 nm laser at 100% intensity: this pulse of violet light reactivates ‘shelved’ SNAP-tagged molecules regardless of whether or not they are complexed. These frames are not saved.</p></list-item><list-item><p>30 frames of 1 ms stroboscopic 1 W 639 nm laser at 100% intensity: these frames are saved and read out the violet-reactivated molecules from the previous pulse.</p></list-item><list-item><p>200 frames of 1 W 639 nm laser at 100% intensity: these frames are not saved and serve to shelve SNAP-tagged molecules before the next reactivation pulse.</p></list-item><list-item><p>30 frames of 1 ms stroboscopic 1 W 639 nm laser at 100% intensity: these frames are saved and are a readout for ‘spontaneous reactivation’, reactivation of molecules that is independent of a green or violet pulse.</p></list-item><list-item><p>50 frames of 100 mW 561 nm laser at 100% intensity: this pulse of green light reactivates SNAP-tagged molecules dependent on their proximity to p300-HaloTag. These frames are not saved.</p></list-item><list-item><p>30 frames of 1 ms stroboscopic 1 W 639 nm laser at 100% intensity: these frames are saved and read out the green-reactivated molecules from the previous pulse.</p></list-item></list><p>This sequence is repeated five times before the cell-finding phase of the macro starts again.</p></sec><sec id="s4-9"><title>SMT and PAPA-SMT analysis</title><p>Spots were detected, subpixel-localized, and linked into trajectories using algorithms within the open-source Python package quot (<ext-link ext-link-type="uri" xlink:href="https://github.com/alecheckert/quot">https://github.com/alecheckert/quot</ext-link>, copy archived at <xref ref-type="bibr" rid="bib56">Heckert and Fan, 2025c</xref>) using the following parameters:</p><p>'filter': {’start': 0, 'method': 'identity'}, 'detect': {'method': 'llr', 'k': 1.5, 'w': 11, 't': 18.0}, 'localize': {'method': 'ls_int_gaussian', 'window_size': 11, ’sigma': 1.5, 'ridge': 0.0001, 'max_iter': 10, 'damp': 0.3, 'camera_gain': 109.0, 'camera_bg': 470.0}, 'track': {'method': 'conservative', 'pixel_size_um': 0.16, 'search_radius': 1.0, 'max_blinks': 0, 'min_I0': 0.0}.</p><p>We segmented cell nuclei images with either StarDist (<xref ref-type="bibr" rid="bib107">Schmidt et al., 2018</xref>) or cellpose (<xref ref-type="bibr" rid="bib117">Stringer et al., 2021</xref>) as a starting point but found that manual QC and refining were necessary for accurate masking. This was done with a custom Python GUI (<ext-link ext-link-type="uri" xlink:href="https://github.com/vinsfan368/qtpicker">https://github.com/vinsfan368/qtpicker</ext-link>, copy archived at <xref ref-type="bibr" rid="bib33">Fan, 2025a</xref>).</p><p>Only trajectories whose points lie entirely within one, and only one, curated mask were analyzed. For nuclei with more than six localizations per frame in at least one frame, we truncated frames from the beginning of the movie until all frames had fewer than seven localizations per frame. We then excluded cells with fewer than 100 displacements to ensure greater confidence in cell-wise posterior estimates. These three filters were post hoc choices and not pre-established exclusion criteria.</p><p>The resulting trajectories were analyzed using the open-source and previously published Python package saspt (<ext-link ext-link-type="uri" xlink:href="https://github.com/alecheckert/saspt">https://github.com/alecheckert/saspt</ext-link>, copy archived at <xref ref-type="bibr" rid="bib54">Heckert et al., 2025a</xref>; <xref ref-type="bibr" rid="bib53">Heckert et al., 2022</xref>). We used the following inference parameters: focal_depth = 0.7, sample_size = 1,000,000, likelihood_type='rbme', splitsize = 3, start_frame = 0 (with the sample_size parameter being arbitrarily large to analyze all trajectories). For <xref ref-type="fig" rid="fig4">Figure 4B and C</xref>, we used the above parameters but replaced splitsize = 3 with splitsize = 8 to maintain consistency with our previously published results (<xref ref-type="bibr" rid="bib14">Chen et al., 2022</xref>).</p><p>In figures where errors are reported, we followed a similar scheme previously described in <xref ref-type="bibr" rid="bib37">Ferrie et al., 2024</xref>: for a dataset comprising n cells, we subsampled n random cells with replacement 96 times. For each of these trials, we pooled all trajectories from the n random cells, ran inference using the parameters described above, and noted the fractions bound. The bootstrapping means, standard deviations, and 95% confidence intervals are reported and/or plotted where indicated.</p></sec><sec id="s4-10"><title>Quantifying sources of variance in SMT data</title><p>To quantitatively describe sources of variance (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>) within our data in a non-model-dependent and computationally inexpensive way, we were inspired by <xref ref-type="bibr" rid="bib27">Driouchi et al., 2025</xref>. Briefly, we collate trajectories, noting the day on which they were imaged and the cell from which they were collected. We then decompose this data into individual displacements and subsample arbitrary numbers (n) of these jumps 1000 times, noting the mean value of these 1000 trials. By varying both n and the sampling scheme, we can assess sources of variance. We sampled according to three schemes: (1, gray) n jumps from the entire pool of trajectories, which establishes the baseline and should follow the law of large numbers as n becomes larger; (2, blue) by picking one cell from the dataset and sampling n jumps from only that cell; and (3, orange) by picking an imaging day from the dataset and sampling n jumps imaged only on that day. When curves 2 and 3 diverge from 1, all variance with respect to n has been captured. We note that variability between fields of view could contribute to cell-to-cell variability, but given that most of our fields of view contained only one cell, we did not quantify this source of variability. We found in <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref> that cell-to-cell variability is about 100× higher than day-to-day variability.</p></sec><sec id="s4-11"><title>Normalized PAPA ratio and confidence intervals</title><p>To calculate the normalized PAPA ratio (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), we tallied green- and violet-reactivated molecules in PAPA movies and additionally controlled for spontaneous reactivation of molecules: green- and violet-independent reactivations that likely depend on the expression level of the SNAP-tagged protein in a given nucleus. To do this, we subtracted the number of spontaneously reactivated molecules from the number of molecules reactivated by a preceding green or violet pulse; e.g., molecules localized in phase 2 of the illumination sequence in ‘PAPA SMT movie acquisition’ were subtracted from those in phase 4, and molecules localized in phase 6 of this sequence were subtracted from those in phase 8. This yielded a corrected green-to-violet (G/V) ratio for each cell measured.</p><p>Next, we divided these cell-wise corrected G/V ratios for each condition by the aggregate corrected G/V ratio of the SNAP-tag2 control imaged on the same day (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D–F</xref>). For example, if a cell expressing HIF1α AD-synthetic TF had a G/V ratio of 0.36 on a day the aggregate G/V ratio for SNAP-tag2 alone was 0.26, its normalized G/V ratio is 1.4.</p><p>Finally, we calculated the mean and derived error bounds for the normalized PAPA ratios by bootstrapping. For a condition comprising n cells (imaged over multiple days, but each normalized to their appropriate SNAP-tag2 control), we picked n cells from that condition with replacement and calculated the combined normalized G/V ratio of this pool. We repeated this 96 times and used this to derive 95% confidence intervals.</p></sec><sec id="s4-12"><title>FRAP movie acquisition</title><p>The day of imaging, cells were stained for 5 min with TMR-HaloTag ligand (Promega) added to a final concentration of 50 nM, rinsed once with imaging medium, and incubated in imaging medium for 10 min. The dishes were rinsed one more time, replenished with imaging medium, and mounted on the microscope with Immersol 518 F (Zeiss). The dish was then left to equilibrate thermally for about 5 min prior to imaging.</p><p>FRAP was conducted using a ZEISS LSM900 Airyscan 2 laser-scanning confocal microscope mounted on an inverted Axio Observer.Z1/7 platform and operated with ZEN 3.1 blue software. The system was equipped with a temperature- and CO<sub>2</sub>-controlled incubation chamber (Zeiss/PeCon) maintained at 37°C and 5% CO<sub>2</sub>. Fluorophores were excited using a 561 nm laser with a maximally sized pinhole, 3.5% laser power, and 800 V detector gain. Movies were acquired with a 40× oil-immersion objective with a numerical aperture of 1.3 using bidirectional scanning to maximize scan speed. Intentional photobleaching (100% 561 nm laser and 100% 405 nm laser) was applied during frame 16.</p></sec><sec id="s4-13"><title>FRAP analysis</title><p>We used custom Python code (<ext-link ext-link-type="uri" xlink:href="https://github.com/vinsfan368/FRAPpy">https://github.com/vinsfan368/FRAPpy</ext-link>, copy archived at <xref ref-type="bibr" rid="bib34">Fan, 2025b</xref>) to quality-control FRAP movies and calculate normalized recoveries. FRAP movies were rejected if there was substantial axial drift.</p><p>Fitting FRAP models to experimental data carries model-dependent assumptions (<xref ref-type="bibr" rid="bib92">Mueller et al., 2008</xref>; <xref ref-type="bibr" rid="bib112">Sprague et al., 2004</xref>). We followed the analysis scheme outlined by <xref ref-type="bibr" rid="bib93">Mueller et al., 2012</xref>, subheading 3.3.2. Briefly, this involves:</p><list list-type="order" id="list2"><list-item><p>Defining a nuclear mask for each FRAP movie. We took a sum-intensity projection across the FRAP movie after normalizing each frame by mean subtraction and dividing by each frame’s standard deviation. We applied a Gaussian blur to this image and used isodata thresholding followed by hole-filling to define the nucleus.</p></list-item><list-item><p>Background subtracting each frame of the FRAP movie. We took the median value of the pixels of the frame defined as non-nuclear as the ‘background’ of that frame and subtracted this value from all of the pixels in that frame.</p></list-item><list-item><p>Normalizing fluorescence values within the nuclear mask to correct for observational photobleaching. Images in the pre-bleach phase of the movie were normalized such that their nuclear intensities were equal to that of the last frame before photobleaching. Images in the post-bleach phase of the movie were normalized such that their nuclear intensities were equal to that of the first image acquired after bleaching.</p></list-item><list-item><p>Calculating FRAP(t), the fluorescence recovery curve over time. At each time point, this was defined as the mean FRAP spot intensity. (These values have been background-subtracted in step 2 and corrected for observational photobleaching in step 3.) We then divided these values by the mean of the pre-bleach frames, which normalizes the FRAP(t) curve to 1.</p></list-item><list-item><p>Resampling FRAP(t) using log-spaced bins to prevent overrepresentation of the long FRAP recovery tail. We defined 100 log-spaced bins between 0.01 s and the max time point recorded for any of the movies in a condition. Then, we took the arithmetic mean of both the timestamps and normalized recovery values falling between these bins. These were used to fit recovery curves below.</p></list-item><list-item><p>Testing if diffusion plays a role in FRAP recovery with the gradient-smoothing test. We plotted the radial intensity profile of the frames immediately after bleaching, normalized them to between 0 and 1, and checked for shape changes as recovery progressed. We did not see changes that would indicate diffusion is contributing to our measured FRAP recoveries for any condition (<xref ref-type="fig" rid="fig2s4">Figure 2—figure supplement 4D-F</xref>). We also note that for the radius of our bleach spot (0.75 µm) and the diffusion coefficient measured by SMT (slower-diffusing population: ~2 µm<sup>2</sup>/s), we would expect diffusive molecules on the edge of the bleach circle to reach the center in about 70 ms on average (mean squared displacement = 4Dt), and our imaging setup allowed us to capture the first post-bleach frame only ~250 ms after bleaching.</p></list-item><list-item><p>Fitting the FRAP(t) curves to a single-exponential recovery function:</p></list-item></list><list list-type="simple" id="list3"><list-item><p><disp-formula id="equ1"><alternatives><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mi>A</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>t</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mi>τ</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t1">\begin{document}$$\displaystyle \mathrm{FRAP}(\Delta t) = A \left( 1 - e^{-\Delta t / \tau} \right)$$\end{document}</tex-math></alternatives></disp-formula></p></list-item><list-item><p>with an implicit constant term constraining A to [0, 1]. Only FRAP recovery for H2B-HaloTag was well fit by this equation. We instead fit FRAP recoveries for the synthetic TFs to a double-exponential recovery function:</p></list-item><list-item><p><disp-formula id="equ2"><alternatives><mml:math id="m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">F</mml:mi><mml:mi mathvariant="normal">R</mml:mi><mml:mi mathvariant="normal">A</mml:mi><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mspace width="negativethinmathspace"/><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>t</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mspace width="negativethinmathspace"/><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msup><mml:mi>e</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>t</mml:mi><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:msup></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:mstyle></mml:math><tex-math id="t2">\begin{document}$$\displaystyle \mathrm{FRAP}(\Delta t) = A_{1}\!\left( 1 - e^{-\Delta t / \tau_{1}} \right) + A_{2}\!\left( 1 - e^{-\Delta t / \tau_{2}} \right)$$\end{document}</tex-math></alternatives></disp-formula></p></list-item><list-item><p>also with an implicit constant term constraining A<sub>1</sub> and A<sub>2</sub> to [0, 1] and their sum to [0, 1].</p></list-item></list><p>We have tabulated the values from these fits in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p></sec><sec id="s4-14"><title>Cleavage under targets and release using nuclease (CUT&amp;RUN) protocol</title><p>We followed steps 1–13, 21–37, and 57–60 of a published CUT&amp;RUN protocol (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17504/protocols.io.zcpf2vn">https://doi.org/10.17504/protocols.io.zcpf2vn</ext-link>), a revised protocol from <xref ref-type="bibr" rid="bib88">Meers et al., 2019</xref>, with the following modifications.</p><p>Cells were counted prior to mixing with concanavalin A beads, and ~299,000 cells were used for each condition. All cell centrifugation steps were 500×<italic>g</italic> for 3 min. The digitonin concentration optimized for our U2OS cell lines was 0.02%. For all experimental conditions, we used a polyclonal rabbit anti-V5 antibody (Abcam ab9116). The wash buffer and Dig-wash buffer were supplemented with 1 µM estradiol. All wash steps with the Dig-wash buffer were repeated once (for a total of two washes) with 200 µL of Dig-wash buffer.</p><p>Following phenol-chloroform extraction, we used ferromagnetic bead cleanup to concentrate and purify DNA fragments:</p><list list-type="order" id="list4"><list-item><p>Add 200 µL SPRI-like homemade magnetic beads to 200 µL eluate from the phenol-chloroform extraction.</p></list-item><list-item><p>Add 400 µL of PEG-8000 buffer to this mixture to help precipitate the DNA fragments.</p></list-item><list-item><p>Rotate at room temperature for 1 hr.</p></list-item><list-item><p>Place the tubes on a magnet stand.</p></list-item><list-item><p>Pipette off supernatant.</p></list-item><list-item><p>Add 800 µL of freshly made 80% ethanol to the tube, being careful not to disturb the beads.</p></list-item><list-item><p>Pipette off supernatant.</p></list-item><list-item><p>Repeat steps 6 and 7.</p></list-item><list-item><p>Air-dry the tubes until beads appear dull brown but not dry and cracked.</p></list-item><list-item><p>Elute in 21 µL H<sub>2</sub>O.</p></list-item></list><p>For library preparation, we used NEBNext Ultra II DNA Library Prep Kit for Illumina and followed the manufacturer’s instructions with the following modifications.</p><p>The Illumina hairpin adapter was diluted 25-fold (i.e. 1 part concentrated adapter plus 24 parts water). Eleven PCR cycles were used for amplification. We performed a dual-sided bead selection with homemade SPRI-like beads with bead concentrations 0.67× (and discarding bead-bound large fragments) and 1.0× (and keeping bead-bound fragments). Fragment sizes were checked by Bioanalyzer (Agilent). Libraries were pooled replicate-wise and sequenced on a NextSeq 2000. Two replicates for each condition were sequenced.</p></sec><sec id="s4-15"><title>Genomics analysis</title><p>We generated a custom hg38 genome with our reporter locus engineered at the AAVS1 locus with bespoke bash scripts. We generated bowtie2 indices for this genome and used this as a reference for both ATAC-seq and CUT&amp;RUN data. We also used the blacklist from <xref ref-type="bibr" rid="bib95">Nordin et al., 2023</xref>, for both ATAC-seq and CUT&amp;RUN analyses.</p><p>We used publicly available ATAC-seq data (<xref ref-type="bibr" rid="bib97">Oomen et al., 2019</xref>) in U2OS cells as a baseline for genomic accessibility in our cell line. We used the nf-core (<xref ref-type="bibr" rid="bib32">Ewels et al., 2020</xref>) pipeline atacseq (<xref ref-type="bibr" rid="bib99">Patel et al., 2023</xref>) to generate genomic accessibility signal (bigWig files) and to call peaks (BED files). We used the pipeline with the following non-default parameters: aligner: ‘bowtie2’, narrow_peak: true, min_reps_consensus: 2. This dataset had two biological replicates with four technical replicates each; we merged peak sets between the two biological replicates with custom bash scripts for our analyses. For genomic tracks, we took the mean of the two bigWig files corresponding to the two biological replicates.</p><p>For our CUT&amp;RUN data, we used the cutandrun (<xref ref-type="bibr" rid="bib15">Cheshire et al., 2024</xref>) nf-core pipeline with the following non-default parameters: spikein_genome: BDGP6, trim_nextseq: 20, remove_mitochondrial_reads: true, mito_name: chrM, dedup_target_reads: true, use_control: false, seacr_peak_threshold: 0.01, replicate_threshold: 2. This normalized our occupancy data to sheared <italic>Drosophila</italic> DNA introduced in the CUT&amp;RUN STOP buffer. For genomic tracks and quantification of signal, we took the mean of the two bigWig files corresponding to two biological replicates for each of cell lines expressing synthetic TFs. For peak sets, we limited ourselves to peaks that were reproduced in both replicates. To call CUT&amp;RUN peak overlaps with ATAC-seq peaks (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>), we considered a peak overlapping if at least one base pair of the CUT&amp;RUN peak was shared with any ATAC-seq peak.</p></sec><sec id="s4-16"><title>Materials availability</title><p>Plasmids used in this study have been deposited with Addgene (Addgene ID numbers 240165–240174). Cell lines are available upon reasonable request.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>is a co-founder of Eikon Therapeutics, Inc</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Methodology</p></fn><fn fn-type="con" id="con3"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Supervision, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Fluorescence recovery after photobleaching (FRAP) parameters extracted from a double-exponential recovery model.</title><p>FRAP population fractions and recovery times for cells expressing various synthetic transcription factors (TFs) and H2B. Stronger activation domains have longer slow-recovery times, indicating longer residence times bound to chromatin. *Note that &gt;95% of H2B molecules do not recover on the timescale of the FRAP experiment.</p></caption><media xlink:href="elife-105776-supp1-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Summary of single-molecule tracking (SMT) measurements.</title><p>Fraction bound, number of cells imaged across all replicates, number of trajectories, number of jumps, and number of detections for all SMT experiments reported in this article. All tabulated values are post-filtering (Materials and methods: SMT and PAPA-SMT analysis). Number of trajectories and number of detections include singlets: detections that were not linked to any other detection and do not contribute any data to downstream analyses but have their own ‘trajectory’ index. * indicates datasets acquired without an automated nucleus-finding macro.</p></caption><media xlink:href="elife-105776-supp2-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-105776-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>SMT trajectories (CSV files tabulating all detections surviving filtering steps) are available on Dryad (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.41ns1rnqt">https://doi.org/10.5061/dryad.41ns1rnqt</ext-link>). We were unable to deposit underlying SMT movies due to their large size. The raw movies are available on request for non-commercial use. Please email the corresponding author to make data transfer arrangements. A representative subset of the raw data and a processed version of the dataset have been deposited in Dryad. FRAP movies are also available as part of the same Dryad dataset (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5061/dryad.41ns1rnqt">https://doi.org/10.5061/dryad.41ns1rnqt</ext-link>). CUT&amp;RUN data has been deposited to the Sequence Read Archive under Accession PRJNA1305492. ATAC-seq data from <xref ref-type="bibr" rid="bib97">Oomen et al., 2019</xref> is available on the GEO as Series GSE121840. Plasmids have been submitted to Addgene and are available under IDs 240165–240174. All essential code is available on public GitHub repositories. We used quot to detect, localize, and connect spots in SMT movies; commit 1b9051e of (<ext-link ext-link-type="uri" xlink:href="https://github.com/vinsfan368/quot">https://github.com/vinsfan368/quot</ext-link>, copy archived at <xref ref-type="bibr" rid="bib55">Heckert, 2025b</xref>) was used for this article. We used qtpicker to refine nuclear masks; commit 6bcbf12 of (<ext-link ext-link-type="uri" xlink:href="https://github.com/vinsfan368/qtpicker">https://github.com/vinsfan368/qtpicker</ext-link>, copy archived at <xref ref-type="bibr" rid="bib33">Fan, 2025a</xref>) was used for this article. We used saspt (<xref ref-type="bibr" rid="bib53">Heckert et al., 2022</xref>) to generate posterior diffusion spectra; commit 632faad of (<ext-link ext-link-type="uri" xlink:href="https://github.com/vinsfan368/saspt">https://github.com/vinsfan368/saspt</ext-link>, copy archived at <xref ref-type="bibr" rid="bib35">Fan, 2025c</xref>) was used for this article. We used FRAPpy to analyze FRAP movies from CZI files; commit dc3687d of (<ext-link ext-link-type="uri" xlink:href="https://github.com/vinsfan368/FRAPpy">https://github.com/vinsfan368/FRAPpy</ext-link>, copy archived at <xref ref-type="bibr" rid="bib34">Fan, 2025b</xref>) was used for this article.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>VB</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>Data from: Short activation domains control chromatin association of transcription factors</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.41ns1rnqt</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>VB</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>Short activation domains control chromatin association of transcription factors</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA1305492">PRJNA1305492</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Oomen</surname><given-names>ME</given-names></name><name><surname>Hansen</surname><given-names>AS</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>CTCF sites display cell cycle dependent dynamics in factor binding and nucleosome positioning</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121840">GSE121840</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>A heartfelt thank you to all members of the Tjian+Darzacq and Staller groups for their intellectual input and experimental advice for this project, particularly Djem Kissiov, Claudia Cattoglio, Joseph McKenna, Yu Chen, Aditya Udupa, Oscar Whitney, and Alec Heckert. Thank you to Anna Mapp for suggesting the norstictic acid experiment. A large thanks to Sathvik Anantakrishnan for his efforts on microscope automation and maintenance, without which this project would not have been possible. We thank Djem Kissiov, Aditya Udupa, and Robert Tjian for the careful reading of the manuscript. We thank Anders Näär and Haribabu Arthanari for helpful discussions. We thank Luke Lavis for providing us with Janelia Fluor dyes. We thank James McNally for helpful correspondence and code sharing. We thank the Dillin lab, particularly Kimberly Tsui, for training and use of the Incucyte S3 instrument.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Abidi</surname><given-names>AA</given-names></name><name><surname>Dailey</surname><given-names>GM</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Graham</surname><given-names>TGW</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Collective Unstructured Interactions Drive Chromatin Binding of Transcription Factors</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2025.05.16.654615</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alerasool</surname><given-names>N</given-names></name><name><surname>Leng</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>ZY</given-names></name><name><surname>Gingras</surname><given-names>AC</given-names></name><name><surname>Taipale</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Identification and functional characterization of transcriptional activators in human cells</article-title><source>Molecular Cell</source><volume>82</volume><fpage>677</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2021.12.008</pub-id><pub-id pub-id-type="pmid">35016035</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badis</surname><given-names>G</given-names></name><name><surname>Berger</surname><given-names>MF</given-names></name><name><surname>Philippakis</surname><given-names>AA</given-names></name><name><surname>Talukder</surname><given-names>S</given-names></name><name><surname>Gehrke</surname><given-names>AR</given-names></name><name><surname>Jaeger</surname><given-names>SA</given-names></name><name><surname>Chan</surname><given-names>ET</given-names></name><name><surname>Metzler</surname><given-names>G</given-names></name><name><surname>Vedenko</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Kuznetsov</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>CF</given-names></name><name><surname>Coburn</surname><given-names>D</given-names></name><name><surname>Newburger</surname><given-names>DE</given-names></name><name><surname>Morris</surname><given-names>Q</given-names></name><name><surname>Hughes</surname><given-names>TR</given-names></name><name><surname>Bulyk</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Diversity and complexity in DNA recognition by transcription factors</article-title><source>Science</source><volume>324</volume><fpage>1720</fpage><lpage>1723</lpage><pub-id pub-id-type="doi">10.1126/science.1162327</pub-id><pub-id pub-id-type="pmid">19443739</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baughman</surname><given-names>HER</given-names></name><name><surname>Narang</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Villagrán Suárez</surname><given-names>AC</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Bachochin</surname><given-names>MJ</given-names></name><name><surname>Gunther</surname><given-names>TR</given-names></name><name><surname>Wolynes</surname><given-names>PG</given-names></name><name><surname>Komives</surname><given-names>EA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>An intrinsically disordered transcription activation domain increases the DNA binding affinity and reduces the specificity of NFκB p50/RelA</article-title><source>The Journal of Biological Chemistry</source><volume>298</volume><elocation-id>102349</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbc.2022.102349</pub-id><pub-id pub-id-type="pmid">35934050</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bentley</surname><given-names>EP</given-names></name><name><surname>Scholl</surname><given-names>D</given-names></name><name><surname>Wright</surname><given-names>PE</given-names></name><name><surname>Deniz</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Coupling of binding and differential subdomain folding of the intrinsically disordered transcription factor CREB</article-title><source>FEBS Letters</source><volume>597</volume><fpage>917</fpage><lpage>932</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.14554</pub-id><pub-id pub-id-type="pmid">36480418</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berlow</surname><given-names>RB</given-names></name><name><surname>Dyson</surname><given-names>HJ</given-names></name><name><surname>Wright</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Hypersensitive termination of the hypoxic response by a disordered protein switch</article-title><source>Nature</source><volume>543</volume><fpage>447</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1038/nature21705</pub-id><pub-id pub-id-type="pmid">28273070</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjarnason</surname><given-names>S</given-names></name><name><surname>McIvor</surname><given-names>J</given-names></name><name><surname>Prestel</surname><given-names>A</given-names></name><name><surname>Demeny</surname><given-names>K</given-names></name><name><surname>Bullerjahn</surname><given-names>J</given-names></name><name><surname>Kragelund</surname><given-names>BB</given-names></name><name><surname>Mercadante</surname><given-names>D</given-names></name><name><surname>Heidarsson</surname><given-names>PO</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>DNA binding redistributes activation domain ensemble and accessibility in pioneer factor Sox2</article-title><source>Biophysical Journal</source><volume>123</volume><elocation-id>518</elocation-id><pub-id pub-id-type="doi">10.1016/j.bpj.2023.11.518</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brent</surname><given-names>R</given-names></name><name><surname>Ptashne</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor</article-title><source>Cell</source><volume>43</volume><fpage>729</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(85)90246-6</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodaczewska</surname><given-names>KK</given-names></name><name><surname>Szczylik</surname><given-names>C</given-names></name><name><surname>Fiedorowicz</surname><given-names>M</given-names></name><name><surname>Porta</surname><given-names>C</given-names></name><name><surname>Czarnecka</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Choosing the right cell line for renal cell cancer research</article-title><source>Molecular Cancer</source><volume>15</volume><elocation-id>83</elocation-id><pub-id pub-id-type="doi">10.1186/s12943-016-0565-8</pub-id><pub-id pub-id-type="pmid">27993170</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodsky</surname><given-names>S</given-names></name><name><surname>Jana</surname><given-names>T</given-names></name><name><surname>Mittelman</surname><given-names>K</given-names></name><name><surname>Chapal</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>DK</given-names></name><name><surname>Carmi</surname><given-names>M</given-names></name><name><surname>Barkai</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Intrinsically disordered regions direct transcription factor in vivo binding specificity</article-title><source>Molecular Cell</source><volume>79</volume><fpage>459</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.05.032</pub-id><pub-id pub-id-type="pmid">32553192</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>I</given-names></name><name><surname>Lenstra</surname><given-names>TL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Visualizing transcription: key to understanding gene expression dynamics</article-title><source>Current Opinion in Chemical Biology</source><volume>51</volume><fpage>122</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2019.05.031</pub-id><pub-id pub-id-type="pmid">31284216</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callegari</surname><given-names>A</given-names></name><name><surname>Sieben</surname><given-names>C</given-names></name><name><surname>Benke</surname><given-names>A</given-names></name><name><surname>Suter</surname><given-names>DM</given-names></name><name><surname>Fierz</surname><given-names>B</given-names></name><name><surname>Mazza</surname><given-names>D</given-names></name><name><surname>Manley</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-molecule dynamics and genome-wide transcriptomics reveal that NF-kB (p65)-DNA binding times can be decoupled from transcriptional activation</article-title><source>PLOS Genetics</source><volume>15</volume><elocation-id>e1007891</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007891</pub-id><pub-id pub-id-type="pmid">30653501</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>BC</given-names></name><name><surname>Revyakin</surname><given-names>A</given-names></name><name><surname>Hajj</surname><given-names>B</given-names></name><name><surname>Legant</surname><given-names>W</given-names></name><name><surname>Dahan</surname><given-names>M</given-names></name><name><surname>Lionnet</surname><given-names>T</given-names></name><name><surname>Betzig</surname><given-names>E</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Single-molecule dynamics of enhanceosome assembly in embryonic stem cells</article-title><source>Cell</source><volume>156</volume><fpage>1274</fpage><lpage>1285</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.01.062</pub-id><pub-id pub-id-type="pmid">24630727</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Cattoglio</surname><given-names>C</given-names></name><name><surname>Dailey</surname><given-names>GM</given-names></name><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Mechanisms governing target search and binding dynamics of hypoxia-inducible factors</article-title><source>eLife</source><volume>11</volume><elocation-id>75064</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.75064</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Cheshire</surname><given-names>C</given-names></name><name><surname>Charlotte-west</surname><given-names>R</given-names></name><name><surname>Ronkko</surname><given-names>T</given-names></name><name><surname>Patel</surname><given-names>H</given-names></name><name><surname>Ladd</surname><given-names>D</given-names></name><name><surname>Hodgetts</surname><given-names>T</given-names></name><name><surname>Thiery</surname><given-names>A</given-names></name><name><surname>Fields</surname><given-names>C</given-names></name><name><surname>Deu-Pons</surname><given-names>J</given-names></name><name><surname>Ewels</surname><given-names>P</given-names></name><name><surname>Möller</surname><given-names>S</given-names></name><name><surname>Menden</surname><given-names>K</given-names></name><collab>nf-core bot</collab></person-group><year iso-8601-date="2024">2024</year><data-title>Nf-core/cutandrun: nf-core/cutandrun v3.2.2 iridium ibis</data-title><source>Zenodo</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.10606804">https://doi.org/10.5281/zenodo.10606804</ext-link></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>WK</given-names></name><name><surname>Spille</surname><given-names>JH</given-names></name><name><surname>Hecht</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Grube</surname><given-names>V</given-names></name><name><surname>Cisse</surname><given-names>II</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mediator and RNA polymerase II clusters associate in transcription-dependent condensates</article-title><source>Science</source><volume>361</volume><fpage>412</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1126/science.aar4199</pub-id><pub-id pub-id-type="pmid">29930094</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copeland</surname><given-names>JW</given-names></name><name><surname>Nasiadka</surname><given-names>A</given-names></name><name><surname>Dietrich</surname><given-names>BH</given-names></name><name><surname>Krause</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Patterning of the Drosophila embryo by a homeodomain-deleted Ftz polypeptide</article-title><source>Nature</source><volume>379</volume><fpage>162</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1038/379162a0</pub-id><pub-id pub-id-type="pmid">8538765</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowling</surname><given-names>VH</given-names></name><name><surname>Cole</surname><given-names>MD</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding</article-title><source>Molecular and Cellular Biology</source><volume>27</volume><fpage>2059</fpage><lpage>2073</lpage><pub-id pub-id-type="doi">10.1128/MCB.01828-06</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cress</surname><given-names>WD</given-names></name><name><surname>Triezenberg</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Critical structural elements of the VP16 transcriptional activation domain</article-title><source>Science</source><volume>251</volume><fpage>87</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1126/science.1846049</pub-id><pub-id pub-id-type="pmid">1846049</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Currie</surname><given-names>SL</given-names></name><name><surname>Lau</surname><given-names>DKW</given-names></name><name><surname>Doane</surname><given-names>JJ</given-names></name><name><surname>Whitby</surname><given-names>FG</given-names></name><name><surname>Okon</surname><given-names>M</given-names></name><name><surname>McIntosh</surname><given-names>LP</given-names></name><name><surname>Graves</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Structured and disordered regions cooperatively mediate DNA-binding autoinhibition of ETS factors ETV1, ETV4 and ETV5</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>2223</fpage><lpage>2241</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx068</pub-id><pub-id pub-id-type="pmid">28161714</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dahal</surname><given-names>L</given-names></name><name><surname>Graham</surname><given-names>TGW</given-names></name><name><surname>Dailey</surname><given-names>GM</given-names></name><name><surname>Heckert</surname><given-names>A</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Surprising features of nuclear receptor interaction networks revealed by live-cell single-molecule imaging</article-title><source>eLife</source><volume>12</volume><elocation-id>RP92979</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.92979</pub-id><pub-id pub-id-type="pmid">39792435</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Danner</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Effective lonza 4D nucleofection with inexpensive homemade buffers</article-title><ext-link ext-link-type="uri" xlink:href="https://www.protocols.io/view/effective-lonza-4d-nucleofection-with-inexpensive-64mhgu6">https://www.protocols.io/view/effective-lonza-4d-nucleofection-with-inexpensive-64mhgu6</ext-link><date-in-citation iso-8601-date="2020-04-17">April 17, 2020</date-in-citation></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Guzman</surname><given-names>RN</given-names></name><name><surname>Martinez-Yamout</surname><given-names>MA</given-names></name><name><surname>Dyson</surname><given-names>HJ</given-names></name><name><surname>Wright</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Interaction of the TAZ1 domain of the CREB-binding protein with the activation domain of CITED2: regulation by competition between intrinsically unstructured ligands for non-identical binding sites</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>3042</fpage><lpage>3049</lpage><pub-id pub-id-type="doi">10.1074/jbc.M310348200</pub-id><pub-id pub-id-type="pmid">14594809</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DelRosso</surname><given-names>N</given-names></name><name><surname>Tycko</surname><given-names>J</given-names></name><name><surname>Suzuki</surname><given-names>P</given-names></name><name><surname>Andrews</surname><given-names>C</given-names></name><name><surname>Mukund</surname><given-names>A</given-names></name><name><surname>Liongson</surname><given-names>I</given-names></name><name><surname>Ludwig</surname><given-names>C</given-names></name><name><surname>Spees</surname><given-names>K</given-names></name><name><surname>Fordyce</surname><given-names>P</given-names></name><name><surname>Bassik</surname><given-names>MC</given-names></name><name><surname>Bintu</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Large-scale mapping and systematic mutagenesis of human transcriptional effector domains</article-title><source>Systems Biology</source><volume>1</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1101/2022.08.26.505496</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>DelRosso</surname><given-names>N</given-names></name><name><surname>Suzuki</surname><given-names>PH</given-names></name><name><surname>Griffith</surname><given-names>D</given-names></name><name><surname>Lotthammer</surname><given-names>JM</given-names></name><name><surname>Novak</surname><given-names>B</given-names></name><name><surname>Kocalar</surname><given-names>S</given-names></name><name><surname>Sheth</surname><given-names>MU</given-names></name><name><surname>Holehouse</surname><given-names>AS</given-names></name><name><surname>Bintu</surname><given-names>L</given-names></name><name><surname>Fordyce</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>High-throughput affinity measurements of direct interactions between activation domains and co-activators</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2024.08.19.608698</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doughty</surname><given-names>BR</given-names></name><name><surname>Hinks</surname><given-names>MM</given-names></name><name><surname>Schaepe</surname><given-names>JM</given-names></name><name><surname>Marinov</surname><given-names>GK</given-names></name><name><surname>Thurm</surname><given-names>AR</given-names></name><name><surname>Rios-Martinez</surname><given-names>C</given-names></name><name><surname>Parks</surname><given-names>BE</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Marklund</surname><given-names>E</given-names></name><name><surname>Dubocanin</surname><given-names>D</given-names></name><name><surname>Bintu</surname><given-names>L</given-names></name><name><surname>Greenleaf</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Single-molecule states link transcription factor binding to gene expression</article-title><source>Nature</source><volume>636</volume><fpage>745</fpage><lpage>754</lpage><pub-id pub-id-type="doi">10.1038/s41586-024-08219-w</pub-id><pub-id pub-id-type="pmid">39567683</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Driouchi</surname><given-names>A</given-names></name><name><surname>Bretan</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>BJ</given-names></name><name><surname>Heckert</surname><given-names>A</given-names></name><name><surname>Seeger</surname><given-names>M</given-names></name><name><surname>Silva</surname><given-names>MB</given-names></name><name><surname>Forrest</surname><given-names>WSR</given-names></name><name><surname>Hsiung</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>McSwiggen</surname><given-names>DT</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Sule</surname><given-names>A</given-names></name><name><surname>Abaie</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Chhun</surname><given-names>B</given-names></name><name><surname>Conroy</surname><given-names>B</given-names></name><name><surname>Elliott</surname><given-names>LA</given-names></name><name><surname>Gonzalez</surname><given-names>E</given-names></name><name><surname>Ilkov</surname><given-names>F</given-names></name><name><surname>Isaacs</surname><given-names>J</given-names></name><name><surname>Labaria</surname><given-names>G</given-names></name><name><surname>Lagana</surname><given-names>M</given-names></name><name><surname>Larsen</surname><given-names>DD</given-names></name><name><surname>Margolin</surname><given-names>B</given-names></name><name><surname>Nguyen</surname><given-names>MK</given-names></name><name><surname>Park</surname><given-names>E</given-names></name><name><surname>Rine</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Vana</surname><given-names>M</given-names></name><name><surname>Wilkey</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Basham</surname><given-names>S</given-names></name><name><surname>Ho</surname><given-names>JJ</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><name><surname>Klammer</surname><given-names>AA</given-names></name><name><surname>Lin</surname><given-names>K</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name><name><surname>Betzig</surname><given-names>E</given-names></name><name><surname>Berman</surname><given-names>RT</given-names></name><name><surname>Anderson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Oblique line scan illumination enables expansive, accurate and sensitive single-protein measurements in solution and in living cells</article-title><source>Nature Methods</source><volume>22</volume><fpage>559</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1038/s41592-025-02594-6</pub-id><pub-id pub-id-type="pmid">39966678</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyson</surname><given-names>HJ</given-names></name><name><surname>Wright</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Role of intrinsic protein disorder in the function and interactions of the transcriptional coactivators CREB-binding Protein (CBP) and p300</article-title><source>The Journal of Biological Chemistry</source><volume>291</volume><fpage>6714</fpage><lpage>6722</lpage><pub-id pub-id-type="doi">10.1074/jbc.R115.692020</pub-id><pub-id pub-id-type="pmid">26851278</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Gebali</surname><given-names>S</given-names></name><name><surname>Mistry</surname><given-names>J</given-names></name><name><surname>Bateman</surname><given-names>A</given-names></name><name><surname>Eddy</surname><given-names>SR</given-names></name><name><surname>Luciani</surname><given-names>A</given-names></name><name><surname>Potter</surname><given-names>SC</given-names></name><name><surname>Qureshi</surname><given-names>M</given-names></name><name><surname>Richardson</surname><given-names>LJ</given-names></name><name><surname>Salazar</surname><given-names>GA</given-names></name><name><surname>Smart</surname><given-names>A</given-names></name><name><surname>Sonnhammer</surname><given-names>ELL</given-names></name><name><surname>Hirsh</surname><given-names>L</given-names></name><name><surname>Paladin</surname><given-names>L</given-names></name><name><surname>Piovesan</surname><given-names>D</given-names></name><name><surname>Tosatto</surname><given-names>SCE</given-names></name><name><surname>Finn</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The Pfam protein families database in 2019</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D427</fpage><lpage>D432</lpage><pub-id pub-id-type="doi">10.1093/nar/gky995</pub-id><pub-id pub-id-type="pmid">30357350</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endesfelder</surname><given-names>U</given-names></name><name><surname>Heilemann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Direct stochastic optical reconstruction microscopy (dSTORM)</article-title><source>Methods in Molecular Biology</source><volume>1251</volume><fpage>263</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-2080-8_14</pub-id><pub-id pub-id-type="pmid">25391804</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erijman</surname><given-names>A</given-names></name><name><surname>Kozlowski</surname><given-names>L</given-names></name><name><surname>Sohrabi-Jahromi</surname><given-names>S</given-names></name><name><surname>Fishburn</surname><given-names>J</given-names></name><name><surname>Warfield</surname><given-names>L</given-names></name><name><surname>Schreiber</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name><name><surname>Söding</surname><given-names>J</given-names></name><name><surname>Hahn</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A high-throughput screen for transcription activation domains reveals their sequence features and permits prediction by deep learning</article-title><source>Molecular Cell</source><volume>78</volume><fpage>890</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.04.020</pub-id><pub-id pub-id-type="pmid">32416068</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewels</surname><given-names>PA</given-names></name><name><surname>Peltzer</surname><given-names>A</given-names></name><name><surname>Fillinger</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>H</given-names></name><name><surname>Alneberg</surname><given-names>J</given-names></name><name><surname>Wilm</surname><given-names>A</given-names></name><name><surname>Garcia</surname><given-names>MU</given-names></name><name><surname>Di Tommaso</surname><given-names>P</given-names></name><name><surname>Nahnsen</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The nf-core framework for community-curated bioinformatics pipelines</article-title><source>Nature Biotechnology</source><volume>38</volume><fpage>276</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0439-x</pub-id><pub-id pub-id-type="pmid">32055031</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>VB</given-names></name></person-group><year iso-8601-date="2025">2025a</year><data-title>Qtpicker</data-title><version designator="swh:1:rev:6bcbf125596d4ea10941e462344d137fc527c9c0">swh:1:rev:6bcbf125596d4ea10941e462344d137fc527c9c0</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:eaf0d50c51a3002f8f9af2dcc0222e30b16e4e27;origin=https://github.com/vinsfan368/qtpicker;visit=swh:1:snp:2deaa7de938cbb293fe0ffaf469af8d38690f771;anchor=swh:1:rev:6bcbf125596d4ea10941e462344d137fc527c9c0">https://archive.softwareheritage.org/swh:1:dir:eaf0d50c51a3002f8f9af2dcc0222e30b16e4e27;origin=https://github.com/vinsfan368/qtpicker;visit=swh:1:snp:2deaa7de938cbb293fe0ffaf469af8d38690f771;anchor=swh:1:rev:6bcbf125596d4ea10941e462344d137fc527c9c0</ext-link></element-citation></ref><ref id="bib34"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>VB</given-names></name></person-group><year iso-8601-date="2025">2025b</year><data-title>FRAPpy</data-title><version designator="swh:1:rev:dc3687d895dd733d2ac714bedb8a5278310a61fa">swh:1:rev:dc3687d895dd733d2ac714bedb8a5278310a61fa</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:74cb3806c95dea0fc162b020645642ffa92d20de;origin=https://github.com/vinsfan368/FRAPpy;visit=swh:1:snp:999f9b5b8d442cc2adc2e4b9e53d4a26396741f0;anchor=swh:1:rev:dc3687d895dd733d2ac714bedb8a5278310a61fa">https://archive.softwareheritage.org/swh:1:dir:74cb3806c95dea0fc162b020645642ffa92d20de;origin=https://github.com/vinsfan368/FRAPpy;visit=swh:1:snp:999f9b5b8d442cc2adc2e4b9e53d4a26396741f0;anchor=swh:1:rev:dc3687d895dd733d2ac714bedb8a5278310a61fa</ext-link></element-citation></ref><ref id="bib35"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>VB</given-names></name></person-group><year iso-8601-date="2025">2025c</year><data-title>Saspt</data-title><version designator="swh:1:rev:632faad61df4dc2ee90cb6adf657daf7296aa366">swh:1:rev:632faad61df4dc2ee90cb6adf657daf7296aa366</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:b335aa7ca1f1ab86b6430b70b9a8824cf06116b8;origin=https://github.com/vinsfan368/saspt;visit=swh:1:snp:c5919bd112d75b5d1a90c9269c49a3059c75dc89;anchor=swh:1:rev:632faad61df4dc2ee90cb6adf657daf7296aa366">https://archive.softwareheritage.org/swh:1:dir:b335aa7ca1f1ab86b6430b70b9a8824cf06116b8;origin=https://github.com/vinsfan368/saspt;visit=swh:1:snp:c5919bd112d75b5d1a90c9269c49a3059c75dc89;anchor=swh:1:rev:632faad61df4dc2ee90cb6adf657daf7296aa366</ext-link></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrie</surname><given-names>JJ</given-names></name><name><surname>Karr</surname><given-names>JP</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>“Structure”-function relationships in eukaryotic transcription factors: The role of intrinsically disordered regions in gene regulation</article-title><source>Molecular Cell</source><volume>82</volume><fpage>3970</fpage><lpage>3984</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2022.09.021</pub-id><pub-id pub-id-type="pmid">36265487</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrie</surname><given-names>JJ</given-names></name><name><surname>Karr</surname><given-names>JP</given-names></name><name><surname>Graham</surname><given-names>TGW</given-names></name><name><surname>Dailey</surname><given-names>GM</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>P300 is an obligate integrator of combinatorial transcription factor inputs</article-title><source>Molecular Cell</source><volume>84</volume><fpage>234</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2023.12.004</pub-id><pub-id pub-id-type="pmid">38159566</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finn</surname><given-names>RD</given-names></name><name><surname>Coggill</surname><given-names>P</given-names></name><name><surname>Eberhardt</surname><given-names>RY</given-names></name><name><surname>Eddy</surname><given-names>SR</given-names></name><name><surname>Mistry</surname><given-names>J</given-names></name><name><surname>Mitchell</surname><given-names>AL</given-names></name><name><surname>Potter</surname><given-names>SC</given-names></name><name><surname>Punta</surname><given-names>M</given-names></name><name><surname>Qureshi</surname><given-names>M</given-names></name><name><surname>Sangrador-Vegas</surname><given-names>A</given-names></name><name><surname>Salazar</surname><given-names>GA</given-names></name><name><surname>Tate</surname><given-names>J</given-names></name><name><surname>Bateman</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The Pfam protein families database: towards a more sustainable future</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D279</fpage><lpage>D285</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1344</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garlick</surname><given-names>JM</given-names></name><name><surname>Sturlis</surname><given-names>SM</given-names></name><name><surname>Bruno</surname><given-names>PA</given-names></name><name><surname>Yates</surname><given-names>JA</given-names></name><name><surname>Peiffer</surname><given-names>AL</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Goo</surname><given-names>L</given-names></name><name><surname>Bao</surname><given-names>L</given-names></name><name><surname>De Salle</surname><given-names>SN</given-names></name><name><surname>Tamayo-Castillo</surname><given-names>G</given-names></name><name><surname>Brooks</surname><given-names>CL</given-names><suffix>III</suffix></name><name><surname>Merajver</surname><given-names>SD</given-names></name><name><surname>Mapp</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Norstictic acid is a selective allosteric transcriptional regulator</article-title><source>Journal of the American Chemical Society</source><volume>143</volume><fpage>9297</fpage><lpage>9302</lpage><pub-id pub-id-type="doi">10.1021/jacs.1c03258</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gera</surname><given-names>T</given-names></name><name><surname>Jonas</surname><given-names>F</given-names></name><name><surname>More</surname><given-names>R</given-names></name><name><surname>Barkai</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Evolution of binding preferences among whole-genome duplicated transcription factors</article-title><source>eLife</source><volume>11</volume><elocation-id>e73225</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.73225</pub-id><pub-id pub-id-type="pmid">35404235</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gill</surname><given-names>G</given-names></name><name><surname>Pascal</surname><given-names>E</given-names></name><name><surname>Tseng</surname><given-names>ZH</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation</article-title><source>PNAS</source><volume>91</volume><fpage>192</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.1.192</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillespie</surname><given-names>MA</given-names></name><name><surname>Palii</surname><given-names>CG</given-names></name><name><surname>Sanchez-Taltavull</surname><given-names>D</given-names></name><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Longabaugh</surname><given-names>WJR</given-names></name><name><surname>Downes</surname><given-names>DJ</given-names></name><name><surname>Sivaraman</surname><given-names>K</given-names></name><name><surname>Espinoza</surname><given-names>HM</given-names></name><name><surname>Hughes</surname><given-names>JR</given-names></name><name><surname>Price</surname><given-names>ND</given-names></name><name><surname>Perkins</surname><given-names>TJ</given-names></name><name><surname>Ranish</surname><given-names>JA</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Absolute quantification of transcription factors reveals principles of gene regulation in erythropoiesis</article-title><source>Molecular Cell</source><volume>78</volume><fpage>960</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.03.031</pub-id><pub-id pub-id-type="pmid">32330456</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman</surname><given-names>N</given-names></name><name><surname>Chandra</surname><given-names>A</given-names></name><name><surname>Johnson</surname><given-names>I</given-names></name><name><surname>Sullivan</surname><given-names>MA</given-names></name><name><surname>Patil</surname><given-names>AR</given-names></name><name><surname>Vanderbeck</surname><given-names>A</given-names></name><name><surname>Jay</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Ferrari</surname><given-names>EK</given-names></name><name><surname>Mayne</surname><given-names>L</given-names></name><name><surname>Aguilan</surname><given-names>J</given-names></name><name><surname>Xue</surname><given-names>HH</given-names></name><name><surname>Faryabi</surname><given-names>RB</given-names></name><name><surname>John Wherry</surname><given-names>E</given-names></name><name><surname>Sidoli</surname><given-names>S</given-names></name><name><surname>Maillard</surname><given-names>I</given-names></name><name><surname>Vahedi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Intrinsically disordered domain of transcription factor TCF-1 is required for T cell developmental fidelity</article-title><source>Nature Immunology</source><volume>24</volume><fpage>1698</fpage><lpage>1710</lpage><pub-id pub-id-type="doi">10.1038/s41590-023-01599-7</pub-id><pub-id pub-id-type="pmid">37592014</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golemis</surname><given-names>EA</given-names></name><name><surname>Brent</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Fused protein domains inhibit DNA binding by LexA</article-title><source>Molecular and Cellular Biology</source><volume>12</volume><fpage>3006</fpage><lpage>3014</lpage><pub-id pub-id-type="doi">10.1128/mcb.12.7.3006-3014.1992</pub-id><pub-id pub-id-type="pmid">1620111</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>TGW</given-names></name><name><surname>Ferrie</surname><given-names>JJ</given-names></name><name><surname>Dailey</surname><given-names>GM</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Detecting molecular interactions in live-cell single-molecule imaging with proximity-assisted photoactivation (PAPA)</article-title><source>eLife</source><volume>11</volume><elocation-id>76870</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.76870</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>TGW</given-names></name><name><surname>Dugast-Darzacq</surname><given-names>C</given-names></name><name><surname>Dailey</surname><given-names>GM</given-names></name><name><surname>Weng</surname><given-names>B</given-names></name><name><surname>Anantakrishnan</surname><given-names>S</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Single-molecule live imaging of subunit interactions and exchange within cellular regulatory complexes</article-title><source>Molecular Cell</source><volume>85</volume><fpage>2854</fpage><lpage>2868</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2025.06.028</pub-id><pub-id pub-id-type="pmid">40706597</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimm</surname><given-names>JB</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Casler</surname><given-names>JC</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><name><surname>Tkachuk</surname><given-names>AN</given-names></name><name><surname>Falco</surname><given-names>N</given-names></name><name><surname>Choi</surname><given-names>H</given-names></name><name><surname>Lippincott-Schwartz</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>TA</given-names></name><name><surname>Glick</surname><given-names>BS</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Lavis</surname><given-names>LD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A general method to improve fluorophores using deuterated auxochromes</article-title><source>JACS Au</source><volume>1</volume><fpage>690</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1021/jacsau.1c00006</pub-id><pub-id pub-id-type="pmid">34056637</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>LP</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>GQ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms</article-title><source>Apoptosis</source><volume>11</volume><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/s10495-005-3085-3</pub-id><pub-id pub-id-type="pmid">16374551</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahn</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Transcriptional regulation in <italic>Saccharomyces cerevisiae</italic> : transcription factor regulation and function, mechanisms of initiation, and roles of activators and coactivators</article-title><source>Genetics</source><volume>189</volume><fpage>705</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.127019</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>AS</given-names></name><name><surname>Woringer</surname><given-names>M</given-names></name><name><surname>Grimm</surname><given-names>JB</given-names></name><name><surname>Lavis</surname><given-names>LD</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Robust model-based analysis of single-particle tracking experiments with Spot-On</article-title><source>eLife</source><volume>7</volume><elocation-id>e33125</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.33125</pub-id><pub-id pub-id-type="pmid">29300163</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>MM</given-names></name><name><surname>Li</surname><given-names>XY</given-names></name><name><surname>Kaplan</surname><given-names>T</given-names></name><name><surname>Botchan</surname><given-names>MR</given-names></name><name><surname>Eisen</surname><given-names>MB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Zelda binding in the early <italic>Drosophila melanogaster</italic> embryo marks regions subsequently activated at the maternal-to-zygotic transition</article-title><source>PLOS Genetics</source><volume>7</volume><elocation-id>e1002266</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002266</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>F</given-names></name><name><surname>Borcherds</surname><given-names>W</given-names></name><name><surname>Song</surname><given-names>T</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Das</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Daughdrill</surname><given-names>GW</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding</article-title><source>PNAS</source><volume>116</volume><fpage>8859</fpage><lpage>8868</lpage><pub-id pub-id-type="doi">10.1073/pnas.1903077116</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heckert</surname><given-names>A</given-names></name><name><surname>Dahal</surname><given-names>L</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Recovering mixtures of fast-diffusing states from short single-particle trajectories</article-title><source>eLife</source><volume>11</volume><elocation-id>e70169</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.70169</pub-id><pub-id pub-id-type="pmid">36066004</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Heckert</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>VB</given-names></name><name><surname>Hong</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2025">2025a</year><data-title>Saspt</data-title><version designator="swh:1:rev:ad0fa303d5000672ab88d16494e7587c366409d9">swh:1:rev:ad0fa303d5000672ab88d16494e7587c366409d9</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:dfdfc8c6e63564880b098cb9edef432bc17deb37;origin=https://github.com/alecheckert/saspt;visit=swh:1:snp:ccfb13ebcf24cb4f3b362d6a5047e75dfe676de4;anchor=swh:1:rev:ad0fa303d5000672ab88d16494e7587c366409d9">https://archive.softwareheritage.org/swh:1:dir:dfdfc8c6e63564880b098cb9edef432bc17deb37;origin=https://github.com/alecheckert/saspt;visit=swh:1:snp:ccfb13ebcf24cb4f3b362d6a5047e75dfe676de4;anchor=swh:1:rev:ad0fa303d5000672ab88d16494e7587c366409d9</ext-link></element-citation></ref><ref id="bib55"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Heckert</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2025">2025b</year><data-title>Quot</data-title><version designator="swh:1:rev:1b9051e277894bc65372412e641c8c01d974ae96">swh:1:rev:1b9051e277894bc65372412e641c8c01d974ae96</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:700dbc4d743180a9b39ce4e5fe6f2cbc235f940b;origin=https://github.com/vinsfan368/quot;visit=swh:1:snp:2a0b41e540b861f419a5f02d5e6d0e431c4eca91;anchor=swh:1:rev:1b9051e277894bc65372412e641c8c01d974ae96">https://archive.softwareheritage.org/swh:1:dir:700dbc4d743180a9b39ce4e5fe6f2cbc235f940b;origin=https://github.com/vinsfan368/quot;visit=swh:1:snp:2a0b41e540b861f419a5f02d5e6d0e431c4eca91;anchor=swh:1:rev:1b9051e277894bc65372412e641c8c01d974ae96</ext-link></element-citation></ref><ref id="bib56"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Heckert</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>VB</given-names></name></person-group><year iso-8601-date="2025">2025c</year><data-title>Quot</data-title><version designator="swh:1:rev:1b9051e277894bc65372412e641c8c01d974ae96">swh:1:rev:1b9051e277894bc65372412e641c8c01d974ae96</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:700dbc4d743180a9b39ce4e5fe6f2cbc235f940b;origin=https://github.com/alecheckert/quot;visit=swh:1:snp:2e5c79512d05590680d402b117c814197e78a49d;anchor=swh:1:rev:1b9051e277894bc65372412e641c8c01d974ae96">https://archive.softwareheritage.org/swh:1:dir:700dbc4d743180a9b39ce4e5fe6f2cbc235f940b;origin=https://github.com/alecheckert/quot;visit=swh:1:snp:2e5c79512d05590680d402b117c814197e78a49d;anchor=swh:1:rev:1b9051e277894bc65372412e641c8c01d974ae96</ext-link></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>AR</given-names></name><name><surname>Henley</surname><given-names>MJ</given-names></name><name><surname>Foster</surname><given-names>NJ</given-names></name><name><surname>Peiffer</surname><given-names>AL</given-names></name><name><surname>Beyersdorf</surname><given-names>MS</given-names></name><name><surname>Stanford</surname><given-names>KD</given-names></name><name><surname>Sturlis</surname><given-names>SM</given-names></name><name><surname>Linhares</surname><given-names>BM</given-names></name><name><surname>Hill</surname><given-names>ZB</given-names></name><name><surname>Wells</surname><given-names>JA</given-names></name><name><surname>Cierpicki</surname><given-names>T</given-names></name><name><surname>Brooks</surname><given-names>CL</given-names></name><name><surname>Fierke</surname><given-names>CA</given-names></name><name><surname>Mapp</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Conservation of coactivator engagement mechanism enables small-molecule allosteric modulators</article-title><source>PNAS</source><volume>115</volume><fpage>8960</fpage><lpage>8965</lpage><pub-id pub-id-type="doi">10.1073/pnas.1806202115</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henley</surname><given-names>MJ</given-names></name><name><surname>Linhares</surname><given-names>BM</given-names></name><name><surname>Morgan</surname><given-names>BS</given-names></name><name><surname>Cierpicki</surname><given-names>T</given-names></name><name><surname>Fierke</surname><given-names>CA</given-names></name><name><surname>Mapp</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Unexpected specificity within dynamic transcriptional protein–protein complexes</article-title><source>PNAS</source><volume>117</volume><fpage>27346</fpage><lpage>27353</lpage><pub-id pub-id-type="doi">10.1073/pnas.2013244117</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewitson</surname><given-names>KS</given-names></name><name><surname>McNeill</surname><given-names>LA</given-names></name><name><surname>Riordan</surname><given-names>MV</given-names></name><name><surname>Tian</surname><given-names>YM</given-names></name><name><surname>Bullock</surname><given-names>AN</given-names></name><name><surname>Welford</surname><given-names>RW</given-names></name><name><surname>Elkins</surname><given-names>JM</given-names></name><name><surname>Oldham</surname><given-names>NJ</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name><name><surname>Gleadle</surname><given-names>JM</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name><name><surname>Pugh</surname><given-names>CW</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Hypoxia-inducible Factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><fpage>26351</fpage><lpage>26355</lpage><pub-id pub-id-type="doi">10.1074/jbc.C200273200</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hope</surname><given-names>IA</given-names></name><name><surname>Struhl</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of yeast</article-title><source>Cell</source><volume>46</volume><fpage>885</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(86)90070-x</pub-id><pub-id pub-id-type="pmid">3530496</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hope</surname><given-names>IA</given-names></name><name><surname>Mahadevan</surname><given-names>S</given-names></name><name><surname>Struhl</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Structural and functional characterization of the short acidic transcriptional activation region of yeast GCN4 protein</article-title><source>Nature</source><volume>333</volume><fpage>635</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1038/333635a0</pub-id><pub-id pub-id-type="pmid">3287180</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hume</surname><given-names>MA</given-names></name><name><surname>Barrera</surname><given-names>LA</given-names></name><name><surname>Gisselbrecht</surname><given-names>SS</given-names></name><name><surname>Bulyk</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>UniPROBE, update 2015: new tools and content for the online database of protein-binding microarray data on protein-DNA interactions</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>D117</fpage><lpage>D122</lpage><pub-id pub-id-type="doi">10.1093/nar/gku1045</pub-id><pub-id pub-id-type="pmid">25378322</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurieva</surname><given-names>B</given-names></name><name><surname>Kumar</surname><given-names>DK</given-names></name><name><surname>Morag</surname><given-names>R</given-names></name><name><surname>Lupo</surname><given-names>O</given-names></name><name><surname>Carmi</surname><given-names>M</given-names></name><name><surname>Barkai</surname><given-names>N</given-names></name><name><surname>Jonas</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Disordered sequences of transcription factors regulate genomic binding by integrating diverse sequence grammars and interaction types</article-title><source>Nucleic Acids Research</source><volume>52</volume><fpage>8763</fpage><lpage>8777</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae521</pub-id><pub-id pub-id-type="pmid">38908024</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jana</surname><given-names>T</given-names></name><name><surname>Brodsky</surname><given-names>S</given-names></name><name><surname>Barkai</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Speed-specificity trade-offs in the transcription factors search for their genomic binding sites</article-title><source>Trends in Genetics</source><volume>37</volume><fpage>421</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1016/j.tig.2020.12.001</pub-id><pub-id pub-id-type="pmid">33414013</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolma</surname><given-names>A</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Whitington</surname><given-names>T</given-names></name><name><surname>Toivonen</surname><given-names>J</given-names></name><name><surname>Nitta</surname><given-names>KR</given-names></name><name><surname>Rastas</surname><given-names>P</given-names></name><name><surname>Morgunova</surname><given-names>E</given-names></name><name><surname>Enge</surname><given-names>M</given-names></name><name><surname>Taipale</surname><given-names>M</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Palin</surname><given-names>K</given-names></name><name><surname>Vaquerizas</surname><given-names>JM</given-names></name><name><surname>Vincentelli</surname><given-names>R</given-names></name><name><surname>Luscombe</surname><given-names>NM</given-names></name><name><surname>Hughes</surname><given-names>TR</given-names></name><name><surname>Lemaire</surname><given-names>P</given-names></name><name><surname>Ukkonen</surname><given-names>E</given-names></name><name><surname>Kivioja</surname><given-names>T</given-names></name><name><surname>Taipale</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>DNA-binding specificities of human transcription factors</article-title><source>Cell</source><volume>152</volume><fpage>327</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.12.009</pub-id><pub-id pub-id-type="pmid">23332764</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonas</surname><given-names>F</given-names></name><name><surname>Carmi</surname><given-names>M</given-names></name><name><surname>Krupkin</surname><given-names>B</given-names></name><name><surname>Steinberger</surname><given-names>J</given-names></name><name><surname>Brodsky</surname><given-names>S</given-names></name><name><surname>Jana</surname><given-names>T</given-names></name><name><surname>Barkai</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The molecular grammar of protein disorder guiding genome-binding locations</article-title><source>Nucleic Acids Research</source><volume>51</volume><fpage>4831</fpage><lpage>4844</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad184</pub-id><pub-id pub-id-type="pmid">36938874</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadoch</surname><given-names>C</given-names></name><name><surname>Crabtree</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics</article-title><source>Science Advances</source><volume>1</volume><elocation-id>e1500447</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.1500447</pub-id><pub-id pub-id-type="pmid">26601204</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keegan</surname><given-names>L</given-names></name><name><surname>Gill</surname><given-names>G</given-names></name><name><surname>Ptashne</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein</article-title><source>Science</source><volume>231</volume><fpage>699</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1126/science.3080805</pub-id><pub-id pub-id-type="pmid">3080805</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krois</surname><given-names>AS</given-names></name><name><surname>Dyson</surname><given-names>HJ</given-names></name><name><surname>Wright</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain</article-title><source>PNAS</source><volume>115</volume><fpage>E11302</fpage><lpage>E11310</lpage><pub-id pub-id-type="doi">10.1073/pnas.1814051115</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kühn</surname><given-names>S</given-names></name><name><surname>Nasufovic</surname><given-names>V</given-names></name><name><surname>Wilhelm</surname><given-names>J</given-names></name><name><surname>Kompa</surname><given-names>J</given-names></name><name><surname>de Lange</surname><given-names>EMF</given-names></name><name><surname>Lin</surname><given-names>Y-H</given-names></name><name><surname>Egoldt</surname><given-names>C</given-names></name><name><surname>Fischer</surname><given-names>J</given-names></name><name><surname>Lennoi</surname><given-names>A</given-names></name><name><surname>Tarnawski</surname><given-names>M</given-names></name><name><surname>Reinstein</surname><given-names>J</given-names></name><name><surname>Vlijm</surname><given-names>R</given-names></name><name><surname>Hiblot</surname><given-names>J</given-names></name><name><surname>Johnsson</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>SNAP-tag2 for faster and brighter protein labeling</article-title><source>Nature Chemical Biology</source><volume>21</volume><fpage>1754</fpage><lpage>1761</lpage><pub-id pub-id-type="doi">10.1038/s41589-025-01942-z</pub-id><pub-id pub-id-type="pmid">40610720</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>DK</given-names></name><name><surname>Jonas</surname><given-names>F</given-names></name><name><surname>Jana</surname><given-names>T</given-names></name><name><surname>Brodsky</surname><given-names>S</given-names></name><name><surname>Carmi</surname><given-names>M</given-names></name><name><surname>Barkai</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Complementary strategies for directing in vivo transcription factor binding through DNA binding domains and intrinsically disordered regions</article-title><source>Molecular Cell</source><volume>83</volume><fpage>1462</fpage><lpage>1473</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2023.04.002</pub-id><pub-id pub-id-type="pmid">37116493</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kvon</surname><given-names>EZ</given-names></name><name><surname>Stampfel</surname><given-names>G</given-names></name><name><surname>Yáñez-Cuna</surname><given-names>JO</given-names></name><name><surname>Dickson</surname><given-names>BJ</given-names></name><name><surname>Stark</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>HOT regions function as patterned developmental enhancers and have a distinct cis-regulatory signature</article-title><source>Genes &amp; Development</source><volume>26</volume><fpage>908</fpage><lpage>913</lpage><pub-id pub-id-type="doi">10.1101/gad.188052.112</pub-id><pub-id pub-id-type="pmid">22499593</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lando</surname><given-names>D</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name><name><surname>Gorman</surname><given-names>JJ</given-names></name><name><surname>Whelan</surname><given-names>DA</given-names></name><name><surname>Whitelaw</surname><given-names>ML</given-names></name><name><surname>Bruick</surname><given-names>RK</given-names></name></person-group><year iso-8601-date="2002">2002a</year><article-title>FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor</article-title><source>Genes &amp; Development</source><volume>16</volume><fpage>1466</fpage><lpage>1471</lpage><pub-id pub-id-type="doi">10.1101/gad.991402</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lando</surname><given-names>D</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name><name><surname>Whelan</surname><given-names>DA</given-names></name><name><surname>Gorman</surname><given-names>JJ</given-names></name><name><surname>Whitelaw</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2002">2002b</year><article-title>Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch</article-title><source>Science</source><volume>295</volume><fpage>858</fpage><lpage>861</lpage><pub-id pub-id-type="doi">10.1126/science.1068592</pub-id><pub-id pub-id-type="pmid">11823643</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lasko</surname><given-names>LM</given-names></name><name><surname>Jakob</surname><given-names>CG</given-names></name><name><surname>Edalji</surname><given-names>RP</given-names></name><name><surname>Qiu</surname><given-names>W</given-names></name><name><surname>Montgomery</surname><given-names>D</given-names></name><name><surname>Digiammarino</surname><given-names>EL</given-names></name><name><surname>Hansen</surname><given-names>TM</given-names></name><name><surname>Risi</surname><given-names>RM</given-names></name><name><surname>Frey</surname><given-names>R</given-names></name><name><surname>Manaves</surname><given-names>V</given-names></name><name><surname>Shaw</surname><given-names>B</given-names></name><name><surname>Algire</surname><given-names>M</given-names></name><name><surname>Hessler</surname><given-names>P</given-names></name><name><surname>Lam</surname><given-names>LT</given-names></name><name><surname>Uziel</surname><given-names>T</given-names></name><name><surname>Faivre</surname><given-names>E</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Buchanan</surname><given-names>FG</given-names></name><name><surname>Martin</surname><given-names>RL</given-names></name><name><surname>Torrent</surname><given-names>M</given-names></name><name><surname>Chiang</surname><given-names>GG</given-names></name><name><surname>Karukurichi</surname><given-names>K</given-names></name><name><surname>Langston</surname><given-names>JW</given-names></name><name><surname>Weinert</surname><given-names>BT</given-names></name><name><surname>Choudhary</surname><given-names>C</given-names></name><name><surname>de Vries</surname><given-names>P</given-names></name><name><surname>Van Drie</surname><given-names>JH</given-names></name><name><surname>McElligott</surname><given-names>D</given-names></name><name><surname>Kesicki</surname><given-names>E</given-names></name><name><surname>Marmorstein</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Cole</surname><given-names>PA</given-names></name><name><surname>Rosenberg</surname><given-names>SH</given-names></name><name><surname>Michaelides</surname><given-names>MR</given-names></name><name><surname>Lai</surname><given-names>A</given-names></name><name><surname>Bromberg</surname><given-names>KD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours</article-title><source>Nature</source><volume>550</volume><fpage>128</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1038/nature24028</pub-id><pub-id pub-id-type="pmid">28953875</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Latchman</surname><given-names>DS</given-names></name></person-group><year iso-8601-date="2008">2008</year><source>Eukaryotic Transcription Factors</source><edition>5th Edition. ed</edition><publisher-name>Elsevier Science</publisher-name><pub-id pub-id-type="doi">10.1016/B978-012373983-4.50017-1</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauberth</surname><given-names>SM</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Ferris</surname><given-names>AL</given-names></name><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Hughes</surname><given-names>SH</given-names></name><name><surname>Roeder</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activation</article-title><source>Cell</source><volume>152</volume><fpage>1021</fpage><lpage>1036</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.01.052</pub-id><pub-id pub-id-type="pmid">23452851</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>White</surname><given-names>JT</given-names></name><name><surname>Saavedra</surname><given-names>H</given-names></name><name><surname>Wrabl</surname><given-names>JO</given-names></name><name><surname>Motlagh</surname><given-names>HN</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Sowers</surname><given-names>J</given-names></name><name><surname>Schroer</surname><given-names>TA</given-names></name><name><surname>Thompson</surname><given-names>EB</given-names></name><name><surname>Hilser</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetically tunable frustration controls allostery in an intrinsically disordered transcription factor</article-title><source>eLife</source><volume>6</volume><elocation-id>e30688</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.30688</pub-id><pub-id pub-id-type="pmid">29022880</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lionnet</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-molecule tracking of transcription protein dynamics in living cells: seeing is believing, but what are we seeing?</article-title><source>Current Opinion in Genetics &amp; Development</source><volume>67</volume><fpage>94</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2020.12.001</pub-id><pub-id pub-id-type="pmid">33422933</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Perumal</surname><given-names>NB</given-names></name><name><surname>Oldfield</surname><given-names>CJ</given-names></name><name><surname>Su</surname><given-names>EW</given-names></name><name><surname>Uversky</surname><given-names>VN</given-names></name><name><surname>Dunker</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Intrinsic disorder in transcription factors</article-title><source>Biochemistry</source><volume>45</volume><fpage>6873</fpage><lpage>6888</lpage><pub-id pub-id-type="doi">10.1021/bi0602718</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Matthews</surname><given-names>KS</given-names></name><name><surname>Bondos</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Multiple intrinsically disordered sequences alter DNA binding by the homeodomain of the <italic>Drosophila</italic> hox protein ultrabithorax</article-title><source>Journal of Biological Chemistry</source><volume>283</volume><fpage>20874</fpage><lpage>20887</lpage><pub-id pub-id-type="doi">10.1074/jbc.M800375200</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Legant</surname><given-names>WR</given-names></name><name><surname>Chen</surname><given-names>BC</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Grimm</surname><given-names>JB</given-names></name><name><surname>Lavis</surname><given-names>LD</given-names></name><name><surname>Betzig</surname><given-names>E</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>3D imaging of Sox2 enhancer clusters in embryonic stem cells</article-title><source>eLife</source><volume>3</volume><elocation-id>e04236</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.04236</pub-id><pub-id pub-id-type="pmid">25537195</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Ptashne</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>A new class of yeast transcriptional activators</article-title><source>Cell</source><volume>51</volume><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(87)90015-8</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahendrawada</surname><given-names>L</given-names></name><name><surname>Warfield</surname><given-names>L</given-names></name><name><surname>Donczew</surname><given-names>R</given-names></name><name><surname>Hahn</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Low overlap of transcription factor DNA binding and regulatory targets</article-title><source>Nature</source><volume>642</volume><fpage>796</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1038/s41586-025-08916-0</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>S</given-names></name><name><surname>Roeder</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation</article-title><source>Nature Reviews Genetics</source><volume>11</volume><fpage>761</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1038/nrg2901</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Már</surname><given-names>M</given-names></name><name><surname>Nitsenko</surname><given-names>K</given-names></name><name><surname>Heidarsson</surname><given-names>PO</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Multifunctional intrinsically disordered regions in transcription factors</article-title><source>Chemistry</source><volume>29</volume><elocation-id>e202203369</elocation-id><pub-id pub-id-type="doi">10.1002/chem.202203369</pub-id><pub-id pub-id-type="pmid">36648282</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzocca</surname><given-names>M</given-names></name><name><surname>Loffreda</surname><given-names>A</given-names></name><name><surname>Colombo</surname><given-names>E</given-names></name><name><surname>Fillot</surname><given-names>T</given-names></name><name><surname>Gnani</surname><given-names>D</given-names></name><name><surname>Falletta</surname><given-names>P</given-names></name><name><surname>Monteleone</surname><given-names>E</given-names></name><name><surname>Capozi</surname><given-names>S</given-names></name><name><surname>Bertrand</surname><given-names>E</given-names></name><name><surname>Legube</surname><given-names>G</given-names></name><name><surname>Lavagnino</surname><given-names>Z</given-names></name><name><surname>Tacchetti</surname><given-names>C</given-names></name><name><surname>Mazza</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Chromatin organization drives the search mechanism of nuclear factors</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>6433</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-42133-5</pub-id><pub-id pub-id-type="pmid">37833263</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meers</surname><given-names>MP</given-names></name><name><surname>Bryson</surname><given-names>TD</given-names></name><name><surname>Henikoff</surname><given-names>JG</given-names></name><name><surname>Henikoff</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Improved CUT&amp;RUN chromatin profiling tools</article-title><source>eLife</source><volume>8</volume><elocation-id>e46314</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.46314</pub-id><pub-id pub-id-type="pmid">31232687</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mindel</surname><given-names>V</given-names></name><name><surname>Brodsky</surname><given-names>S</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Manadre</surname><given-names>W</given-names></name><name><surname>Jonas</surname><given-names>F</given-names></name><name><surname>Carmi</surname><given-names>M</given-names></name><name><surname>Barkai</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2024">2024a</year><article-title>Intrinsically disordered regions of the Msn2 transcription factor encode multiple functions using interwoven sequence grammars</article-title><source>Nucleic Acids Research</source><volume>52</volume><fpage>2260</fpage><lpage>2272</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad1191</pub-id><pub-id pub-id-type="pmid">38109289</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mindel</surname><given-names>V</given-names></name><name><surname>Brodsky</surname><given-names>S</given-names></name><name><surname>Yung</surname><given-names>H</given-names></name><name><surname>Manadre</surname><given-names>W</given-names></name><name><surname>Barkai</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2024">2024b</year><article-title>Revisiting the model for coactivator recruitment: Med15 can select its target sites independent of promoter-bound transcription factors</article-title><source>Nucleic Acids Research</source><volume>52</volume><fpage>12093</fpage><lpage>12111</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae718</pub-id><pub-id pub-id-type="pmid">39187372</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morffy</surname><given-names>N</given-names></name><name><surname>Van den Broeck</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>C</given-names></name><name><surname>Emenecker</surname><given-names>RJ</given-names></name><name><surname>Bryant</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>TM</given-names></name><name><surname>Sageman-Furnas</surname><given-names>K</given-names></name><name><surname>Wilkinson</surname><given-names>EG</given-names></name><name><surname>Pathak</surname><given-names>S</given-names></name><name><surname>Kotha</surname><given-names>SR</given-names></name><name><surname>Lam</surname><given-names>A</given-names></name><name><surname>Mahatma</surname><given-names>S</given-names></name><name><surname>Pande</surname><given-names>V</given-names></name><name><surname>Waoo</surname><given-names>A</given-names></name><name><surname>Wright</surname><given-names>RC</given-names></name><name><surname>Holehouse</surname><given-names>AS</given-names></name><name><surname>Staller</surname><given-names>MV</given-names></name><name><surname>Sozzani</surname><given-names>R</given-names></name><name><surname>Strader</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Identification of plant transcriptional activation domains</article-title><source>Nature</source><volume>632</volume><fpage>166</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1038/s41586-024-07707-3</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>F</given-names></name><name><surname>Wach</surname><given-names>P</given-names></name><name><surname>McNally</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Evidence for a common mode of transcription factor interaction with chromatin as revealed by improved quantitative fluorescence recovery after photobleaching</article-title><source>Biophysical Journal</source><volume>94</volume><fpage>3323</fpage><lpage>3339</lpage><pub-id pub-id-type="doi">10.1529/biophysj.107.123182</pub-id><pub-id pub-id-type="pmid">18199661</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>F</given-names></name><name><surname>Karpova</surname><given-names>TS</given-names></name><name><surname>Mazza</surname><given-names>D</given-names></name><name><surname>McNally</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Monitoring dynamic binding of chromatin proteins in vivo by fluorescence recovery after photobleaching</article-title><source>Methods in Molecular Biology</source><volume>833</volume><fpage>153</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-477-3_11</pub-id><pub-id pub-id-type="pmid">22183594</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ning</surname><given-names>S</given-names></name><name><surname>Chao</surname><given-names>HJ</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Zou</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Duan</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The auto-inhibition mechanism of transcription factor Ets-1 induced by phosphorylation on the intrinsically disordered region</article-title><source>Computational and Structural Biotechnology Journal</source><volume>20</volume><fpage>1132</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2022.02.025</pub-id><pub-id pub-id-type="pmid">35317227</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordin</surname><given-names>A</given-names></name><name><surname>Zambanini</surname><given-names>G</given-names></name><name><surname>Pagella</surname><given-names>P</given-names></name><name><surname>Cantù</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The CUT&amp;RUN suspect list of problematic regions of the genome</article-title><source>Genome Biology</source><volume>24</volume><elocation-id>185</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-023-03027-3</pub-id><pub-id pub-id-type="pmid">37563719</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noyes</surname><given-names>MB</given-names></name><name><surname>Meng</surname><given-names>X</given-names></name><name><surname>Wakabayashi</surname><given-names>A</given-names></name><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Brodsky</surname><given-names>MH</given-names></name><name><surname>Wolfe</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A systematic characterization of factors that regulate Drosophila segmentation via a bacterial one-hybrid system</article-title><source>Nucleic Acids Research</source><volume>36</volume><fpage>2547</fpage><lpage>2560</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn048</pub-id><pub-id pub-id-type="pmid">18332042</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oomen</surname><given-names>ME</given-names></name><name><surname>Hansen</surname><given-names>AS</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>CTCF sites display cell cycle–dependent dynamics in factor binding and nucleosome positioning</article-title><source>Genome Research</source><volume>29</volume><fpage>236</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1101/gr.241547.118</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Keung</surname><given-names>AJ</given-names></name><name><surname>Khalil</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Engineering epigenetic regulation using synthetic read-write modules</article-title><source>Cell</source><volume>176</volume><fpage>227</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.11.002</pub-id><pub-id pub-id-type="pmid">30528434</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>H</given-names></name><name><surname>Espinosa-Carrasco</surname><given-names>J</given-names></name><name><surname>Langer</surname><given-names>B</given-names></name><name><surname>Ewels</surname><given-names>P</given-names></name><name><surname>Bot</surname><given-names>NC</given-names></name><name><surname>Garcia</surname><given-names>MU</given-names></name><name><surname>Syme</surname><given-names>R</given-names></name><name><surname>Peltzer</surname><given-names>A</given-names></name><name><surname>Talbot</surname><given-names>A</given-names></name><name><surname>Behrens</surname><given-names>D</given-names></name><name><surname>Gabernet</surname><given-names>G</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Hörtenhuber</surname><given-names>M</given-names></name><name><surname>Rodriguez</surname><given-names>JG</given-names></name><name><surname>Menden</surname><given-names>K</given-names></name><name><surname>An</surname><given-names>Ö</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Nf-core/atacseq</data-title><version designator="2.1.2">2.1.2</version><source>Zenodo</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.8222875">https://doi.org/10.5281/zenodo.8222875</ext-link></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ptashne</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>How eukaryotic transcriptional activators work</article-title><source>Nature</source><volume>335</volume><fpage>683</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1038/335683a0</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pufall</surname><given-names>MA</given-names></name><name><surname>Lee</surname><given-names>GM</given-names></name><name><surname>Nelson</surname><given-names>ML</given-names></name><name><surname>Kang</surname><given-names>HS</given-names></name><name><surname>Velyvis</surname><given-names>A</given-names></name><name><surname>Kay</surname><given-names>LE</given-names></name><name><surname>McIntosh</surname><given-names>LP</given-names></name><name><surname>Graves</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Variable control of Ets-1 DNA binding by multiple phosphates in an unstructured region</article-title><source>Science</source><volume>309</volume><fpage>142</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1126/science.1111915</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>TR</given-names></name><name><surname>Slattery</surname><given-names>M</given-names></name><name><surname>Abe</surname><given-names>N</given-names></name><name><surname>Rastogi</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Mann</surname><given-names>RS</given-names></name><name><surname>Bussemaker</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>SELEX-seq: a method for characterizing the complete repertoire of binding site preferences for transcription factor complexes</article-title><source>Methods in Molecular Biology</source><volume>1196</volume><fpage>255</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-1242-1_16</pub-id><pub-id pub-id-type="pmid">25151169</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadowski</surname><given-names>I</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Triezenberg</surname><given-names>S</given-names></name><name><surname>Ptashne</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>GAL4-VP16 is an unusually potent transcriptional activator</article-title><source>Nature</source><volume>335</volume><fpage>563</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1038/335563a0</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanborn</surname><given-names>AL</given-names></name><name><surname>Yeh</surname><given-names>BT</given-names></name><name><surname>Feigerle</surname><given-names>JT</given-names></name><name><surname>Hao</surname><given-names>CV</given-names></name><name><surname>Townshend</surname><given-names>RJ</given-names></name><name><surname>Lieberman Aiden</surname><given-names>E</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name><name><surname>Kornberg</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Simple biochemical features underlie transcriptional activation domain diversity and dynamic, fuzzy binding to Mediator</article-title><source>eLife</source><volume>10</volume><elocation-id>e68068</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.68068</pub-id><pub-id pub-id-type="pmid">33904398</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Schaepe</surname><given-names>JM</given-names></name><name><surname>Fries</surname><given-names>T</given-names></name><name><surname>Doughty</surname><given-names>BR</given-names></name><name><surname>Crocker</surname><given-names>OJ</given-names></name><name><surname>Hinks</surname><given-names>MM</given-names></name><name><surname>Marklund</surname><given-names>E</given-names></name><name><surname>Greenleaf</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Thermodynamic Principles Link <italic>in Vitro</italic> Transcription Factor Affinities to Single-Molecule Chromatin States in Cells</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2025.01.27.635162</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schick</surname><given-names>S</given-names></name><name><surname>Grosche</surname><given-names>S</given-names></name><name><surname>Kohl</surname><given-names>KE</given-names></name><name><surname>Drpic</surname><given-names>D</given-names></name><name><surname>Jaeger</surname><given-names>MG</given-names></name><name><surname>Marella</surname><given-names>NC</given-names></name><name><surname>Imrichova</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>JMG</given-names></name><name><surname>Hofstätter</surname><given-names>G</given-names></name><name><surname>Schuster</surname><given-names>M</given-names></name><name><surname>Rendeiro</surname><given-names>AF</given-names></name><name><surname>Koren</surname><given-names>A</given-names></name><name><surname>Petronczki</surname><given-names>M</given-names></name><name><surname>Bock</surname><given-names>C</given-names></name><name><surname>Müller</surname><given-names>AC</given-names></name><name><surname>Winter</surname><given-names>GE</given-names></name><name><surname>Kubicek</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Acute BAF perturbation causes immediate changes in chromatin accessibility</article-title><source>Nature Genetics</source><volume>53</volume><fpage>269</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1038/s41588-021-00777-3</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>U</given-names></name><name><surname>Weigert</surname><given-names>M</given-names></name><name><surname>Broaddus</surname><given-names>C</given-names></name><name><surname>Myers</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Lecture Notes in Computer Science</article-title><conf-name>Medical Image Computing and Computer Assisted Intervention – MICCAI 2018</conf-name><fpage>265</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-00934-2_30</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sigler</surname><given-names>PB</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Transcriptional activation: Acid blobs and negative noodles</article-title><source>Nature</source><volume>333</volume><fpage>210</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1038/333210a0</pub-id><pub-id pub-id-type="pmid">3367995</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skene</surname><given-names>PJ</given-names></name><name><surname>Henikoff</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites</article-title><source>eLife</source><volume>6</volume><elocation-id>e21856</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.21856</pub-id><pub-id pub-id-type="pmid">28079019</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soto</surname><given-names>LF</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Santoso</surname><given-names>CS</given-names></name><name><surname>Berenson</surname><given-names>A</given-names></name><name><surname>Ho</surname><given-names>I</given-names></name><name><surname>Shen</surname><given-names>VX</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Fuxman Bass</surname><given-names>JI</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Compendium of human transcription factor effector domains</article-title><source>Molecular Cell</source><volume>82</volume><fpage>514</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2021.11.007</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitz</surname><given-names>F</given-names></name><name><surname>Furlong</surname><given-names>EEM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Transcription factors: from enhancer binding to developmental control</article-title><source>Nature Reviews. Genetics</source><volume>13</volume><fpage>613</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1038/nrg3207</pub-id><pub-id pub-id-type="pmid">22868264</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sprague</surname><given-names>BL</given-names></name><name><surname>Pego</surname><given-names>RL</given-names></name><name><surname>Stavreva</surname><given-names>DA</given-names></name><name><surname>McNally</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Analysis of binding reactions by fluorescence recovery after photobleaching</article-title><source>Biophysical Journal</source><volume>86</volume><fpage>3473</fpage><lpage>3495</lpage><pub-id pub-id-type="doi">10.1529/biophysj.103.026765</pub-id><pub-id pub-id-type="pmid">15189848</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staller</surname><given-names>MV</given-names></name><name><surname>Holehouse</surname><given-names>AS</given-names></name><name><surname>Swain-Lenz</surname><given-names>D</given-names></name><name><surname>Das</surname><given-names>RK</given-names></name><name><surname>Pappu</surname><given-names>RV</given-names></name><name><surname>Cohen</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A high-throughput mutational scan of an intrinsically disordered acidic transcriptional activation domain</article-title><source>Cell Systems</source><volume>6</volume><fpage>444</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2018.01.015</pub-id><pub-id pub-id-type="pmid">29525204</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staller</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2022">2022a</year><article-title>Transcription factors perform a 2-step search of the nucleus</article-title><source>Genetics</source><volume>222</volume><elocation-id>iyac111</elocation-id><pub-id pub-id-type="doi">10.1093/genetics/iyac111</pub-id><pub-id pub-id-type="pmid">35939561</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staller</surname><given-names>MV</given-names></name><name><surname>Ramirez</surname><given-names>E</given-names></name><name><surname>Kotha</surname><given-names>SR</given-names></name><name><surname>Holehouse</surname><given-names>AS</given-names></name><name><surname>Pappu</surname><given-names>RV</given-names></name><name><surname>Cohen</surname><given-names>BA</given-names></name></person-group><year iso-8601-date="2022">2022b</year><article-title>Directed mutational scanning reveals a balance between acidic and hydrophobic residues in strong human activation domains</article-title><source>Cell Systems</source><volume>13</volume><fpage>334</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2022.01.002</pub-id><pub-id pub-id-type="pmid">35120642</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Stormo</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2013">2013</year><source>Introduction to Protein-DNA Interactions: Structure, Thermodynamics, and Bioinformatics</source><publisher-name>Cold Spring Harbor Laboratory Press</publisher-name></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stringer</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Michaelos</surname><given-names>M</given-names></name><name><surname>Pachitariu</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cellpose: a generalist algorithm for cellular segmentation</article-title><source>Nature Methods</source><volume>18</volume><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1038/s41592-020-01018-x</pub-id><pub-id pub-id-type="pmid">33318659</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Strugo</surname><given-names>N</given-names></name><name><surname>Burstein</surname><given-names>C</given-names></name><name><surname>Hossain</surname><given-names>SS</given-names></name><name><surname>Nago</surname><given-names>N</given-names></name><name><surname>Goldsmith</surname><given-names>M</given-names></name><name><surname>Khamis</surname><given-names>H</given-names></name><name><surname>Kaplan</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2025">2025</year><article-title>Intrinsically Disordered Regions Facilitate Msn2 Target Search to Drive Promoter Selectivity</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2025.05.23.654710</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Struhl</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Promoters, activator proteins, and the mechanism of transcriptional initiation in yeast</article-title><source>Cell</source><volume>49</volume><fpage>295</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(87)90277-7</pub-id><pub-id pub-id-type="pmid">2882858</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Struhl</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Molecular mechanisms of transcriptional regulation in yeast</article-title><source>Annual Review of Biochemistry</source><volume>58</volume><fpage>1051</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1146/annurev.bi.58.070189.005155</pub-id><pub-id pub-id-type="pmid">2673007</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Struhl</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Yeast transcription factors</article-title><source>Current Opinion in Cell Biology</source><volume>5</volume><fpage>513</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/0955-0674(93)90018-l</pub-id><pub-id pub-id-type="pmid">8352970</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Dyson</surname><given-names>HJ</given-names></name><name><surname>Wright</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2021456118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2021456118</pub-id><pub-id pub-id-type="pmid">33443163</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>WY</given-names></name><name><surname>Shimada</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>UTT</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>XJ</given-names></name><name><surname>Sengoku</surname><given-names>T</given-names></name><name><surname>McGinty</surname><given-names>RK</given-names></name><name><surname>Fernandez</surname><given-names>JP</given-names></name><name><surname>Muir</surname><given-names>TW</given-names></name><name><surname>Roeder</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>SET1 and p300 act synergistically, through coupled histone modifications, in transcriptional activation by p53</article-title><source>Cell</source><volume>154</volume><fpage>297</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.06.027</pub-id><pub-id pub-id-type="pmid">23870121</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teytelman</surname><given-names>L</given-names></name><name><surname>Thurtle</surname><given-names>DM</given-names></name><name><surname>Rine</surname><given-names>J</given-names></name><name><surname>van Oudenaarden</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Highly expressed loci are vulnerable to misleading ChIP localization of multiple unrelated proteins</article-title><source>PNAS</source><volume>110</volume><fpage>18602</fpage><lpage>18607</lpage><pub-id pub-id-type="doi">10.1073/pnas.1316064110</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tokunaga</surname><given-names>M</given-names></name><name><surname>Imamoto</surname><given-names>N</given-names></name><name><surname>Sakata-Sogawa</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Highly inclined thin illumination enables clear single-molecule imaging in cells</article-title><source>Nature Methods</source><volume>5</volume><fpage>159</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1038/nmeth1171</pub-id><pub-id pub-id-type="pmid">18176568</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trojanowski</surname><given-names>J</given-names></name><name><surname>Frank</surname><given-names>L</given-names></name><name><surname>Rademacher</surname><given-names>A</given-names></name><name><surname>Mücke</surname><given-names>N</given-names></name><name><surname>Grigaitis</surname><given-names>P</given-names></name><name><surname>Rippe</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Transcription activation is enhanced by multivalent interactions independent of phase separation</article-title><source>Molecular Cell</source><volume>82</volume><fpage>1878</fpage><lpage>1893</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2022.04.017</pub-id><pub-id pub-id-type="pmid">35537448</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udupa</surname><given-names>A</given-names></name><name><surname>Kotha</surname><given-names>SR</given-names></name><name><surname>Staller</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Commonly asked questions about transcriptional activation domains</article-title><source>Current Opinion in Structural Biology</source><volume>84</volume><elocation-id>102732</elocation-id><pub-id pub-id-type="doi">10.1016/j.sbi.2023.102732</pub-id><pub-id pub-id-type="pmid">38056064</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Cottrell</surname><given-names>KA</given-names></name><name><surname>Lavagnino</surname><given-names>Z</given-names></name><name><surname>Thomas</surname><given-names>EN</given-names></name><name><surname>Pavlovic-Djuranovic</surname><given-names>S</given-names></name><name><surname>Szczesny</surname><given-names>P</given-names></name><name><surname>Piston</surname><given-names>DW</given-names></name><name><surname>Zaher</surname><given-names>HS</given-names></name><name><surname>Puglisi</surname><given-names>JD</given-names></name><name><surname>Djuranovic</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A short translational ramp determines the efficiency of protein synthesis</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>5774</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13810-1</pub-id><pub-id pub-id-type="pmid">31852903</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walther</surname><given-names>N</given-names></name><name><surname>Anantakrishnan</surname><given-names>S</given-names></name><name><surname>Graham</surname><given-names>TGW</given-names></name><name><surname>Dailey</surname><given-names>GM</given-names></name><name><surname>Tjian</surname><given-names>R</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Automated live-cell single-molecule tracking in enteroid monolayers reveals transcription factor dynamics probing lineage-determining function</article-title><source>Cell Reports</source><volume>43</volume><elocation-id>114914</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2024.114914</pub-id><pub-id pub-id-type="pmid">39480809</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitney</surname><given-names>PH</given-names></name><name><surname>Lionnet</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>The method in the madness: Transcriptional control from stochastic action at the single-molecule scale</article-title><source>Current Opinion in Structural Biology</source><volume>87</volume><elocation-id>102873</elocation-id><pub-id pub-id-type="doi">10.1016/j.sbi.2024.102873</pub-id><pub-id pub-id-type="pmid">38954990</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Yan</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-molecule displacement mapping unveils nanoscale heterogeneities in intracellular diffusivity</article-title><source>Nature Methods</source><volume>17</volume><fpage>524</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1038/s41592-020-0793-0</pub-id><pub-id pub-id-type="pmid">32203387</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yusa</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>MA</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name><name><surname>Craig</surname><given-names>NL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A hyperactive piggyBac transposase for mammalian applications</article-title><source>PNAS</source><volume>108</volume><fpage>1531</fpage><lpage>1536</lpage><pub-id pub-id-type="doi">10.1073/pnas.1008322108</pub-id><pub-id pub-id-type="pmid">21205896</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.105776.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University Frankfurt</institution></institution-wrap><addr-line><named-content content-type="city">Frankfurt am Main</named-content></addr-line><country>Germany</country></aff></contrib></contrib-group></front-stub><body><p>This useful study presents evidence that the duration and/or the frequency with which transcription factors interact with chromatin/DNA in living cells is influenced by the transactivation domains of transcription factors. The methods used are solid, combining imaging and genomics experiments. The work will be of interest to molecular biologists and biochemists, working in the transcriptional regulation field.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.105776.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University Frankfurt</institution></institution-wrap><addr-line><named-content content-type="city">Frankfurt am Main</named-content></addr-line><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Short activation domains control chromatin association of transcription factors&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Volker Dötsch as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential Revisions:</p><p>1) Add, change and discuss the literature suggested by reviewer #1 in points 1-4.</p><p>2) This work clearly demonstrates that stronger TADs result in stronger/more frequent TF binding 'genome-wide'. However the data presented in this manuscript does not allow to conclude if such stronger binding has some specific effects at the binding sites, or if stronger regulation and stronger genomewide binding are two independent events. Performing chromatin immunoprecipitation(or single molecule footprinting, as in Doughty et al., 2024) experiments at the binding sites of the reporter gene, to test the occupancy of the same DBD with different TADs would significantly increase the impact of this work.</p><p>3) The authors should cite some previous papers that, by using SMT, have tested the effect of removing TADs on endogeneous TF binding and diffusion. Some of them (Chen et al., Cell 2014) have shown that less binding to chromatin is observed, in agreement with this study, while others (Callegari et al., Embo Rep, 2019, Mazzocca et al., Nat Comm., 2023), have shown no effect on binding, but a modulation of their diffusion properties.</p><p>4) The authors present an interesting methodological approach to extract errors from SMT data, using cell-based boot-strapping. This allows to provide estimates of Bound fractions with error bars (Figure 3D). The authors should include error estimates using the same approach also in Figure 2C.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The authors have already shown that sequences outside the HIF DBD can affect chromatin occupancy; the present paper refines this to activation domains. Activation domains are well known to directly interact with nucleosome remodelers and histone acetylase complexes and recruit them to the genome. Such interactions/recruitment are independent of specific DNA-binding and would occur throughout the genome, albeit at much lower levels for a non-specific sequence. However, non-specific sequences far outnumber specific target sites, and assays of total genome association represent contributions from both. Nucleosome remodelers and histone acetylase complexes typically (and maybe always) strongly bind to DNA and/or histones. Thus, it is obvious that the combination of specific DNA-binding domains and associated chromatin-modifying activities will result in higher genome association and residence times. The paper is useful in that it provides experimental evidence for the obvious, but it doesn't break any new ground.</p><p>The paper hypes the results by seriously misrepresenting the &quot;traditional view&quot;. I don't think anyone ever claimed the so-called traditional view that &quot;the DBD is solely responsible for binding chromatin&quot;. Instead, the DBD was historically viewed as being solely responsible for binding to specific target sites, although this has been challenged recently by work from the Barkai lab. The Barkai work indicates that sequences outside the DBD can affect target specificity, but this is not due to activation domains. To put it differently, traditional views of transcription were not concerned with generic chromatin association especially given that activation domains recruit chromatin-modifying activities that interact with nucleosomes and DNA.</p><p>The scholarship is weak.</p><p>1. First, Brent and Ptashne 1985 was an important paper, but it only showed that DNA-binding domains of activators could be swapped. It did not map an activation domain. That was first done by Hope and Struhl 1986 and elaborated upon by subsequent papers from the Ptashne and Struhl labs (Gill and Ptashne, 1987 Cell; Ma and Ptashne, 1987 Cell; Hope et al., 1988 Nature; see also reviews Struhl, 1987 Cell; 1989 Ann Rev. Biochem; Ptashne 1988 Nature; Ptashne 1989 Sci Amer).</p><p>2. Brent and Ptashne 1985 never proposed that &quot;the DBD scans the DNA and binds to a cognate motif and only then does the activation domain recruit coactivators from solution&quot;. That highly mechanistic statement is far beyond anything Brent and Ptashne said, and it should be noted that coactivators weren't even known in 1985. To put it different, all the early papers clearly distinguished between specific DNA-binding and transcriptional activation domains, but they never addressed generic chromatin binding or kinetic mechanisms.</p><p>3. It is strange that the authors uniquely cite Gill et al. 1994 for activation domains interact with and recruit the basal transcription machinery including Pol II. That paper showed an in vitro interaction between the Sp1 glutamine-rich activation domain and TAF110, but the paper claiming physiological relevance (Sauer et al. 1996) was fraudulent and retracted. On the other hand, it is surprising that the authors do not cite any papers related to Mediator, which is a well-established target of numerous activation domains or more recent work from Roeder showing that TFIID can be a target in selected cases.</p><p>4. Ning et al. 2022 and Sun et al. 2021 are interesting papers, but they have nothing to do with challenges to the &quot;traditional view&quot;. There are decades of examples of intramolecular interactions that affect biochemical activities of proteins.</p><p>The experiments and results per se are fine, but the context in which they are placed is highly misleading and this needs to be significantly modified.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>In this work Fan, Darzacq and Staller, perform live-cell single molecule tracking (SMT) on a collection of synthetic transcription factors (sTFs), previously developed by the last author, and correlate the dynamics sTFs with the expression of a reporter gene. The authors find that – contrarily to the standard model for transcriptional regulation – association to chromatin does not only depend on the DNA binding domain. Rather, sTFs with activation domains that result in stronger activity, also display slower dynamics, possibly representing tighter (or more frequent) associations with chromatin. These results were further corroborated by looking at single molecule dynamics of two different natural DNA binding domains fused with activation domains of different strength. Finally perturbation experiments using a couple of small-molecule inhibitors were used to show that interaction of transcriptional coactivators with TFs activator domains might be responsible for increasing TF dwell time on chromatin.</p><p>Although some hints on the role of activation domains on transcription factor binding could be found in other SMT studies from other groups, this work has the strength of resorting to artificial, tuneable systems to show that this phenomenon might be shared among multiple classes of transcription factors.</p><p>The conclusions of the paper are – to a large extent – supported by the presented data, except for a couple of claims that could benefit from some more extended analysis of the data.</p><p>1) The authors claim that the constructs with stronger activation domains display higher bound fractions and longer residence times on chromatin. The fraction of bound molecules is measured by calculating the spectra of diffusion coefficients and by kinetic modelling of single molecule displacements, approaches that have been validated by multiple studies. The claim about residence times is instead based on Fluorescence Recovery after Photobleaching experiments (FRAP, Figure 2D, Figure S4B-C, Figure S6D), and this analysis is a bit more problematic. Indeed, as the authors correctly report, multiple phenomena and multiple models can explain FRAP recovery in presence of a mixture of diffusion and binding (Sprague, Biophys J., 2004, Mueller, Curr. Op. Cell Biol., 2010), and slower recovery curves can be caused by either slower dissociation (longer residence times), faster association, or slower diffusion – or a combination of these. Identifying whether longer binding or more frequent association to chromatin would be important, especially considering that recent SMF data is highlighting that also in mammalian cells on-rates are more relevant than off-rates in controlling occupancy of binding sites (Schaepe et al.,, BiorXiv, 2025). One possibility to address these issues would be to fit the FRAP data with the kinetic models that estimate binding rates (Mueller et al., Biophys J, 2008). An alternative solution could be to resort to slow frame-rates single molecule tracking to retrieve the distribution of binding times, and then estimate off-rates with the one of the approaches previously developed for this goal (Chen, Cell, 2013, Loffreda, Nat. Comm. 2017, Hansen, <italic>eLife</italic>, 2017, Nguyen, Mol Cell, 2021).</p><p>2) The discussion of the results on the p300 inhibitor (Figure 5A, incorrectly mislabeled as Figure 5B in the figure legend) was not very clear for me. The authors show that a drug that stabilize p300 binding on chromatin, also stabilize the binding of a sTF. Yet, this could be an indirect effect, and does not directly demonstrate that TFs can be tethered to chromatin through interactions with p300. At a minimum the effects of the p300 inhibitor on the chromatin interactions of same DBD, but without an activator domain, should be shown to support the authors' claim. A similar control would help discussing the results on the BAF inhibitor (Figure 5B, incorrectly mislabeled as Figure 4A in the figure legend).</p><p>3) This work clearly demonstrates that stronger TADs result in stronger/more frequent TF binding 'genome-wide'. However the data presented in this manuscript does not allow to conclude if such stronger binding has some specific effects at the binding sites, or if stronger regulation and stronger genomewide binding are two independent events. Performing chromatin immunoprecipitation(or single molecule footprinting, as in Doughty et al., 2024) experiments at the binding sites of the reporter gene, to test the occupancy of the same DBD with different TADs would significantly increase the impact of this work.</p><p>4) The authors should cite some previous papers that, by using SMT, have tested the effect of removing TADs on endogeneous TF binding and diffusion. Some of them (Chen et al., Cell 2014) have shown that less binding to chromatin is observed, in agreement with this study, while others (Callegari et al., Embo Rep, 2019, Mazzocca et al., Nat Comm., 2023), have shown no effect on binding, but a modulation of their diffusion properties.</p><p>5) The authors present an interesting methodological approach to extract errors from SMT data, using cell-based boot-strapping. This allows to provide estimates of Bound fractions with error bars (Figure 3D). The authors should include error estimates using the same approach also in Figure 2C.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Short activation domains control chromatin association of transcription factors&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by Volker Dötsch (Senior Editor).</p><p>Please address the concerns of reviewer 1 that are listed below.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Although the revised paper is improved by better literature citation and a new experiment, I'm sorry to say that my overall opinion hasn't changed. As I stated before, the experiments are useful, but the main conclusions are incremental, entirely expected, and hardly challenge traditional views of anything. I don't have a problem with the paper being published in <italic>eLife</italic>, but I recommend rejection if the authors refused to remove all statements claiming that their paper challenges traditional/previous views.</p><p>1. As can be seen from the figure and associated text in their response letter, the authors have misunderstood my main point. This authors' figure concerns cooperative effects involving separate DNA-binding proteins bound to separate sequences. That can certainly happen, but it has nothing to do with my main point, and it has nothing to do with their observations. Instead, my point is that activation domains directly interact with chromatin-modifying activities (e.g. nucleosome remodelers such as Swi/Snf and histone acetylases such as SAGA/Gcn5) that directly interact with DNA and/or histones. As such, the cooperativity that causes increased chromatin association does not involve a second DNA-binding but rather occurs between a single DNA-binding protein and the recruited chromatin-modifying activity. All DNA-binding proteins have low-level affinity for all sequences (typically called non-specific binding), and the interaction of activation domains and chromatin-modifying activities is independent of specific DNA-binding and would occur throughout the genome, albeit at much lower levels for a non-specific sequence. Thus, it is obvious that the combination of specific DNA-binding domains and associated chromatin-modifying activities will result in higher genome association and residence times. The paper is useful in that it provides experimental evidence and measurements for this, but it doesn't break any new ground, and it certainly doesn't challenge traditional views.</p><p>2. Although the citations are significantly improved, the paper still hypes the results by claiming to overturn the &quot;traditional view&quot;. No one has ever claimed the so-called traditional view that &quot;the DBD is solely responsible for binding chromatin&quot;. As such, the results here cannot challenge a view that no one has expressed or even believed. Instead, the authors have invented this &quot;traditional view&quot; and used it as a straw man to shoot down. All the early work on activation domains and the vast majority of subsequent work ignored generic chromatin association because it was hard to imagine how it would contribute to the specificity of gene regulation. Even with this paper, the biological significance of generic chromatin association is unclear. I do agree that the measurements here are useful, but this is far from overturning a traditional view that has not even been expressed.</p><p>3. Regarding the key concept of modularity of DNA-binding and activation domains, the authors have invented ideas that were not expressed or even contemplated in previous papers. The original papers on modularity were concerned with specific DNA-binding and transcriptional activation. They were published well before the concept of co-activators, and indeed the prevailing view based on bacterial activators is that activation domains would contact some component of the basic Pol II machinery. Indeed, there were numerous experiments claiming that various general factors (e.g. TBP, TFIIB, TFIIA) were the target. These early papers establishing modularity were also well before any connection to chromatin, and at the time, chromatin was largely ignored in the gene expression field. Eventually, it became clear that activation domains not only stimulated transcription directly (mostly through Mediator) but also indirectly through chromatin via Swi/Snf and SAGA. The connection of activation domains and chromatin is 30 years old, so using early papers on modularity to claim that activation domains had nothing to do with chromatin is historically unfair. And, this 30-year connection between activation domains and chromatin-modifying activities is what renders the results in this paper entirely predictable.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The authors have satisfactorily addressed my comments.</p><p>In particular, the addition of CUT&amp;RUN experiments clarifies that swapping ADs only slightly impacts where the TF will bind, but rather modulates binding frequency and/or stability at pre-determined sites. I think that this result should be highlighted at the end of the introduction. Also, as a minor point I would be curious to see if the motifs bound by the different TFs variants are identical, an observation that could further support their observation.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.105776.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions:</p><p>1) Add, change and discuss the literature suggested by reviewer #1 in points 1-4.</p></disp-quote><p>Thank you for these suggestions. We have completely rewritten the introduction to discuss these four points.</p><disp-quote content-type="editor-comment"><p>2) This work clearly demonstrates that stronger TADs result in stronger/more frequent TF binding 'genome-wide'. However the data presented in this manuscript does not allow to conclude if such stronger binding has some specific effects at the binding sites, or if stronger regulation and stronger genomewide binding are two independent events. Performing chromatin immunoprecipitation(or single molecule footprinting, as in Doughty et al., 2024) experiments at the binding sites of the reporter gene, to test the occupancy of the same DBD with different TADs would significantly increase the impact of this work.</p></disp-quote><p>We have undertaken CUT&amp;RUN on 5 synthetic TFs. These results are included in the new Figure 7. As the reviewer notes, there are two primary possibilities: TFs with a higher bound fraction could bind the same genomic loci with higher occupancy, or they could bind new loci.</p><p>Looking at the reporter locus, we see binding by all five TFs, including the ‘no activation domain’ control. At the reporter, the stronger activation domains have higher occupancy.</p><p>Comparing the HIF1α WT and superactive alleles show they have overlapping genome-wide binding patterns. The superactive allele binds the same sites as WT but more strongly, and it binds additional sites. The majority of all sites bound by both TFs are preexisting ATAC-seq peaks.</p><p>Genome-wide, we find that the majority of TF binding overlaps with existing ATAC-seq peaks. We conclude that the primary effect observed in the SMT is increased binding at the active loci.</p><disp-quote content-type="editor-comment"><p>3) The authors should cite some previous papers that, by using SMT, have tested the effect of removing TADs on endogeneous TF binding and diffusion. Some of them (Chen et al., Cell 2014) have shown that less binding to chromatin is observed, in agreement with this study, while others (Callegari et al., Embo Rep, 2019, Mazzocca et al., Nat Comm., 2023), have shown no effect on binding, but a modulation of their diffusion properties.</p></disp-quote><p>These are fantastic suggestions. We have incorporated these ideas and citations. Please see pg 3 line 92-93 and pg 22 line 505.</p><disp-quote content-type="editor-comment"><p>4) The authors present an interesting methodological approach to extract errors from SMT data, using cell-based boot-strapping. This allows to provide estimates of Bound fractions with error bars (Figure 3D). The authors should include error estimates using the same approach also in Figure 2C.</p></disp-quote><p>We have added error bars to Figure 2C.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The authors have already shown that sequences outside the HIF DBD can affect chromatin occupancy; the present paper refines this to activation domains. Activation domains are well known to directly interact with nucleosome remodelers and histone acetylase complexes and recruit them to the genome. Such interactions/recruitment are independent of specific DNA-binding and would occur throughout the genome, albeit at much lower levels for a non-specific sequence. However, non-specific sequences far outnumber specific target sites, and assays of total genome association represent contributions from both. Nucleosome remodelers and histone acetylase complexes typically (and maybe always) strongly bind to DNA and/or histones. Thus, it is obvious that the combination of specific DNA-binding domains and associated chromatin-modifying activities will result in higher genome association and residence times. The paper is useful in that it provides experimental evidence for the obvious, but it doesn't break any new ground.</p></disp-quote><p>Although it is always possible that interactions between two proteins can facilitate cooperative binding to chromatin, it is not obvious that this cooperative binding will occur to an appreciable extent at physiologically relevant concentrations in live cells. Critically, the magnitude of the cooperative binding cannot be predicted <italic>a priori</italic>. It must be measured.</p><p>Consider <xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>:</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Conceptual model for how a coactivator can lead to apparent cooperativity between transcription factors.</title><p>(<bold>A</bold>) A transcription factor nonspecifically-bound to random DNA. (<bold>B</bold>) A transcription factor specifically-bound to a cognate DNA motif at our reporter. (<bold>C</bold>) A transcription factor non-specifically-bound to random DNA and simultaneously bound to a coactivator. The coactivator is also bound to another transcription factor specifically bound to its cognate motif. This situation represents other active loci. (<bold>D</bold>) A transcription factor specifically-bound to a cognate DNA motif and simultaneously bound to a coactivator tethered to the DNA by another transcription factor. This binding mode could occur at our reporter locus, but the identity of the dark blue transcription factor is unknown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-sa2-fig1-v1.tif"/></fig><p>Specific-binding to a motif (B) will have a longer lifetime on DNA and higher bound fraction than non-specific binding to random DNA (A). Simultaneous specific binding to a DNA motif and a coactivator (D) will have a longer lifetime than non-specific binding to random DNA and a coactivator (C). In addition, D will have more stable binding than B because a doubly-bound protein requires two dissociation events before floating away.</p><p>In contrast, it is difficult to predict <italic>a priori</italic> if C will have a longer dwell time than B, and it will depend on the relative affinities of the three interactions.</p><p>We agree that multivalent binding will increase dwell time on DNA. However, we were surprised by the magnitude of the difference. We expected C and D to be very rare compared to A, such that they would not be detectable in the SMT data.</p><p>Our direct live-cell measurements show that activation domains exert a strikingly large effect on chromatin binding of synthetic TFs. A DBD fused to the superactive K&gt;A mutant of the CITED2 AD had a bound fraction of 64%, for instance, while the same DBD fused to the inactive L&gt;F mutant had a bound fraction of only 25%. In this case, the AD contributes the majority of binding. This large magnitude was unexpected and not obvious.</p><p>The magnitude of this effect is all the more striking given that—as the reviewer correctly notes—many TF binding events are thought to occur outside of regulatory elements on &quot;nonspecific&quot; DNA. One might have reasonably predicted that only a small fraction of TF ADs—perhaps a few percent co-bound with other TFs at regulatory elements—engage coactivators at any instant, such that these interactions would have little effect on overall chromatin binding measured by SMT. Alternatively, one might have reasonably predicted that AD-coactivator interactions would be too weak and transient to impact global chromatin binding. While previous results showed that long IDRs can influence both overall chromatin binding and binding specificity of TFs, it was unclear whether activation domains <italic>per se</italic> were responsible or whether minimal ADs would have the same effect.</p><p>Instead, our results imply that at any instant, a large fraction of TF ADs contact other proteins—likely coactivators—such that ADs exert a large effect on overall chromatin binding of TFs. This result was not obvious, and such a claim would have been mere speculation prior to our work.</p><disp-quote content-type="editor-comment"><p>The paper hypes the results by seriously misrepresenting the &quot;traditional view&quot;. I don't think anyone ever claimed the so-called traditional view that &quot;the DBD is solely responsible for binding chromatin&quot;. Instead, the DBD was historically viewed as being solely responsible for binding to specific target sites, although this has been challenged recently by work from the Barkai lab. The Barkai work indicates that sequences outside the DBD can affect target specificity, but this is not due to activation domains. To put it differently, traditional views of transcription were not concerned with generic chromatin association especially given that activation domains recruit chromatin-modifying activities that interact with nucleosomes and DNA.</p></disp-quote><p>We agree with the reviewer that &quot;the DBD was historically viewed as being solely responsible for binding to specific target sites.&quot; The reviewer also articulates what we consider the traditional view, here and above, namely that the function of ADs is to &quot;recruit&quot; other proteins to chromatin.</p><p>Our key point is that this traditional perspective is incomplete. TFs do not bind naked DNA in cells; they bind chromatin alongside many other proteins. Activation domains do not just recruit coactivators; they and coactivators recruit each other. Interactions between TFs, coactivators, and chromatin must be understood collectively, not in isolation, which requires probing these interactions under physiological conditions in live cells. We have done this systematically for a series of activation domains, and we believe that our results are not over-hyped.</p><p>Our results have several important implications. First, the strong effect of activation domains on chromatin binding implies that a substantial fraction (~40% or more) of activation domains are bound by coactivators in live cells. To our knowledge, this fraction has not previously been measured, and it provides an important quantitative constraint for models of transcription. Second, the strong global effect of activation domains on chromatin binding suggests that activation domains could likewise influence binding of TFs at specific sites—dependent on local coactivator enrichment—contrary to the historical view that DBDs are &quot;solely responsible.&quot; Third, as noted by the reviewer, our results extend previous work from the Barkai Lab and others: we demonstrate that short activation domains, isolated from longer IDRs, are sufficient to affect the overall affinity of TFs for chromatin.</p><p>Separately, we wish to point out that there are many review articles and textbooks that expose the idea that the “DBD is solely responsible for binding DNA.” We suspect that Ptashne pushed TF modularity and his recruitment model so strongly that more nuanced ideas were lost amongst his shouting.</p><p>“Activators are modular proteins whose activating regions are readily interchangeable; so are their DNA-binding regions” –Ptashne M. 1988. How eukaryotic transcriptional activators work. <italic>Nature</italic> <bold>335</bold>:683–689.</p><p>“It is believed that the DNA binding domain serves merely to bring the protein to the DNA target, whereupon the activation region stimulates the basic transcription machinery” –Struhl K. 1993. Yeast transcription factors. <italic>Curr Opin Cell Biol</italic> 5:513–520.</p><p>“Site-specific TFs are modular in their structure reflecting their ability to bind to DNA via their DNA binding domains and simultaneously bind to other transcriptional regulatory proteins via so-called effector domains. The modular nature of site-specific TFs has been repeatedly demonstrated using in vitro and in vivo reporter assays.” –Frietze S, Farnham PJ. 2011. Transcription factor effector domains. <italic>Subcell Biochem</italic> <bold>52</bold>:261–277.</p><p>“Most gene regulatory proteins that activate gene transcription—that is, most gene activator proteins—have a modular design consisting of at least two distinct domains. One domain usually contains one of the structural motifs discussed previously that recognizes a specific regulatory DNA sequence. In the simplest cases, a second domain—sometimes called an activation domain—accelerates the rate of transcriptional initiation.” –Alberts et al. <italic>The Molecular Biology of the Cell</italic> 4th edition, 2004, pg 401</p><p>“Extensive studies on a variety of transcription factors have shown that they have a modular structure in which distinct regions of the protein mediate particular functions such as DNA binding (see Chapter 4) or interaction with specific effector molecules such as steroid hormones. It is likely therefore that a specific region of each individual transcription factor will be involved in its ability to activate transcription following DNA binding. As described in Chapter 2 (section 2.4.1), such activation domains have been identified by so-called 'domain swap' experiments in which various regions of one factor are linked to the DNA binding domain of another factor and the ability to activate transcription assessed.</p><p>In general, these experiments have confirmed the modular nature of transcription factors with distinct domains mediating DNA binding and transcriptional activation.” –Latchman Eukaryotic Transcription Factors 5th edition, 2008, pg 161.</p><p>“Proteins that regulate transcription in eukaryotes are typically modular in nature, with a DNA-binding domain that recognizes specific DNA sequences and a separate activation or repression domain that recruits a co-activator or co-repressor, respectively” –Craig, Green, Storz et al. <italic>Molecular Biology: Principles of Genome Function</italic> 3rd edition, 2021, pg 344.;</p><disp-quote content-type="editor-comment"><p>The scholarship is weak.</p><p>1. First, Brent and Ptashne 1985 was an important paper, but it only showed that DNA-binding domains of activators could be swapped. It did not map an activation domain. That was first done by Hope and Struhl 1986 and elaborated upon by subsequent papers from the Ptashne and Struhl labs (Gill and Ptashne, 1987 Cell; Ma and Ptashne, 1987 Cell; Hope et al., 1988 Nature; see also reviews Struhl, 1987 Cell; 1989 Ann Rev. Biochem; Ptashne 1988 Nature; Ptashne 1989 Sci Amer).</p><p>2. Brent and Ptashne 1985 never proposed that &quot;the DBD scans the DNA and binds to a cognate motif and only then does the activation domain recruit coactivators from solution&quot;. That highly mechanistic statement is far beyond anything Brent and Ptashne said, and it should be noted that coactivators weren't even known in 1985. To put it different, all the early papers clearly distinguished between specific DNA-binding and transcriptional activation domains, but they never addressed generic chromatin binding or kinetic mechanisms.</p><p>3. It is strange that the authors uniquely cite Gill et al. 1994 for activation domains interact with and recruit the basal transcription machinery including Pol II. That paper showed an in vitro interaction between the Sp1 glutamine-rich activation domain and TAF110, but the paper claiming physiological relevance (Sauer et al. 1996) was fraudulent and retracted. On the other hand, it is surprising that the authors do not cite any papers related to Mediator, which is a well-established target of numerous activation domains or more recent work from Roeder showing that TFIID can be a target in selected cases.</p><p>4. Ning et al. 2022 and Sun et al. 2021 are interesting papers, but they have nothing to do with challenges to the &quot;traditional view&quot;. There are decades of examples of intramolecular interactions that affect biochemical activities of proteins.</p></disp-quote><p>We have completely rewritten the introduction to address these four points.</p><disp-quote content-type="editor-comment"><p>The experiments and results per se are fine, but the context in which they are placed is highly misleading and this needs to be significantly modified.</p></disp-quote><p>Please see the revised introduction.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>[…]</p><p>1) The authors claim that the constructs with stronger activation domains display higher bound fractions and longer residence times on chromatin. The fraction of bound molecules is measured by calculating the spectra of diffusion coefficients and by kinetic modelling of single molecule displacements, approaches that have been validated by multiple studies. The claim about residence times is instead based on Fluorescence Recovery after Photobleaching experiments (FRAP, Figure 2D, Figure S4B-C, Figure S6D), and this analysis is a bit more problematic. Indeed, as the authors correctly report, multiple phenomena and multiple models can explain FRAP recovery in presence of a mixture of diffusion and binding (Sprague, Biophys J., 2004, Mueller, Curr. Op. Cell Biol., 2010), and slower recovery curves can be caused by either slower dissociation (longer residence times), faster association, or slower diffusion – or a combination of these. Identifying whether longer binding or more frequent association to chromatin would be important, especially considering that recent SMF data is highlighting that also in mammalian cells on-rates are more relevant than off-rates in controlling occupancy of binding sites (Schaepe et al.,, BiorXiv, 2025). One possibility to address these issues would be to fit the FRAP data with the kinetic models that estimate binding rates (Mueller et al., Biophys J, 2008). An alternative solution could be to resort to slow frame-rates single molecule tracking to retrieve the distribution of binding times, and then estimate off-rates with the one of the approaches previously developed for this goal (Chen, Cell, 2013, Loffreda, Nat. Comm. 2017, Hansen, eLife, 2017, Nguyen, Mol Cell, 2021).</p></disp-quote><p>Thank you for suggesting this comprehensive FRAP analysis. We have replaced our original analysis with that of (Mueller et al., 2012) and tabulated fit parameters in Supplementary Table 1. We agree that differences in FRAP recovery curves can be due to differences in dissociation (k<sub>off</sub>), association (k<sub>on</sub>) or diffusion (D); these are the parameters that (Mueller et al., 2010) seek to fit. However, we believe our FRAP measurements are very “reaction-dominant” for two reasons:</p><p>1 We have conducted the gradient-smoothing test outlined in (Mueller et al., 2012; Methods: FRAP analysis-step 6) and included this in Figure 2—figure supplement 5. This tests for the role of diffusion during FRAP recovery, and we found no evidence that diffusion plays a role in our movies.</p><p>2. We also argue that diffusion has occurred before the first frame has been imaged after photobleaching. With the mobile diffusion coefficient we measured from SMT (slower population: D=2 µm<sup>2</sup>/s) and the radius of our bleach spot (0.75 µm), we can solve the equation:</p><p>mean squared displacement = 4 * D * t for t and calculate that, on average, molecules would diffuse from the edge of the FRAP spot to its center in ~70 milliseconds. Our frame rates were ~250 ms. We have also included this argument in Methods: FRAP analysis-step 6.</p><p>Given that diffusion is much faster than the observed recovery time, we can conclude that the measured rate is approximately equal to the rate of dissociation (which is equal to the rate of association in this steady-state system).</p><disp-quote content-type="editor-comment"><p>2) The discussion of the results on the p300 inhibitor (Figure 5A, incorrectly mislabeled as Figure 5B in the figure legend) was not very clear for me. The authors show that a drug that stabilize p300 binding on chromatin, also stabilize the binding of a sTF. Yet, this could be an indirect effect, and does not directly demonstrate that TFs can be tethered to chromatin through interactions with p300. At a minimum the effects of the p300 inhibitor on the chromatin interactions of same DBD, but without an activator domain, should be shown to support the authors' claim. A similar control would help discussing the results on the BAF inhibitor (Figure 5B, incorrectly mislabeled as Figure 4A in the figure legend).</p></disp-quote><p>We apologize for the errors. The logic of the p300 inhibitor experiment is confusing, so we have revised this section of the manuscript.</p><p>First, we have added a figure showing the effects of the drugs on a synthetic TF without any activation domain (Figure 6).</p><p>Second, we have added a new pharmacological perturbation: norstictic acid, which selectively inhibits VP16 interactions with Med25 (pg 17 line 395). This perturbation more directly supports the idea that activation domain coactivator interactions tether the TF to chromatin. It is still not definitive evidence.</p><p>Garlick JM, Sturlis SM, Bruno PA, Yates JA, Peiffer AL, Liu Y, Goo L, Bao L, De Salle SN, Tamayo-Castillo G, Brooks CL 3rd, Merajver SD, Mapp AK. 2021. Norstictic acid is a selective allosteric transcriptional regulator. <italic>J Am Chem Soc</italic> 143:9297–9302.</p><p>Finally, we have added a proximity-assisted photoactivation (PAPA) experiment that shows the HIF1α activation domain is in close proximity to p300 (Figure 5). Furthermore, the two alleles that increased HIF1α strength and chromatin association have increased proximity to p300. Molecules in proximity to p300 are also more likely to be bound to chromatin. This more direct measurement further supports the idea that activation domain interactions with coactivators can tether TFs to chromatin. This experiment demonstrates how PAPA has been applied to measure TF-coactivator interactions in vivo, which we anticipate will be a powerful new experimental approach.</p><disp-quote content-type="editor-comment"><p>3) This work clearly demonstrates that stronger TADs result in stronger/more frequent TF binding 'genome-wide'. However the data presented in this manuscript does not allow to conclude if such stronger binding has some specific effects at the binding sites, or if stronger regulation and stronger genomewide binding are two independent events. Performing chromatin immunoprecipitation(or single molecule footprinting, as in Doughty et al., 2024) experiments at the binding sites of the reporter gene, to test the occupancy of the same DBD with different TADs would significantly increase the impact of this work.</p></disp-quote><p>As mentioned above, we have included CUT&amp;RUN experiments for six synthetic TFs (Figure 7).</p><disp-quote content-type="editor-comment"><p>4) The authors should cite some previous papers that, by using SMT, have tested the effect of removing TADs on endogeneous TF binding and diffusion. Some of them (Chen et al., Cell 2014) have shown that less binding to chromatin is observed, in agreement with this study, while others (Callegari et al., Embo Rep, 2019, Mazzocca et al., Nat Comm., 2023), have shown no effect on binding, but a modulation of their diffusion properties.</p></disp-quote><p>Thank you for these suggestions. Please see the revised introduction (pg 3 line 92-93).</p><disp-quote content-type="editor-comment"><p>5) The authors present an interesting methodological approach to extract errors from SMT data, using cell-based boot-strapping. This allows to provide estimates of Bound fractions with error bars (Figure 3D). The authors should include error estimates using the same approach also in Figure 2C.</p></disp-quote><p>We have added error bars to Figure 2C.</p><p>[Editors’ note: what follows is the authors’ response to the second round of review.]</p><disp-quote content-type="editor-comment"><p>Please address the concerns of reviewer 1 that are listed below.</p><p>Reviewer #1 (Recommendations for the authors):</p><p>Although the revised paper is improved by better literature citation and a new experiment, I'm sorry to say that my overall opinion hasn't changed. As I stated before, the experiments are useful, but the main conclusions are incremental, entirely expected, and hardly challenge traditional views of anything. I don't have a problem with the paper being published in eLife, but I recommend rejection if the authors refused to remove all statements claiming that their paper challenges traditional/previous views.</p><p>1. As can be seen from the figure and associated text in their response letter, the authors have misunderstood my main point. This authors' figure concerns cooperative effects involving separate DNA-binding proteins bound to separate sequences. That can certainly happen, but it has nothing to do with my main point, and it has nothing to do with their observations. Instead, my point is that activation domains directly interact with chromatin-modifying activities (e.g. nucleosome remodelers such as Swi/Snf and histone acetylases such as SAGA/Gcn5) that directly interact with DNA and/or histones. As such, the cooperativity that causes increased chromatin association does not involve a second DNA-binding but rather occurs between a single DNA-binding protein and the recruited chromatin-modifying activity. All DNA-binding proteins have low-level affinity for all sequences (typically called non-specific binding), and the interaction of activation domains and chromatin-modifying activities is independent of specific DNA-binding and would occur throughout the genome, albeit at much lower levels for a non-specific sequence. Thus, it is obvious that the combination of specific DNA-binding domains and associated chromatin-modifying activities will result in higher genome association and residence times. The paper is useful in that it provides experimental evidence and measurements for this, but it doesn't break any new ground, and it certainly doesn't challenge traditional views.</p></disp-quote><p>We apologize that we did not understand your original comments. Thank you for clarifying.</p><p>If we understand correctly, you are saying: sequence specific TFs bind the genome and recruit chromatin modifying complexes. Once they are recruited, the chromatin modifying complexes bind to nucleosomes or DNA, but without any sequence specificity. The molecular bridging and avidity of a TF bound to both DNA and a chromatin modifying complex bound to a nucleosome increase TF dwell time on DNA (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>,Panel B and D). This recruitment can occur at specific binding sites (C+D) or at non-specific DNA (A+B). We think you are saying that B will have a longer dwell time than A, and D will have a longer dwell time than C.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-105776-sa2-fig2-v1.tif"/></fig><p>If this is your model, we agree that it is compatible with our data. We have added a sentence to the discussion to include this interpretation:“We cannot distinguish whether the coactivator directly binds DNA, binds a nucleosome, or binds another TF bound to DNA, but we suspect all three binding modes are involved.” (pg 22 line 520)</p><p>However we do not think it was “obvious” that this was the only possible model <italic>a priori</italic>. The nucleus is chalk full of TF-TF interactions (Abidi et al. 2025) and TF-RNA interactions (Nabeel-Shah et al. 2024). We focused on AD:coactivator interactions through drug perturbations and PAPA experiments.</p><disp-quote content-type="editor-comment"><p>2. Although the citations are significantly improved, the paper still hypes the results by claiming to overturn the &quot;traditional view&quot;. No one has ever claimed the so-called traditional view that &quot;the DBD is solely responsible for binding chromatin&quot;. As such, the results here cannot challenge a view that no one has expressed or even believed. Instead, the authors have invented this &quot;traditional view&quot; and used it as a straw man to shoot down. All the early work on activation domains and the vast majority of subsequent work ignored generic chromatin association because it was hard to imagine how it would contribute to the specificity of gene regulation. Even with this paper, the biological significance of generic chromatin association is unclear. I do agree that the measurements here are useful, but this is far from overturning a traditional view that has not even been expressed.</p></disp-quote><p>We have revised the introduction to remove the rhetoric about the DBD being “solely responsible for binding chromatin.” In the abstract, we now say the DBD is “primarily responsible for binding DNA and chromatin.” Last week the corresponding author attended a conference entitled <italic>“Rules of protein-DNA Interactions,”</italic> where he polled the audience of ~36 PIs about this word choice. This group felt the revised sentence is much more appropriate than our original sentence. The revised sentence is:</p><p>Despite evidence to the contrary, DBDs are often assumed to be the primary mediators of TF interactions with DNA and chromatin. (pg 1 line 15)</p><p>We instituted a major change in how we motivate the manuscript. We now motivate the work by setting out to measure the relative contribution of DBDs and activation domains to chromatin binding. We believe that the relative contributions cannot be predicted and need to be measured.</p><p>Revised abstract (with emphasis added to major changes):</p><p>“Transcription factors regulate gene expression with DNA-binding domains (DBDs) and activation domains. Despite evidence to the contrary, DBDs are often assumed to be the primary mediators of TF interactions with DNA and chromatin. Here, we used fast single-molecule tracking of transcription factors in living cells to show that short activation domains can control the fraction of molecules bound to chromatin. Stronger activation domains have higher bound fractions and longer residence times on chromatin. Furthermore, mutations that increase activation domain strength also increase chromatin binding. This trend was consistent in four different activation domains and their mutants. This effect further held for activation domains appended to three different structural classes of DBDs. Stronger activation domains with high chromatin-bound fractions also exhibited increased binding to the p300 coactivator in proximity-assisted photoactivation experiments. Genome-wide measurements indicate these activation domains primarily control the occupancy of binding rather than the genomic location. Taken together, these results demonstrate that very short activation domains play a major role in tethering transcription factors to chromatin.”</p><p>We also removed the paragraphs about the history of the recruitment model and TF modularity. Instead we include the following text:</p><p>“Both DBDs and activation domains contribute to DNA binding and chromatin binding. DNA binding results from direct protein-DNA interaction, is well established for DBDs in vitro, and is measured in vivo with single-molecule footprinting (Doughty et al., 2024; Stormo, 2013).</p><p>Chromatin binding includes DNA binding but can also result from protein-protein interactions with histones, other TFs, corepressors, or coactivators that can indirectly tether a TF to DNA (Spitz and Furlong, 2012). Nearly all cell-based assays of TF genome localization (e.g. ChIP-seq or CUT&amp;RUN) measure the combination of DNA binding and chromatin binding. Some activation domains interfere with DNA binding (Golemis and Brent, 1992). in vitro, interactions between activation domains and DBDs can increase DNA binding specificity (Krois et al., 2018; Liu et al., 2008; Ning et al., 2022; Sun et al., 2021). IDRs can increase non-specific binding (Baughman et al., 2022), regulate DNA binding via post-translational modifications (Pufall et al., 2005), or allosterically regulate DNA binding (Li et al., 10 2017). There is long-standing evidence that the DBD does not confer all genomic targeting information because in ChIP-seq experiments, 30-70% of peaks lack a motif for the query TF (Harrison et al., 2011; Jana et al., 2021; Kvon et al., 2012; Spitz and Furlong, 2012; Teytelman et al., 2013). There is also low agreement between the promoters a TF binds and the genes it regulates (Mahendrawada et al., 2025). Finally, there is extensive literature demonstrating how long IDRs—and not DBDs—control TF genomic localization (Brodsky et al., 2020; Gera et al., 2022; Hurieva et al., 2024; Jonas et al., 2023; Kumar et al., 2023; Mindel et al., 2024a, 2024b). These studies show that long IDRs are necessary and sufficient to localize TFs to target promoter genes; minimal activation domains were reported not to contribute (Brodsky et al., 2020). Although the original data could not distinguish between direct DNA binding and chromatin binding via protein-protein interactions with DNA-bound factors (reviewed in (Staller, 2022)), recent studies suggest an IDR can bind DNA directly (Strugo et al., 2025). This genomic targeting by IDRs has also been seen in human cells (Goldman et al., 2023). These findings can explain why removing the DBD can increase the number of genomic binding sites detected by ChIP-seq (Chen et al., 2014), have little effect on genome binding (Cowling and Cole, 2007), or complement null mutants (Copeland et al., 1996). We have shown that long IDRs control the fraction of TF molecules bound to chromatin for factors in the HIF family (Chen et al., 2022). Other single-molecule imaging studies reported that IDRs impact nuclear diffusion but not genome binding (Callegari et al., 01 2019; Mazzocca et al., 2023). A single-molecule footprinting assay found that a strong activation domain can increase TF occupancy (Doughty et al., 2024). Together, these studies demonstrate how long IDRs or activation domains modulate chromatin binding.</p><p>In this study, we asked whether short activation domains within an IDR are sufficient to control chromatin association. While both DBDs and activation domains contribute to DNA binding and chromatin binding, the relative magnitude of these contributions cannot be predicted and must be measured. Activation domains recruit remodelers, like BAF, which move nucleosomes (Kadoch and Crabtree, 2015), coactivators, like p300/CBP, which modify chromatin (DelRosso et al., 2024; Dyson and Wright, 2016), and general transcription components like the Mediator complex (Currie et al., 2017; Henley et al., 2020; Lauberth et al., 02 2013; Malik and Roeder, 2010; Tang et al., 07 2013) that recruits RNA polymerase II (Alerasool et al., 2022; Gill et al., 1994). Although mechanistic understanding of activation domains still lags far behind DBDs, recent screens have cataloged many activation domains (DelRosso et al., 2023; Erijman et al., 2020; Morffy et al., 2024; Sanborn et al., 2021) and shown how the strength of acidic activation domains, the oldest and largest class (Sigler, 05 1988), depends on a balance of acidic, aromatic, and leucine residues (DelRosso et al., 2023; Staller et al., 2022, 2018; Udupa et al., 2024). For consistency, we define activation domain strength as the fluorescence of a GFP reporter construct driven by a heterologous promoter.”</p><p>In addition, we made minor changes to two paragraphs in the discussion:</p><p>“How a TF binds the genome is controlled by both DBDs and IDRs, but it remains difficult to predict the relative contributions of these two regions. We demonstrated that very short activation domains can control the fraction of TF molecules bound to chromatin, sometimes accounting for more binding than the DBD. Mutations that increase activation domain strength in reporter assays increase the fraction of molecules bound to chromatin. Conversely, mutations that decrease activation domain strength decrease the fraction of molecules bound to chromatin. This trend holds for allelic series of four acidic activation domains, for three structurally diverse DBDs, and for synthetic and full-length TFs.”</p><disp-quote content-type="editor-comment"><p>3. Regarding the key concept of modularity of DNA-binding and activation domains, the authors have invented ideas that were not expressed or even contemplated in previous papers. The original papers on modularity were concerned with specific DNA-binding and transcriptional activation. They were published well before the concept of co-activators, and indeed the prevailing view based on bacterial activators is that activation domains would contact some component of the basic Pol II machinery. Indeed, there were numerous experiments claiming that various general factors (e.g. TBP, TFIIB, TFIIA) were the target. These early papers establishing modularity were also well before any connection to chromatin, and at the time, chromatin was largely ignored in the gene expression field. Eventually, it became clear that activation domains not only stimulated transcription directly (mostly through Mediator) but also indirectly through chromatin via Swi/Snf and SAGA. The connection of activation domains and chromatin is 30 years old, so using early papers on modularity to claim that activation domains had nothing to do with chromatin is historically unfair. And, this 30-year connection between activation domains and chromatin-modifying activities is what renders the results in this paper entirely predictable.</p></disp-quote><p>We have removed the rhetoric about transcription factor modularity (see above.)</p><p>We were genuinely surprised by our result. We expected chromatin binding to be controlled by the long, intrinsically disordered regions between DBDs and activation domains, as shown by (Brodsky et al. 2020; Chen et al. 2022). Brodsky showed for Msn2 that the activation domains were not responsible for genome localization (Brodsky et al. 2020).</p><p>We think the main value of our paper is quantitatively measuring relative contributions of the DBD and very short activation domains on chromatin binding under physiological conditions in live cells. The magnitude of the activation domain contribution could not be predicted <italic>a priori</italic>.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The authors have satisfactorily addressed my comments.</p><p>In particular, the addition of CUT&amp;RUN experiments clarifies that swapping ADs only slightly impacts where the TF will bind, but rather modulates binding frequency and/or stability at pre-determined sites. I think that this result should be highlighted at the end of the introduction. Also, as a minor point I would be curious to see if the motifs bound by the different TFs variants are identical, an observation that could further support their observation.</p></disp-quote><p>Thank you for these comments and suggestions. We have looked for motifs in the CUT&amp;RUN data with MEME using scrambled sequences as the controls. We did not find anything that jumped out at us. All the TFs share runs of A’s, which could be nucleosome repelling sequences.</p></body></sub-article></article>